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Abstract 
Development of an orally relevant biofilm disinfection model.  
 
This thesis describes the development and use of a novel microtitre plate biofilm 
system for testing the antimicrobial activity of test materials. The developed 
model is capable of high-throughput screening and furthermore the system has 
been shown to be stable and reproducible. The search for new antimicrobial 
agents for improved plaque control requires appropriate screening models. Key 
criteria for these models include; predictive of clinical data, orally relevant 
organisms (mixed species, bacteria present in biofilms), short contact time, rapid, 
reproducible and high throughput. The most widely used biofilm system for 
evaluating oral antimicrobials are the Constant Depth Film Fermentor (CDFF) and 
the Minimum Biofilm Eradication Concentration (MBEC) model systems. Each 
system has advantages for specific investingations; however neither and no other 
single system fulfils all of the criteria listed above.  The CDFF is an orally 
relevant model that mimics biofilm development under constant salivary flow; 
typically the inoculum is derived from human dental plaque.  Microbial analyses 
of in vitro growth show populations that are representative of in vivo plaque.  
However, the system is prone to contamination, is labour intensive and has limited 
capacity for testing multiple agents.  The MBEC model investigates the 
antibacterial susceptibility of attached bacteria to the 96-pegs on the lid of a 
microtitre plate based system.  Unfortunately, this model was not originally 
designed for use with oral bacteria; therefore, concerns exist for the use of the 
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MBEC with oral bacteria including the development of oral biofilms on non-
orally relevant surfaces such as polystyrene, as found in the MBEC pegs.  The aim 
of this project was to develop a microtitre plate based biofilm assay that could 
assess the effects of antimicrobials against orally relevant biofilms grown on a 
relevant surface and compare it to recognised standard model systems.  Biofilms 
derived from a defined inoculum were grown on hydroxyapatite-coated microtitre 
plate wells.  Biofilm characteristics were assessed and were shown to be 
reproducible and allow for high-throughput screening. Antimicrobial testing 
showed a dose response and known actives were able to be „ranked‟ in the same 
order as seen in clinical trials. This research has culminated in the development of 
a simple, high-throughput, reproducible „off-the-shelf‟ method for the rapid 
screening of antimicrobial compounds against an orally relevant biofilm. 
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1.1 Introduction 
Do Consumer Healthcare companies need another biofilm model? 
Current populations globally continue not only to grow but also increase in age. 
This is a global challenge brought on by better healthcare provision and diet, 
moreover, the challenge to ensure a lifetime of full dentition is one currently 
facing all that work in dentistry. Oral healthcare status is inextricably linked to the 
physical health of the individual.  More importantly, though less investigated, is 
the effect of dentition on the individual‟s quality of life. Therefore, it is a 
challenge for the dental industry and consumer healthcare companies not only to 
understand possible oral healthcare issues faced by an aging population, but how 
to, reduce or treat conditions, thus giving patients and consumers a better oral 
health status for greater quality of „later‟ life. 
 
Projections for 2025 suggest the global population expanding from the current 6 
billion to over 8 billion, with an average increase in life expectancy to 70-75 years 
for both sexes, in the next 25 years, according to the United Nations Population 
Division (United Nations Population Division, 2003). Some developed countries 
are already reporting average life expectancies to 80 years. A more recent study 
from the UNPD shows an unprecedented level of increase in „the proportion of 
older persons (that is, those aged 60 years or older) are accompanied by 
reductions in the proportions of children (persons under the age of 15). At the 
world level, the number of older persons is expected to exceed the number of 
children for the first time in 2045. In more developed regions, where population 
aging is far advanced, the number of children dropped below that of older persons 
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in 1998.‟ (United Nations Population Division, 2009). It is projected in 2050 that 
the proportion of the world population 60 years or older will be 22%, with nearly 
a third in that age bracket in developed countries (United Nations Population 
Division, 2009).  Peterson (2003) discusses how this change in population 
dynamic will need to be addressed to ensure continual improvement in oral health, 
in particular focussing on three main points 
 Oral health is integral and essential to general health 
 Oral health is a determinant factor for quality of life 
 Oral health and general health are strongly associated. 
The perception of quality of life requires understanding, not only of the tangible 
factors such as sensitivity, pain, ability to eat and talk, but also those factors 
which although present in everyone, have effects as individual as the individual 
themselves, such as the emotional and social aspects of oral health, from 
appearance and confidence, to self-esteem and social interaction. So the question 
is, what can we do to help?  
 
As described (United Nations Population Division, 2009) the aged population can 
be split into three broad but distinct groups, 
 The independent 
 The frail 
 The dependent 
Since the poorest healthcare status is in the latter 2 groups, key caregivers are 
instrumental in the overall wellbeing of the patient/consumer rather than the 
patient themselves. Therefore, it is paramount to support the primary key care 
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providers with knowledge and materials to help to continue to support 
improvements in the oral care status of these two populations, building and 
supporting the materials provided to and by the dental professional. Interestingly, 
there is a wealth of material provided for mothers of children, to help in the 
child‟s oral health provision, however, at the other end of the scale the material 
for primary care givers of the elderly is much scarcer.  The provision of training 
and education materials is only one side of the equation, there is an obvious 
opportunity as people are aging to meet their dental needs now that will secure the 
best possible dental outcome for their future.  This is where most of the dental 
challenges need to be met. 
 
In the latter part of the 20
th
 century, substantial efforts were made to prevent, or 
reduce dental caries and these efforts resulted in a marked decline in caries 
incidence in Western Europe and North America, largely attributed to the use of 
fluoride in various forms and fluoride toothpastes in particular. Wherever fluoride 
has been widely used, it has reduced caries incidence substantially. It has been 
estimated that the ~25% reduction in caries effected, in adults, by the daily use of 
fluoride toothpastes during many caries clinical trials (Marinho et al. 2003, 
Griffin et al. 2007) typically of 3 years' duration. However, caries remains 
ubiquitous in populations globally; indeed; it is the most common chronic disease 
worldwide, even in developed market economies, where the use of fluoride 
toothpastes has been the norm for decades. Although the phrase ‟caries 
prevention‟ is often used, „caries postponement‟ might actually be a better 
description. Thus, it can be deduced that caries will develop, only later in life. 
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Therefore with fluoride only achieving half of the equation, it is paramount that 
the bacteria responsible for caries development and progression be addressed also. 
 
The human oral cavity contains a number of different surfaces each providing a 
unique physiological environment for bacterial colonisation and biofilm (plaque) 
development. The physical removal of plaque bacteria by brushing is the main 
contributor to the maintenance of healthy teeth and gums. Increasing the numbers 
of bacteria removed and/or killed during brushing is an approach favoured by 
many healthcare companies via the addition of effective antimicrobial agents to 
oral care products. Therefore, there is an on going need to identify novel 
antimicrobial agents that can be incorporated into oral healthcare products e.g. 
dentifrices and mouthrinses. 
 
The search for new antimicrobial agents for improved plaque control requires that 
appropriate screening models be put in place. Key criteria for these models 
include; 
- Results should be predictive of clinical outcome 
- Orally relevant organisms (including mixed species if possible)  
- Bacteria should be present in biofilms 
- Short, relevant contact time should be used 
- Reproducible methodology 
- Rapid and high throughput (~800 screenings/year) capacity 
This introduction will therefore consider general biofilms, their importance and 
why we need to be concerned with them. Moreover, it will focus on oral biofilms 
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specifically, biofilm diseases, properties of biofilm and how we as researchers can 
visualise, and model oral biofilms. Finally, the chapter will focus on the pros and 
cons of these models systems and discuss how the model system that has been 
developed addresses these deficiencies and subsequently discuss the future 
possibilities for this model system. Below is an overview of biofilms and their 
importance in bacterial survival. 
 
1.2 General Biofilm Overview 
The survival of microorganisms in various environments is dependent on their 
ability to attach/adhere to surfaces and subsequently their development into a 
biofilm. This mode of growth provides bacteria many resistance strategies to 
antimicrobial challenges and fluctuations in their environment. It is therefore, 
particularly difficult to remove or disrupt biofilms via either chemical or 
mechanical means. 
 
1.2.1 Definition of a Biofilm 
A biofilm consists of a community of microorganisms enclosed in an extracellular 
polysaccharide (EPS) matrix which helps retain bacteria at the surface. This mode 
of growth is distinguishable from planktonic organisms by a number of different 
characteristic features, including: metabolic collaboration between organisms and 
co-operation to retain homeostasis (Costerton et al., 1995), cell-to-cell signalling 
(Cooper et al., 1995) and resistance to antimicrobial agents of up to 
  
 
43 
 
concentrations 1000 greater than that required to kill planktonic organisms 
(Anwar et al., 1989; Lewis, 2001).  
 
1.2.2 Development of a Biofilm 
Once cells have attached to a substratum, growth and division occurs and the first 
step of biofilm development occurs, the formation of micro-colonies as in Figure 
1.  
 
 
Figure 1. Schematic and micrographs of biofilm development from initial attachment (1), 
microcolony development (2,3) through to biofilm development (4,5). In this example there is 
shown release of planktonic cells and re-colonisation (5-1). 
Reproduced with kind permission from Dr D. Davies, Binghamton University, New York 
 
Bacteria will attach to a substratum by either single or multiple processes 
including ionic interaction, hydrogen bonding (Pimentel and McClellan, 1960) 
and hydrophobic interactions (Duncan-Hewitt, 1990). These mechanisms are 
commonly referred to as being non-specific interactions (Busscher and 
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Weerkamp, 1987). In addition, adhesion to a surface can also be frequently 
stereospecific, such as the interactions between carbohydrates and lectins (Ofek et 
al., 1977); these are termed specific interactions. Surface-associated molecules 
which aid in stereospecific adhesion to a substratum are termed adhesins. 
Adhesins can be found on a number of bacterial surface associated appendages 
such as fimbriae, capsules, flagella, outer membranes amongst others (Coutte et 
al., 2003; Kolenbrander et al., 2006). These adhesins, located at a distance from 
the main bulk of the cell, enable the bacterium to overcome an energy barrier to 
adhesion. This barrier was predicted by the DLVO theory (Derjaguin and Landau, 
1941; Verwey and Overbeek, 1948). Adhesins of bacteria (may) adhere to 
receptors on the substratum. 
 
1.2.2.1 Effect of Surface Properties on Biofilm Development 
Chemical and physical properties of the underlying substratum can affect the 
development of an acquired pellicle including its composition, density and 
configuration. These changes in the physico-chemical properties of the acquired 
pellicle may influence bacterial attachment and subsequent biofilm development.  
 
1.2.2.1.1 DLVO Theory 
The DLVO theory (Derjaguin and Landau 1941; Verwey and Overbeek 1948) 
approach to bacterial attachment is based upon simple colloidal interactions such 
as charge and dipole-dipole interactions. Typical force-distance curves derived 
from DLVO theory, where a positive G represents a repulsive force between the 
surface and bacterium is shown in Figure 2.  These force-distance curves are the 
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product of two separate competing forces, that of van der Waals attraction and 
ionic repulsion. Hence, the overall force curve is dependent upon the relative 
contributions of these separate forces.  At large separations between the bacterium 
and the surface, there is no net attractive or repulsive force acting.  However, as 
the surface and bacterium approach there is a mild attractive force generated from 
van der Waals forces (dipole-dipole interactions).  The strength of this attraction 
increases in proportion to the reciprocal of the separation distance as the 
bacterium approaches the surface in accordance with Hamaker theory (1937), 
leading to a net attractive force at the secondary minimum.  While the importance 
of the secondary minimum to weakly flocculated colloid gels has been well 
described, its role in bacterial attachment to surfaces is relatively poorly 
understood (Redman et al., 2004). At smaller separations, the overlap of the 
diffuse double-layer charges of the surface and the bacterium can have a repulsive 
effect if (as is often the case) the bacterium and the surface are both similarly 
negatively charged.   
G
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Primary minimum
Secondary minimum
Maximum
0
+
-
0
G
Separation
Primary minimum
Secondary minimum
0
+
-
0
(a) (b)
 
Figure 2. Schematic of DVLO curves for systems with high (a) and low (b) electrostatic repulsion 
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This repulsion tends to be relatively strong at medium separation compared to the 
van der Waals attraction and generally leads to a prominent repulsive maximum 
element in the DLVO curve (fig 2a) restricting the ability of the bacterium to 
approach the surface.  If the bacterium has sufficient energy to overcome this 
electrostatic repulsion barrier there is, at short separations, a net attraction (the 
primary minimum) between the bacterium and surface which will lead to contact 
of the two.  It should be noted that this attachment process is driven entirely from 
an energetics perspective and as such is a reversible process.  Further it describes 
idealised „simple‟ cells and surface, and thus doesn‟t consider adhesion-receptor 
interactions. 
 
1.2.2.1.2 Surface Properties 
Most bacterial cells display a net-negative charge at neutral pH (Jucker et al., 
1996), although this charge is usually reduced as the pH is lowered owing to 
neutralisation of acid groups on the surface of the bacteria (Hayashi et al., 2001).  
This negative charge will hinder bacterial attachment to negatively charged 
surfaces due to charge-charge repulsions.  Most surfaces are negatively charged in 
aqueous environments as a consequence of cations being generally more solvated 
than anions which are more generally associated with the surface (Shaw, 1986).  
Therefore, in most cases at neutral pH there is a net electrostatic repulsion 
between the surface and the bacterium leading to DLVO curves similar to fig 2a.  
However, if the pH is lowered to below the pKa of the bacterium or surface 
(Horka et al., 2006) the electrostatic repulsion will diminish, leading to curves 
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more similar to fig 2b, where van der Waals attractions dominate (Abu-Lail and 
Camesano, 2003). Similarly, the electrostatic repulsion may be strongly reduced 
by increasing the ionic strength of the solvent.  In the case where the charge of the 
bacterium is positive, strong attraction to negatively charged surfaces has been 
observed under conditions where negatively charged bacteria were still repelled 
from the surface (Jucker et al., 1996).  Work has also shown bacterial adsorption 
could be increased on negatively charged polymethyl methacrylate (PMMA) 
surfaces, by varying the concentration of a positively-charged co-polymer 
(Kiremitci-Gumusderelioglu and Pesmen, 1996). 
 
Of most interest in the development of model systems is where polyelectrolytes or 
surfactants (Olsson et al., 1991) are physisorbed to the surface so reversing or 
reducing the charge of the surface.  Of particular concern for oral biofilm models 
is the role of the salivary pellicle, a proteinacious layer that can be detected within 
30s of placing clean enamel in saliva (Vacca Smith and Bowen, 2000).  This 
pellicle effectively reverses the charge of the surface since positively charged 
proteins provide the initial attachment to the surface.  The pellicle can therefore 
reduce the repulsive aspects of the DLVO force-curve, promoting bacterial 
adhesion (Shimotoyodome et al., 2007). Hydrophobicity of the surface can also 
affect bacterial adsorption, either directly or by affecting the adsorption of a 
proteinaceous pellicle (Sethuraman et al., 2004).  Tegoulia (2002) showed that 
adhesion of Staphylococcus aureus to surfaces generally increased as the 
hydrophobicity of the surface was increased.  Triandafillu and co-workers (2003) 
showed that treatment of a PVC surface with oxygen plasma reduced its 
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hydrophobicity and subsequently reduced bacterial adhesion.  These hydrophobic 
effects have been rationalised by Rijnaarts et al. (1999) as due to reduced 
reversibility of the bacterial adsorption.  Unlike hydrophilic surfaces, once a 
hydrophobic bacterium adhered to a hydrophobic surface it was not able to 
detach.  Such strong binding of bacteria to hydrophobic surfaces can be explained 
by a hydrophobic dehydration mechanisms (Norde and Lyklema, 1991). 
 
The physical properties of surfaces have also been investigated to determine the 
effect of topography on bacterial attachment (Quirynen et al., 1990; Taylor et al., 
1998), retention (Nyvad and Fejerskov, 1987), subsequent biofilm development 
(Pratten et al., 2003) and susceptibility to test agents (Korber et al., 1997).  The 
effect of surface roughness has been evaluated for its effect on food processing 
(Korber et al., 1997), denture and implant manufacture (Taylor et al., 1998) and 
dental plaque development (Bollen et al., 1997; Quirynen et al., 1990; Charman et 
al., 2009). Figure 3 shows an increase in Streptococcus oralis attachment to 
acrylic with increase in surface roughness. 
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Figure 3 Photomicrographs showing bacterial attachment on acrylic samples with differing Ra 
values, after 60 min incubation. (a) Ra 0·07 μm; (b) Ra 0·38 μm; (c) Ra 1·14 μm. Scale bar = 50 μm 
(Charman et al., 2009) 
 
Surface roughness (Ra) is usually characterised as the sum of departure of the 
mean of the profile from the mean line (see Figure 4).  
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Figure 4. Schematic of surface topography where Ra = arithmetic average roughness. 
 
To fully understand the implications of Ra on bacterial attachment, the surface 
area should also be taken into consideration.  Figure 5 shows two graphs which 
have the same Ra, however, the surface areas are very different.  Increased surface 
area may assist the retention of organisms on these surfaces due to the increase in 
contact points (Whitehead et al., 2006).  
 
 
Figure 5 Different surface areas may produce the same Ra. In this example image (a) has the 
smaller surface area than (b), but both still have the same Ra value. 
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There are a number of key parameters that will determine biofilm attachment, 
retention, subsequent growth and potential effects.  Below is a summary of the 
effects of biofilms in medicine. To understand the biofilm structure is a potential 
route to understanding a treatment against it.  
 
1.2.2.2 Biofilm Structure and Form 
In vitro biofilm structure is determined by available nutrients, substratum, 
organisms present and incubation conditions.  Changes in any one of these 
parameters will affect bacterial growth and biofilm development, thus affecting 
biofilm structure.  Co-aggregation is a specific bacteria-to-bacteria adhesion 
which plays a critical role in the development of a multispecies biofilm.  
Coaggregation is controlled through specific adhesion interactions (Rickard et al. 
2000; Rickard et al. 2004) with planktonic cells showing a decrease in 
coaggregation compared with their biofilm counterparts (Rickard et al. 2003).  
This offers an advantage metabolically, as Bradshaw et al. (1998) discovered to 
obligate anaerobes living in an oxygen containing environment.  Using 
fluorescent in situ hybridisation (FISH) to determine the location of bacteria held 
within the EPS matrix (Costerton et al., 1995) in conjunction with confocal 
scanning laser microscopy to reveal the overall structure (Auschill et al., 2001; 
Wood et al., 2000), it has been shown that biofilms are highly structured and 
contain water channels, which have been proposed as a simple circulatory system 
(Costerton et al., 1995).  This open system allows transport of nutrients and 
solutes to the bacteria and can excrete molecules away from the cell.  The most 
viable cells are found to be lining these voids and channels (Auschill et al., 2001).  
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It is reported that EPS matrix forms 75-80% volume of the biofilm (Socransky 
and Haffajee, 2002).  EPS plays a prominent role in bacterial retention at a 
surface.  Not only does the EPS form the sticky matrix that can ultimately regulate 
the structural component of the biofilm, but it may also affect initial attachment 
(see Figure 6).  Tsuneda (2003) compared attachment of 27 bacterial strains 
correlating those expressing high EPS with greater adhesion onto glass beads.  
The authors ascribe this effect as being due to the polymer interacting between the 
surface and the bacterium like a tether.  Such polymeric interactions, often 
referred to as steric interactions, can cause strong attractive bridging when the 
polymer has a high affinity to the surface.  It is estimated that of the total organic 
carbon content of biofilms, 50-90% comes from the EPS (Flemming et al., 2000) 
with 40% of the dry weight of dental biofilms being polysaccharide in nature 
(Paes Leme et al., 2006).  
 
 
Figure 6. The morphology of a biofilm can vary from a compact and smooth layer to a very 
diffuse layer, depending on a number of factors such as shear, nutrient availability (image taken 
from http://www.delftoutlook.tudelft.nl/info/indexe0ee.html) 
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Hence to evaluate the efficacy of novel test agents, relevant biofilms should be 
employed to determine the active concentrations which may be required to 
eliminate the organisms growing within these structures, as it is well reported that 
the formation of biofilms by the organisms confers increased antibacterial 
resistance. 
 
1.2.3 Antimicrobial Resistance of Biofilms 
Biofilms have been shown to be more resistant when under an antimicrobial 
challenge compared with planktonic cultures of the same organism (Costerton et 
al., 1995; Larsen and Fiehn, 1996; Wilson, 1996).  This has been found to be as 
much as 1000-fold increase in resistance (Mah and O‟Toole, 2001).  Biofilms 
have shown responses including incomplete penetration of antimicrobial agents 
through the biofilm, which prevents the antimicrobial from reaching its target, 
reduced metabolism of bacterial cells due to changes in microenvironments, 
slower growth rate and expression of novel phenotypes at the surface (Mah and 
O'Toole, 2001; Stewart and Costerton, 2001; Szomolay et al., 2005).  
 
Current reasoning behind why biofilms are more resistant to antimicrobials than 
their planktonic counterparts focuses on two mechanisms, either innate or 
adaptive (Anderson and O‟Toole, 2008).  It is postulated by Anderson and 
O‟Toole that induced resistance has been shown to exist within biofilms, 
however, the main protective mechanisms seem to be innate defences.  
Interestingly, it is known that bacteria which are found in a biofilm can exhibit 
different phenotypes. As stated by Roberts and Mullany (2010), “Most pathogens 
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do not intrinsically contain resistance genes, as has been demonstrated by the 
numerous completed genome sequences of pathogenic bacteria, and it is only the 
acquisition of such genes that leads then to become the multiple antibiotic-
resistant bacteria that are the scourge of modern healthcare.”  Therefore, 
understanding the transfer of these resistance genes within biofilms is of great 
interest to help reduce, and prevent biofilm re-growth. 
 
1.2.3.1 Innate Response - Incomplete Penetration 
Penetration of antimicrobials through the whole biofilm structure is paramount for 
the destruction of all viable bacterial cells and preventing biofilm regrowth.  As 
discussed previously, biofilms are covered in an extracellular polymeric substance 
(EPS).  This material, although containing a number of different materials, such as 
DNA and protein (Donlan and Costerton, 2002), is largely negatively charged and 
very effective at reducing the penetration of positively charged antimicrobials, 
potentially via electrostatic binding (Ishida et al., 1998; Shigeta et al., 1997).  
Retardation of the antimicrobial within the matrix might develop concentration 
gradients across the biofilm.  Thus, there is the potential to retain the 
antimicrobial/antibiotic at sub-MIC levels towards the „core‟ of the biofilm which 
has been studied widely (Suci, 1994; Donlan and Costerton, 2002; Walters et al., 
2003).  Interestingly, in a number of studies, it was observed that the leading 
biofilm edge showed reduced viable bacterial numbers. However, even with the 
penetration of the test agent throughout the biofilm, bacterial viability was not 
drastically impacted (Walters et al., 2003; Zheng and Stewart, 2002).  
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Furthermore, it should be noted that some researchers have identified a number of 
antibiotics which can increase EPS formation.  Rachid et al. (2000) showed that 
sub-inhibitory concentrations of erythromycin, tetracycline and quinupristin-
dalfopristin caused Staphylococcus epidermidis gene expression of the 
polysaccharide intracellular adhesin to be activated; the effect of this was seen in 
microtitre plates which revealed an increase in biofilm formation.  This 
mechanism seems to differ, dependent on the organism under investigation.  Up-
regulation of alginate expression was seen when Pseudomonas aeruginosa was 
exposed to sub-inhibitory concentrations of imipenem (an intravenous β-lactam 
antibiotic) (Bagge et al., 2004b).  This raises an interesting predicament as 
discussed by Anderson and O‟Toole (2008); “It is intriguing to speculate that 
limited antibiotic diffusion through the biofilm matrix, coupled with a 
corresponding decrease in antimicrobial concentration might actually stimulate 
the biofilm formation in some instances by creating a positive feedback loop.” 
 
1.2.3.2 Innate Response - Persister Cells 
Persister cells were first described in 1944 (Bigger, 1944) as a mechanism for 
survival, however, the mechanism itself is still not fully understood.  Bigger found 
that when treated with lethal concentrations of penicillin, a small fraction, found 
to be 1 in 10 of the
 
colony forming units of the original concentration or less, of 
Staphylococcus aureus survived. Surprisingly, if these organisms were cultured 
and exposed to the penicillin again, they had reverted to being sensitive to the 
antibiotic. Little research was carried out in this area until recently, when a 
relationship between the growth rate of the organisms and antibiotic sensitivity 
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was found (Trumanen et al., 1986; Aridesi et al., 2003). Interestingly a 
mathematical model was employed by Roberts and Stewart (2004) to investigate 
the effect of antibiotic challenge on biofilms with respect to changing localised 
nutrients and growth rates.  This supported and confirmed the findings that 
nutrient availability and growth rates may be critical in the resistance to antibiotic 
challenges.  However, evidence does exist to show that persister cells can survive 
even after exposure to ofloxacin, which has been shown to kill non-growing 
organisms (Kaldalu et al., 2004), therefore, concluding that slow growth rates 
cannot be the only survival mechanism at work for persister cells. 
 
1.2.3.3 Adaptive Responses 
Environmental stresses have been investigated for their effect on biofilms and 
planktonic cultures with respect to stress-response genes.  This work has shown 
that the organisms can revert to more tolerant phenotypes under stress such as low 
nutrients, cell density, pH, temperature and osmolarity (Novick, 2003).  There is 
mounting evidence that biofilms can demonstrate different adaptive responses to 
antimicrobial stress (Szomolay et al., 2005).  These adaptive responses include an 
increase in EPS synthesis in response to antimicrobial challenge (Sailer et al., 
2003), as previously discussed.  An example of a specific response is an increase 
in catalase production by P. aeruginosa during exposure to 50mM hydrogen 
peroxide (Elkins et al., 1999; Sailer et al., 2003).  Similarly, β-Lactamase 
production and potentially efflux pumps may help biofilms during an 
antimicrobial challenge (Anderl et al., 2000; Bagge et al., 2004a, 2004b; Denkard 
and Ausubel, 2002).  However, these systems have been disregarded as important 
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in biofilm resistance but do play an active role in planktonic cell antibiotic 
resistance (Patel, 2005; Stewart and Costerton, 2001). 
 
1.2.3.3.1 Genetic Variability 
Roberts and Mullany, (2010), present a clear and concise overview of the 
mechanisms of gene transfer, this can be found in Table 1.  
 
Table 1. Mechanisms of gene transfer among bacteria (modified from Roberts and Mullany, 2010) 
Mechanisms used in DNA transfer between cells 
- Transformation 
- Conjugation 
- Transduction 
Transformation: Uptake of available DNA from the surrounding environment. 
Conjugation:       Sharing of DNA between viable cells 
Transduction:    DNA taken up by a bacteriophage subsequently deposited in a 
secondary cell. 
 
A second key consideration which aids gene transfer is the close proximity of 
mixed species in a biofilm (Roberts and Mullany, 2010).  The extent of this 
exchange of genetic information was discovered in a study carried out by 
Lancaster et al. (2003) and Ready et al. (2003) on children‟s oral microbiota 
where antibiotic resistance genes could be identified.  Lancaster found that 98% 
of children in their study carried tetracycline-resistant bacteria. 
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When grown in a biofilm, Yamanake et al. (2009) showed that Prevotella 
intermedia strains showed different genes to be either positively or negatively 
regulated in comparison to when grown planktonically.  Even within a biofilm, 
bacteria can express the same genes at different levels (van der Woude, 2005).  
Such switching offers a route to evade, in this instance, the immune system 
(Deitsch et al. 1997). Phase variation, as this is termed, can not only be used by 
organisms to evade the immune response.  Escherichia coli outer membrane 
protein, Ag43, aids in biofilm formation (Pratt and Kolter, 1998; Danese et al., 
2000; van der Woude and Baumter, 2004).  Subsequent studies show that if Ag43 
was affected by phase variation, biofilm formation was impacted (Schembri and 
Klemm, 2001; Wallecha et al. 2003; Holden and Gally, 2004).  Therefore, this 
raises the question, if indeed biofilms offers better protection against external 
challenges, what is the benefit of phase variation of Ag43 if it places the cell, 
potentially in the path of the immune system. 
 
As discussed above, all these points above require consideration when trying to 
address biofilms, in particular those associated with disease.  Bacteria have 
developed a number of routes to evade either the immune system or chemical and 
physical removal.  This is of course a concern as the impact of biofilms 
economically, physically, and less studied, mentally is immense.  
 
1.2.4 Importance of Biofilms 
Medical biofilms can increase the morbidity and mortality of affected individuals 
and are usually found either associated with medical implants (Donlan and 
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Costerton, 2002) or disease states such as open wounds, cystic fibrosis, colitis, 
vaginitis, urethritis, conjunctivitis and dental plaque to name a few (Chernish and 
Aaron, 2003; Holby et al., 2005).  In 2007, The Centers for Disease Control and 
Prevention Report stated “In American hospitals alone, healthcare-associated 
infections (i.e. nosocomal infections) account for an estimated 1.7 million 
infections and 99,000 associated deaths each year.  Of these infections: 32% of all 
healthcare-associated infections are urinary tract infections; 22 per cent are 
surgical site infections; 15 per cent are pneumonia (lung infections); and 14 per 
cent are bloodstream infections”.  Persistence of biofilms, as discussed previously 
has serious implications for the patient due to the decrease in antibiotic 
susceptibility.  Interestingly, some of the topics discussed previously, where the 
biofilm may, as a consequence of exposure to an antibiotic, increase biofilm 
volume (Bagge et al., 2004b).  This would be detrimental to, for example, a 
patient suffering cystic fibrosis.  
 
In this next section we will briefly cover the effect of oral biofilm, where the 
economic, social and personal burden can be challenging.  It is reported by the 
World Health Organisation, that oral disease is the 4
th
 most expensive disease to 
treat in industrialised countries, with 60-90% of school children globally suffering 
dental caries (WHO Factsheet 318, 2007).  In England alone, in 2006 the National 
Health Service spent £1977M in dentistry for dental treatments and disease 
prevention, this equates to £39 per head of population (NHS Report, 2008). 
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Therefore, having the ability to efficiently and effectively screen actives against 
orally relevant biofilms is a key challenge for industry to help address patient‟s 
and consumer‟s oral care needs, before treatment is sought.  
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1.3 Oral Biofilms Overview 
The human oral cavity contains a number of different surfaces each providing a 
unique environment for bacterial colonisation and biofilm development.  
Molecular techniques have now identified over 630 different bacterial species in 
the oral cavity (Kazor et al., 2003), and more recently using 454 pyrosequencing 
Zaura et al. (2009) identified over 3600 unique sequences within an individual 
oral cavity. 
 
The main surface that harbours the bulk of the oral bacterial numbers is the 
tongue, with its unique papillary structure and large surface area (Jacobson et al., 
1973), estimated at approximately 107.5cm
2 
(Collins and Dawes, 1987) or 50% of 
the total oral cavity surface area.  In contrast, it is estimated that the teeth 
comprise 20% of the oral cavity surface area (Collins and Dawes, 1987).  The 
tooth/gum structure also allows the development of two further distinct 
environments, supragingival (above the gingival margin and interdental) and 
subgingival (below the gingival margin in the gingival pocket).  
 
Bacterial colonisation of these environments is selective due to the expression of 
specific adhesins that are complementary to different receptors found at these sites 
(Gibbons et al., 1976b; Gibbons, 1989).  This specificity leads to the development 
of specific biofilms associated with each of these environments, which if left 
untreated, can lead to the development of site specific oral conditions.  The oral 
cavity is inevitably prone to colonisation by microorganisms because of its warm, 
moist environmental conditions.  However, under normal/healthy conditions, no 
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invasive infections of the tissue occur (Dommisch et al., 2005).  This is due, in 
part to the defence mechanisms of the oral epithelium.  The oral epithelium acts as 
a barrier to infection.  It also produces antimicrobial peptides called defensins of 
which there are two classes, α and β.  Defensin production is not exclusive to the 
oral epithelium; they are produced by epithelial cells of all mucous membranes in 
the body.  These peptides have a high number of basic amino acid residues which 
give them a positive charge (Dommisch et al., 2005).  Defensins form aggregates 
within the membrane of the organism, resulting in formation of pores.  This 
results in osmotic shock and ultimate death of the pathogen, (Dommisch et al., 
2005).  Three subtypes of human β-defensins, (HBD), have been identified to 
date, called HBD -1, -2, -3.  HBD-1 has antimicrobial activity against gram-
negative bacteria, (Goldman et al., 1997), HBD-2 has antimicrobial activity 
against gram-negative bacteria and some fungi (Harder et al., 1997), while HBD-3 
has antimicrobial activity against both gram-negative and gram-positive bacteria 
(Harder et al., 2001). 
 
1.3.1 Supragingival Plaque 
Supragingival plaque is the result of biofilm development above the gingival 
margin on the tooth surface (this also includes interdental biofilms).  As this 
surface, unlike any other in the body, is non-shedding, therefore, physical and 
chemical means are required to remove accumulated plaque Table 2 shows the 
proportions of bacteria found in accumulating supragingival plaque and how the 
population changes over time.  
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Table 2 Supragingival plaque – Proportions of bacterial species over time (Marsh and Martin, 
1992) 
Bacterium Hours of plaque development 
2 4 6 
S. sanguinis (formerly 
known as S. sanguis)  
8 12 29 
S. oralis 20 21 12 
Mutans streptococci 3 2 4 
S. salivarius <1 <1 <1 
Actinomyces viscosus 6 7 5 
A.  naeslundii 1 1 3 
A. odontolyticis 2 3 6 
Haemophilus spp. 11 18 21 
Capnocytophaga spp. <1 <1 <1 
Fusobacterium spp. <1 <1 <1 
Black-pigmented 
anaerobes 
0 <0.01 <0.01 
 
 
Within the first 24-hours of colonisation, oral streptococci have been shown to 
make up 60-90% of supragingival plaque (Mager et al. 2003; Nyvad & Kilian, 
1987).  However, this is contradicted by Li et al. (2004), who found that during 
early biofilm formation Actinomyces spp. are predominant.  Interestingly, where 
Streptococcus mutans is often discussed as the main aetiological agent associated 
with the development of caries (Kreth, 2005; Marsh, 1995b), Streptococcus 
salivarius is often associated with building stability in the biofilm matrix via 
lactose uptake and urease enzymes (Chen et al., 1996; Sissons and Yakub, 2000) 
and with this stability prevent colonisation by opportunistic pathogens (Tada et 
al., 2006; Uehara et al. 2001). 
 
Initial bacterial colonisers do not adhere to the tooth surface, rather they adhere to 
the salivary / dietary derived conditioning film (Dawes et al., 1963).  In the oral 
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cavity this conditioning film and the molecules contained within it act as receptors 
for bacteria to attach (Gibbons et al., 1976a; Gibbons, 1989).  This pellicle 
contains components from the shedding mucosa, saliva and diet and includes 
lysozyme, glycoproteins, phosphoproteins, albumin, lipids and gingival crevicular 
fluid (Marsh, 1995a; Teughels et al., 2006).  The conditioning film affects the 
order of microbial colonisation (Marsh, 2004).  Figure 7, shows the localisation of 
bacteria within supragingival plaque, with respect to the tooth surface. 
 
 
Figure 7 Localisation of the main bacteria found in supragingival biofilms. Bacteria double 
stained with probe EUB338 labelled with FITC or Cy3. Bars are 10 µm , taken from Zijnge 
(2010). Image highlights different stratification that occurs within supragingival biofilms from the 
tooth out towards the oral cavity. 
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1.3.1.1 Caries 
In the latter part of the 20
th
 century, substantial efforts were made to prevent or 
reduce dental caries.  These efforts resulted in a marked decline in caries 
incidence in Western Europe and North America, largely attributed to the use of 
fluoride in various forms and fluoride toothpastes in particular.  
 
As discussed previously, Li et al., (2004) found that during early biofilm 
formation, Actinomyces spp. are predominant.  However, the microbiota shifts 
during colonisation and at 24 hours, streptococci make up 60-90% of dental 
plaque (Marsh and Martin, 1999; Nyrad and Kilian, 1990).  It has been shown that 
S. mutans is able to metabolise dietary carbohydrates to organic acids such as 
pyruvic or lactic acid (Cotter and Hill, 2003),  which in turn can lead to the 
development of carious lesions on enamel surface (Marsh, 1995b).  However, S. 
mutans is not the only aetiological agent associated with caries.  Various 
Lactobacilli sp. along with S. sanguinis some Actinomyces sp., and enterococci 
(Loeche, 1986; Ikeda et al., 1973; Nikiforkuk, 1985) have been shown to cause 
demineralisation of the tooth enamel, the initial stages of caries formation.  Caries 
incidence has also been linked to flow rates, pH, saliva buffering capacity, 
calcium, available protein and saliva antioxidant levels (Preethi et al., 2010). 
 
As with coronal caries, caries on root surfaces is also ubiquitous where root-
surfaces are exposed (Beck, 1993; Nunn, 2000; Stamm et al., 1990, Fejerskov et 
al., 1993; Fure and Zickert, 1990; Splieth et al., 2004; Kularatne and Ekanayake, 
2007).  It seems likely that individuals who have experienced coronal caries will 
  
 
66 
 
go on to develop root surface caries (Beck and Drake, 1997; Burt et al., 1986).  
The findings of a recent US survey suggest that older adults experience high rates 
of new caries (Griffin et al., 2004) and root-caries rates in adults can approach 
caries rates of children (Beck,  1993).  When caries susceptible root and coronal 
surfaces were compared, the rate of root caries was almost double that of coronal 
caries (Hand et al., 1988).  Although often considered a disease of the elderly, 
relatively high numbers of individuals in the 30-50 age-groups were found to have 
untreated carious root lesions (Fejerskov et al., 1993).  Therefore, prevention of 
caries is a lifetime challenge, especially as people are living longer. 
 
1.3.2 Subgingival Plaque 
Subgingival plaque is formed in the protected environment between the gingival 
margin and the tooth surface.  Due to this location, the main nutrition comes from 
gingival crevicular fluid (GCF), as well as potentially blood.  An anaerobic 
environment can develop and lead to a predominance of asaccharolytic species 
(Darveau et al., 1997).  GCF has been shown to contain a number of antimicrobial 
components as part of the innate immune response, which include lysozome, 
complement and vascular permeability enhancers such as bradykinin, thrombin 
and fibrinogen (Darveau et al., 1997).  Figure 8 shows the stratification of the 
organisms that can occur in subgingival plaque within the periodontal pocket. 
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Figure 8 Showing the stratification and location of commonly found organisms in subgingival 
plaque. Biofilms were double-stained with probe EUB338 labelled with FITC or Cy3. The yellow 
colour results from the simultaneous staining with FITC and Cy3 labelled probes. Bars are 10 µm,  
taken from Zijnge (2010). Showing stratification that occurs from the base of the sulcus towards 
the gingival margin. 
 
 
According to Socransky et al., (1998), this complex microbiota can be further 
defined into clusters of organisms; a diagrammatic representation can be found in 
Figure 9.  The authors (Socransky et al., 1998) discuss that their term „red 
complex‟ microbiota, are indicative of increased periodontitis lesions in adults 
(Hosaka et al., 1994; Umeda et al., 1996).  Interestingly, it has been shown that 
the species found in this red complex have been found to produce proteolytic 
enzymes, a contributing factor to periodontitis disease progression (Loesche et al., 
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1992), and have a strong capacity to co-aggregate (Grenier, 1992; Onagawa et al., 
1994; Yao et al., 1996). 
 
 
Figure 9 Diagrammatic representation of subgingival microbiota complexes (Socransky et al., 
1998). 
 
The „orange complex‟ has also been strongly associated with conditions that 
affect the periodontal pocket, such as mobile teeth (Grant et al., 1992), 
periodontitis, (von Troil-Linden et al., 1995), and infected root canals (Sundqvist, 
1992).  Investigations into bacteria associated with a healthy gingival crevice 
found that Streptococcus spp., Actinomyces spp., Capnocytophaga spp., 
Eubacterium spp., Fusobacterium spp. and Veillonella spp. predominate (Darveau 
et al., 1997; Listgarten, 1994). Africa (2010) have shown a correlation between 
the prescence of organisms found in these orange and red complexes and an 
increased risk of pre-term delivery of low birth weight infants. 
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1.3.2.1 Gingivitis 
Gingivitis is characterised by redness, swelling, bleeding gums on brushing or 
probing.  The formation of plaque results in an inflammatory response in the 
gingiva, causing a characteristic redness and swelling.  Swelling also results in 
increased leakage of gingival crevicular fluid, (GCF).  GCF is an inflammatory 
exudate composed predominantly of serum, but also contains immunoglobulin G, 
(IgG), immunoglobulin M, (IgM), leukocytes, albumin and other cellular 
components, (Lamont et al., 2006).  GCF washes the gingival crevice, helping to 
flush it free of bacteria and their metabolites many of which are toxic to the 
epithelial cells.  In healthy gingiva GCF flow is low, but in patients with gingivitis 
it has been shown up to 40 µL can be recovered in as little as 15 minutes, (Lamont 
et al., 2006). 
 
Gingivitis can develop within 10-21 days where oral hygiene regimes have 
stopped (Loe et al., 1966).  This can cause a shift to (Socransky et al., 1998) 
predominantly gram-negative anaerobes and spirochetes.  A number of 
bacterially-derived compounds can help elicit an innate immune response, 
including inflammatory mediators (Page, 1991).  This causes local inflammation 
and swelling of the gingivae, which leads to the characteristic appearance of 
gingivitis (Bernimoulin, 2003).  To the patient, gingivitis is characterised by 
bleeding gums when brushing (Pihlstrom et al., 2005).  
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The keratinized epithelial covering of the upper and lower alveolar ridges is 
termed the gingiva and it surrounds and supports the teeth.  In healthy individuals 
it is a pale pink colour.  Gingivitis is a non-specific inflammatory response by the 
gingivae to the non-specific build-up of plaque.  This condition is easily reversed 
by the removal of the built up plaque.  It has been reported that gingivitis can 
affect between 50-90% of adults globally from time-to-time (Albander et al., 
2002). 
 
Good oral hygiene procedures prevent the build-up and maturation of dental 
plaque and progression to gingivitis.  A wide range of oral care products have 
been developed with the aim of disrupting the plaque biofilm and aiding in its 
dispersal.  Many of these products contain antimicrobials in order to do this.  The 
current gold standard antimicrobial for use in oral care formulations is 
chlorhexidine which is typically delivered as a mouthwash.  However, to prevent 
gingivitis new actives should be sought that can be delivered a variety of routes to 
the oral cavity, e.g. toothpaste, gums. 
 
1.3.2.2 Periodontitis 
Periodontitis is more severe than gingivitis and results in the loss of both 
connective tissue and the surrounding bone, often leading to tooth loss.  The 
leading cause of periodontitis is the deepening of gingival pockets due to 
inflammation brought on by the presence of undisturbed plaque.  Interestingly, the 
disease is more prevalent in developing countries (van Palenstein Helderman et 
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al., 1996), with 22% of US adults reported to have mild disease, and 13% 
suffering more severe periodontitis (Albandar et al., 1999). 
 
Socransky and Haffajee (2003) highlight that the numbers of bacteria associated 
with supragingival plaque can exceed 1x10
9 
cfu, whereas a healthy gingival 
pocket typically contains 1x10
3
cfu.  Although, it is generally accepted that various 
organisms within subgingival plaque are associated with the development and 
progression of periodontitis, including Porphyromonas gingivalis, Tannerella 
forsythia, Treponema denticola and Aggregatibacter actinomycetemcomitans 
[SIC] (Socransky & Haffajee,2003; Newman et al., 1976), it is also becoming 
more evident that a number of key risk factors can aid in the development and 
progression of the disease, including several genetic conditions and environmental 
factors, such as smoking (Van Dyke and Sheilesh, 2005; Bergstrom, 2004; 
Michalowicz et al., 1991).  As recently discussed by Wade (2011), the 
identification of specific organisms associated with periodontitis can no longer be 
a key determination in treatment of the disease, rather the host immunological 
response to these organisms should be considered.  This is key when we consider 
findings by Taubman et al., (2007) who found susceptible individuals would 
initiate excessive immune responses to normal microbiota in the oral cavity. 
 
The prevention of periodontitis requires both the reduction and control of both 
bacteria and any associated risk factors.  The application of a good oral care 
regime and guidance from a professional oral care expert has been shown by 
Axelsson et al., (2004) to slow and stop periodontitis for many years, thus 
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reducing tooth loss.  If, however, periodontitis is present, professional treatment is 
required, often including tissue debridement in the affected periodontal pockets.  
If supported by antibiotic therapy, either local or systemic, this often ensures a 
positive outcome for the patient (Haffajee et al., 2003; Hung and Douglass, 2002). 
 
1.3.3 Tongue Biofilms 
The tongue surface is unique within the oral cavity due to its structure and large 
surface area. It has been proposed that the tongue is a reservoir for most salivary 
bacteria, including periodontal pathogens (Jacobson et al., 1973; Lee et al., 1999).  
The main species accredited with malodour formation within the oral cavity 
include Porphyromonas gingivalis, Prevotella intermedia, Fusobacterium 
nucleatum, Treponema denticola, Veillonella alcalescens, Tannerella forsythia, 
Peptostreptococcus spp., Eubacterium spp., Selenomonas spp. and Solobacterium 
moorei (De Boever et al., 1994; Greenman et al., 2005; Hartley et al., 1999; 
Kazor et al., 2003; Nakano et al., 2002; Spratt and Pratten, 2003).  These bacteria 
tend to reside in the crypts and fissures of the tongue (Greenman et al., 2005; 
Nakano et al., 2002) due to the low REDOX potential of this environment. 
 
It has been estimated that 50% of the population could suffer from oral malodour 
(Grigor and Roberts, 1992), particularly after waking (Sanz et al., 2001). 
However, only a small percentage of this population will suffer from clinical 
halitosis (Loesche and Kazor, 2002).  The main components of oral malodour are 
considered to be the volatile sulfur compounds (VSC), which are chiefly 
comprised of hydrogen sulfide, methyl mercaptan and dimethyl disulfide (Kazor 
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et al., 2003).  However, several other compounds add to the bouquet of oral 
malodour including putresine, cadaverine, indole, skatole, butyric and propionic 
acids (Quirynen, 2003; Spratt and Pratten, 2003).  
 
The production of malodourous chemicals are commonly associated with bacterial 
metabolism (Kazor et al., 2003; Koshimune et al., 2003) and the putrefaction of 
proteins by anaerobic gram-negative organisms (De Boever et al., 1994; 
Koshimune et al., 2003; Quirynen, 2003; Quirynen et al., 2004).  Orally generated 
malodour can be controlled by a number of methods including masking, 
inactivation of malodorous molecules or antimicrobial agents (Carvalho et al., 
2004; Young et al., 2003).  
 
1.3.4 Oral Biofilms and Systemic Health 
Recent research into periodontal disease is generating support for the hypothesis 
that there is an association between periodontal disease and systemic health, in 
particular, cardiovascular disease, adverse pregnancy outcomes, type-II diabetes 
and osteoporosis (Haraszthy et al., 2000; Kim and Amar, 2006; Loos et al., 2000).  
This arena is researched greatly and debated widely as it is a relatively new 
research arena with most correlations not being fully elucidated.  Interestingly, 
DNA from Tannerella forsythia (formerly Bacteroides forsythus), F. nucleatum, 
P. intermedia, P. gingivalis and Aggregatibacter actinomycetemcomitans 
(formerly Actinobacillus actinomycetemcomitans) have been recovered from 
carotid atheromatous plaques by Cairo et al., (2004).  It would be easy to try and 
imagine a correlation between osteoporosis and periodontal disease in that there is 
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a shared clinical feature between both conditions of bone loss.  However, little 
clinical correlation is available and any specific mechanism or association 
between both have not been fully elucidated.  It should be noted that both may 
share key risk factors such as, inflammation, obesity and smoking, in the 
development and progression of each disease (Jeffcoat and Chestnut, 1993; Page 
et al., 1985).  
 
1.4 Methods for Oral Biofilm Analysis 
1.4.1 Biofilm Visualisation Techniques 
1.4.1.1 Scanning Electron Microscopy 
Scanning electron microscopy (SEM) is widely used as a visual aid where high 
resolution and a large field of view is required.  This technique relies on the 
generation of electrons which excite surface electrons as the scanning beam 
moves across the sample in a square raster scan.  Resolution of 30 Ångstroms (1 
Ångstrom is equal to 0.1 nm or 1x10
-10
 metres) under optimal conditions is 
possible (EVO SEM, Carl Zeiss product literature).  However, for biofilm 
structure the resolution is greatly reduced without initial fixation, staining, drying 
and metal sputter coating, which deposits a thin layer of either gold or platinum 
on the surface.  Electrons can penetrate uncoated biological samples, giving an 
image of low resolution, however, if the samples are sputter coated, the electrons 
are reflected to the detectors, thus giving greater resolution of the surface 
topography (Kamper et al., 2004).  Although SEM can give good resolution, the 
high pressure required within the chamber causes dehydration and the generation 
  
 
75 
 
of artefacts (Fassel and Edmiston, Jr., 1999; Kamper et al., 2004; Little et al., 
1991).  The use of Environmental Scanning Electron Microscopy (ESEM) allows 
visualisation of biofilms within a damp atmosphere with moderate vacuum (Little 
et al., 1991), allowing images to be taken on a biofilm surface without 
dehydration and the generation of artefacts.  A number of investigators have 
utilised environmental scanning electron microscopy (ESEM) when imaging 
biofilms (Bergmans et al., 2005; Priester et al., 2006). 
 
1.4.1.2 Atomic Force Microscopy 
The Atomic Force Microscope (AFM) or Scanning Probe Microscope (SPM) was 
invented in 1986 by Binning et al.  Like all SPM, the AFM utilises a sharp probe 
moving over the test surface of a sample in a raster scan.  In the case of the AFM, 
the probe is on the end of a cantilever which bends in response to the force 
between the tip and the sample as in Figure 10. A laser beam deflects off the 
cantilever which is analysed by the AFM. Images are taken of the surface using 
two methods – contact (probe remains in contact with the surface during raster 
scan) and tapping (probe vibrates and taps the surface).  Tapping mode is 
generally used for the study of biological samples where contact mode would 
merely push the material across the sample surface.  AFM technology can have 
resolution as low as 10 Ångstroms (one full twist of DNA double helix = 34 
Ångstroms (Mandelkern et al., 1981)). 
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Figure 10. Schematic diagram of AFM cantilever moving over test surface. 
Image taken from www.nanotech-now.com/Art_Gallery/antonio-siber.htm 
 
A number of studies have utilised the AFM to investigate bacterial attachment 
(Postollec et al., 2006; Whitehead et al., 2006) and salivary pellicle (Berg et al., 
2003; Hannig et al., 2004).  Most analyses will collect height, amplitude and 
phase images.  Where height images capture both the x/y- plane as well as the z-
plane to give true results of the surface topography, however, visually it gives 
little clarity of the fine detail of the image.  Another measurement, amplitude, 
often shows structures in finer details, as it shows a map of the slope of the 
surface; however, using this imaging technique renders the z-plane meaningless.  
Finally, phase images are an image of the interaction of the cantilever with the 
sample surface.  With respect to the data obtained from height and amplitude 
images phase images can differentiate relative softness or hardness of the sample. 
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1.4.1.3 Confocal Microscopy 
 
Figure 11 Optical sections (partial image stack) through a biofilm exhibiting the structural motif 
of an outer layer of viable bacteria.  z-axis separation of optical sections = 2.9µm. Reproduced 
with kind permission from Dr. C. Hope. (Hope et al. 2003). 
 
Confocal laser scanning microscopy (CLSM) permits optical sectioning of a 
specimen by capturing light from the local plane, thus CLSM with subsequent 
collation of the sectioning to produce a 3D rendering of the biofilm structure.  An 
example of this sectioning can be seen in Figure 11. This method of biofilm 
visualisation is normally dependent on fluorescence, either derived from the 
specimen itself, or through staining.  Research carried out by Caldwell (1992) 
utilised fluorescein isothiocyanate, staining the „bulk‟ fluid or „void volume‟, 
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leaving the biofilm biomass unstained; the biofilm was the „negative‟ rendering of 
the image.  Recently, SYTO stains (Invitrogen, Carlsbad, USA) have become 
available to stain specific organisms within the biofilm.  Most commonly utilised 
stains are the LIVE/DEAD® staining where SYTO 9 stains all bacterial cells 
(independent of cell viability), whereas charged propidium iodide penetrates dead 
cells due membrane damage, thus allowing the stain to be internalised within the 
bacterial cell and when both dyes are present, reduce SYTO 9 to fluoresce red.  
This allows for differentiation of live and dead cells within the biofilm.  However, 
this approach has been shown to be of limited use for environmental organisms 
(Shi et al., 2007) due to changes in propidium iodide uptake during some 
environmental bacterial growth cycles.  Visualisation of biofilms helps to 
understand structural differences and similarities that may be seen in comparison 
with those in vivo.  Below is a summary of how models utilised to study biofilms 
can both provide insight into biofilms but can also distort what is seen clinically. 
 
1.5 Oral Biofilm Models 
The search for new antimicrobial agents for improved biofilm control within the 
oral cavity requires that appropriate screening models be put in place.  Key 
criteria for these models would ideally include, the ability to be predictive of 
clinical outcome, the use of orally relevant organisms (mixed species), bacteria 
present in biofilms, short contact time relevant to the use of oral care products, 
reproducibility and high throughput. 
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1.5.1 Surfaces Used in Oral Biofilm Model Systems 
To mimic the attachment of oral bacteria to saliva modified surfaces a number of 
substrata have been investigated including glass (Stinson et al., 1981) and 
powdered enamel (Hillman et al., 1970), to name a few.  The following section 
discusses in more detail model substrata currently used with respect to this oral 
biofilm model system. 
 
1.5.1.1. Hydroxyapatite 
Hydroxyapatite has been used for over 40 years as a model for enamel dissolution 
studies (Higuchi et al., 1965; 1969; Debhiya et al., 1974).  Gibbons (1976) looked 
at using hydroxyapatite coated in saliva as a substrate for the adherence of 
Streptococcus miteor and subsequent biofilm development.  It has been shown 
that most bacterial adherence takes place within the first 10 minutes post-
inoculation with saturation attachment observed after 30 minutes (Gaines et al., 
2003).  
 
The problem with hydroxyapatite is its difficulty in adhering to the underlying 
substratum.  Therefore, either hydroxyapatite discs or beads have been utilised.  
The author recommends using sintered hydroxyapatite as this reduces the porosity 
of the material which is generally manufactured by compression of powdered 
hydroxyapatite and then heated.  However, performing adherence or biofilm 
assays on this material can be tedious due to the washing steps and can lead to 
physical disruption of the biofilm of interest.  To address this, a number of 
methods have been developed to attach hydroxyapatite to a surface either via 
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deposition (Schilling et al., 1994), or sputter-coating (Elliot et al., 2005).  Both 
allow the development of the biofilm with microtitre plates or flow cells, 
respectively.  Using a contact angle goniometer the surface free energy of a 
hydroxyapatite sputter-coated surface has been shown to be 35.3m J m
-2
, which is 
within the range shown to be representative of human tooth enamel (Christersson 
et al., 1989). 
 
1.5.2 In situ Model Systems 
In situ oral biofilm models are considered the „gold standard‟ of oral biofilm 
research as they permit the generation and testing of biofilms under their native 
environments, reflecting what would be seen clinically.  A number of in situ 
models have been developed to investigate caries (Gameiro et al., 2009; Zero, 
1995), dentinal caries (Lima et al., 2009), fluoride penetration through plaque 
(Robertson et al., 1997; Watson et al., 2004; Watson et al., 2005) and to monitor 
the effect of preservatives on oral biofilms (Arweiler et al., 2008).  These models 
can be split into two main groups, those in which the biofilm develops directly on 
to the subject‟s tooth, or models which rely on the development of biofilms on 
surfaces held within the mouth on either palatal devices or intra-oral splints.  
Within these structures, typically sterilised human enamel or dentine slabs, bovine 
enamel or hydroxyapatite discs can be inserted.  These models however, are not 
utilised as screening models due to the small number of replicates permitted, but 
rather an important evaluation tool for allowing the research to be carried out in 
the environment of the mouth and exposed to all shear forces and salivary 
components.  
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1.5.3 In vitro Model Systems 
1.5.3.1 Constant Depth Film Fermenter  
The constant depth film fermenter (CDFF) concept was originally discussed in 
1974 by Atkinson and Fowler, focussing primarily on a microbial film fermenter.  
Utilising this concept and building on research carried out by Coombe (1981), 
further model developments by Peters and Wimpenny in 1988, resulted in a model 
that would allow the development of replicate biofilms of a defined thickness.  
This model permits the development of biofilms between 50-600µm thick, due to 
the biofilms being grown in recessed pans.  The thickness is limited by a static 
Teflon blade which sweeps excess biomaterial from the pans as the system 
rotates.  This is a closed model system where the environmental gas, medium and 
inoculum can be controlled.  The biofilms can then be easily removed and 
evaluated for bacterial counts, architecture and antimicrobial efficacy of any test 
substances.  The CDFF model system has been widely used in oral biofilm 
development and research (McBain et al., 2003; Metcalf et al., 2006; Pratten et 
al., 1998; Vroom et al., 1999; Wilson, 1990). 
 
1.5.3.2 Artificial Mouth 
The artificial mouth model developed by Sissons et al. (1991), allows the long-
term growth and development of dental plaque, derived either from clinical plaque 
or saliva samples.  The methodology permits the addition of different nutrients 
and modification to the environment to understand their effects on the developing 
biomass.  The biomass is grown on a Lux Thermanox cover-slip, where nutrients 
and test agents can be added via entry ports.  Utilising this methodology Sissons 
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was able to show similarities in responses to changes in pH with addition of 
sucrose and urea, and mineralisation as measured by the deposition of Ca, PO4 and 
F to that of natural dental plaques.  As noted by the authors, although the system 
has been run for 6-weeks, after just 3-weeks, the biomass was too large for the 
cover-slip.  A key feature of this „artificial mouth‟ model is the capacity to 
monitor the metabolism and environmental changes within the biomass formed.  
This model has been widely used to evaluate caries development (Tang et al. 
2003; Shu 1998; Shu et al. 2000) and viability (Filoche et al. 2007). 
 
1.5.3.3 Microtitre Plate 
Microtitre multi-well plates were identified for use in biofilm systems due to the 
high number of replicates and high throughput testing possible.  The use of 
microtitre plates for determining the susceptibility and subsequent quantification 
of the antimicrobial activity of an agent against a developed biofilm has been 
investigated previously using a number of different microorganisms (Christensen 
et al., 1985; Djordjevic et al., 2002; Pitts et al., 2003; Stepanovic et al., 2000). 
Different studies have used a range of dyes and visual indicators, for example, 
crystal violet to stain attached organisms (Deighton and Balkau, 1990; Stepanovic 
et al., 2000).  This technique does not indicate the viability of the remaining 
biomass, however, other researchers have investigated the use of indicator dyes 
that can measure cellular metabolism such as, 1,5-cyano-2,3-ditolyl tetrazolium 
chloride and AlamarBlue™ (Baker and Tenover, 1996; Collins and Franzblau, 
1997; Fields and Lancaster, 1993; Springer et al., 1998).  AlamarBlue™ (AB) can 
quantitatively measure the metabolism of bacteria and allows the investigation of 
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the antibacterial activity of test agents (Fields and Lancaster, 1993).  The active 
component of AB has been identified as resazurin (O'Brien et al., 2000).  Under a 
reducing environment AB will elicit a change from the blue (unreduced) form to 
the pink (reduced) form. AB can be reduced by nicotinamide adenine dinucleotide 
phosphate (NADPH), flavin adenine dinucleotide (FADH2), flavin 
mononucleotide (FMNH2), nicotinamide adenine dinucleotide (NADH) and 
cytochromes (Biosource, product literature).  It has therefore been proposed that 
the site of reduction is the electron transport chain (Springer et al., 1998) reducing 
the blue resazurin to pink resorfin which also fluoresces (O'Brien et al., 2000).  
AB has also been utilised as an indicator dye in planktonic bacterial susceptibility 
assays (Baker and Tenover, 1996; Collins and Franzblau, 1997) and is safe, 
reliable, sensitive and very simple to use.  
 
Due to the hydrophobic surface of microtitre plates, a number of investigators 
have coated the wells with hydroxyapatite (HA) (Gaines et al., 2003; Schilling et 
al., 1994).  In these studies, the HA was either precipitated on the surface 
(Schilling et al., 1994) or formed into pellets for use (Gaines et al., 2003).  
 
1.5.3.4 Minimum Biofilm Eradication Concentration (MBEC) Model  
The original model developed was called the Calgary Biofilm Device (CBD) and 
developed by Ceri et al., (1999).  A key reason for utilising this methodology is 
that it is a peer reviewed, 96-well microtitre plate biofilm screening model.  The 
MBEC model system utilises both the lid, which contains 96 pegs, corresponding 
to each of the 96-wells on the base of the plate. Once a test inoculum is added to 
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each of the wells on the microtitre plate and the plate incubated at an appropriate 
temperature and time, biofilms will form on the pegs.  The model was developed 
to investigate the antibiotic susceptibility of attached bacteria. 
 
This system has now been used in a number of studies including investigating the 
effect of metals on biofilms (Harrison et al., 2005) and to evaluate antimicrobials 
for food and food contact surfaces (Ali et al., 2006).  The literature states that an 
average of 2x10
6
 cfu/peg for Listeria innocua (Harrison et al., 2005), 5x10
7
 
cfu/peg for Pseudomonas aeruginosa and 2x10
5
 cfu/peg with S. aureus (Ali et al., 
2006) are possible with this model.  To evaluate further, the pegs can be broken 
and sonicated to determine minimum bactericidal concentration (MBC) and the 
spent medium in the 96-well plate can be analysed for minimum inhibitory 
concentration (MIC) (Harrison et al., 2005).  Although, Ali (2006) reported 
difficulties in aseptically removing the pegs for enumeration of attached 
organisms.  The benefit offered by the CBD assay is the capability to test a range 
of antimicrobials with varied concentrations against reproducible biofilms in one 
assay.  The model was not originally designed for use with oral organisms; 
therefore, concerns exist for the use of this model with these organisms.  The 
problems arise from growing oral biofilms on non-orally relevant surfaces; such 
as polystyrene for the MBEC pegs.  It has been shown that the chemical and 
physical properties of the underlying surface affects the development of the 
conditioning film including physiochemical surface properties, composition, 
density and configuration (Fletcher, 1976; Strevett and Chen, 2003).  It has also 
been observed that oral bacteria can detach from a surface due to a cohesive fault 
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within the conditioning film (Busscher et al., 1995).  Parahitayawa (2006) 
discusses their findings of an increase in attachment of Candida krusei to the pegs 
of the MBEC in comparison with C. albicans attachment.  Previous studies have 
shown that C. krusei is more hydrophobic than C. albicans, thus having a greater 
propensity to attach on these surfaces (Samaranayake et al., 1995).  
 
1.5.3.5 Sorbarod Biofilm Model System 
Previous studies have demonstrated that the perfused Sorbarod biofilm system can 
maintain stable bacterial communities (Ledder et al., 2006; McBain et al., 2005).  
Orally generated malodour can be controlled by a number of methods such as 
masking, inactivation/neutralisation of malodourous molecules or use of 
antimicrobial agents to kill the volatile sulphur compound (VSC) producing 
organisms (Carvalho et al., 2004; Young et al., 2003).  A number of model 
systems exist for in vitro investigation of oral malodour including the CDFF 
(Pratten et al., 2003b).  The Sorbarod biofilm permits the development of an 
orally relevant mixed species biofilm model in which test actives can be evaluated 
for impact on VSC levels and their antibacterial ability under conditions of flow.  
The model is based on the Perfused Biofilm Model (Hodgson et al., 1995), 
modified to include an orally relevant malodourous biofilm derived from tongue 
dorsum scrapings (Greenman et al., 2005), and uses a Sorbarod filter (cylindrical 
paper sleeve encasing a compacted concertina of cellulose fibres, like a cigarette 
filter) to allow the attachment and growth of bacteria and continuous flow of 
media to provide a substantivity challenge when evaluating the efficacy of test 
agents.  The model was used to compare the anti-VSC efficacy of various agents 
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with antimicrobial and/or VSC neutralising activity employing GC analysis for 
the determination of hydrogen sulfide and methyl mercaptan.  Building on a 
model designed by Spencer et al. (2007) utilising a Halimeter to monitor total 
VSC‟s. 
 
The main difference between the conditions used here and those reported by 
Greenman et al., (2005) is the composition of the perfusion gas.  Thus, the 
original Multiple Sorbarod Device model utilised anaerobic gas whereas the 
method reported here uses sterile lab air to better mimic the in vivo situation 
where the tongue and associated biofilm is exposed to air during breathing, speech 
etc.  
 
1.6 Key Oral Care Actives Permitted in Oral Care Products 
Many patients and consumers have difficulty in removing all plaque via 
mechamical means. Indeed, the increase in the incidence of fillings at the least 
accessiable areas, for example aproximal and occlusal fissures are testament to the 
inability to consistently removel built up plaque. Therefore, there is an increasing 
desire to supplement mechanical removal of plaque with an antimicrobial agent to 
help reduce and bacterial still remaining on the tooth‟s surface.  
 
Currently there are a number of key antimicrobial agents that are permitted for use 
in oral care products, however for this PhD three were chosen to help test the 
developed biofilm model, as these actives have been widely studied previously 
and their activity was well understood. 
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1.6.1 Chlorhexidine 
Chlorhexidine (1,1‟-hexamethylene-bis-5(4-chlorophenyl bisguanide) is a broad 
spectrum, cationic antimicrobial. Due to its cationic nature, this antimicrobial is 
well studied for its ability to be retained on a biological surface and continue to 
provide antimicrobial effectiveness (Löe and Schiøtt, 1970; Mandell, 1994; 
Carrilho et al. 2010). This ability to attach to the surface is refered to substantivity 
and was first reported in 1971 (Rølla, G. et al. 1971). Chlorhexidine has often 
been referred to as the „gold-standard‟ antimicrobial for use in the oral cavity, 
however, due to its inherent substantivity, chlorhexidine, can have negative 
properties. McRoy et al. (2008), reported taste changes, tooth staining, sore mouth 
and/or throat, and tongue irritation.  
 
1.6.2 Triclosan 
Triclosan (2,4,4‟trichlor-2‟-hydroxydiphenyl ether) is a chlorinated bisphenol 
antimicrobial. Its antimicrobial activity has been attributed to it‟s ability to inhibit 
the NADH or NADPH-dependent ACP reductase pathway, inhibiting bacterial 
fatty acid biosynthesis. Unlike chlorhexidine, triclosan has no substantivity to oral 
surfaces, however a number of researchers have investigated the use of polymers 
to increase triclosan substantivity, (Loftsson et al. 1999; Zaman et al. 2010; 
Steinberg et al. 2006) as this compound is not inherently substantive in the oral 
cavity. 
 
 Triclosan is widely used in the personal care category and this usage has been 
linked to the appearance of organisms containing efflux pumps for the removal of 
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triclosan (Yazdahankhah et al. 2006; Chuanchuen et al. 2003). Therefore, 
concerns exist about the continued used, for the generation of antimicrobial 
resistance to triclosan. 
 
1.6.3 Zinc Salts 
Zinc salts, more commonly, zinc gluconate, zinc chloride and zinc acetate have 
been used in oral care products for their ability to impart, abeit slight 
antimicrobial effect, but also its effect or oral malodour (Brunette et al. 1998; 
Young et al. 2001; Young et al. 2003). It is now generally accepted that oral 
malodour generates from the bacterial that reside in the crypts and fissures of the 
tongue.  The odour is generated from the bacterial putrefaction of proteins found 
in the oral cavity (Kleinberg and Codipilly, 1997). Zinc salts have been shown in 
reduce oral malodour by chemical neutralisation of the main components of oral 
malodour, hydrogen sulphide and methyl mercaptan (Burnett et al., 2011). 
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1.7 Aims and Objective of this Research 
The overall aim of this research was the development of a reproducible „off-the-
shelf‟ assay to demonstrate the antimicrobial efficacy of test agents against orally 
relevant biofilms.  It was envisaged that these biofilms will represent different 
microbiota associated with oral diseases including the tongue, supragingival and 
subgingival (in particular those responsible for gingivitis) populations.  Therefore, 
the objective was to define each of the test parameters of the model to develop a 
robust and reproducible method for the evaluation of antimicrobials.  The work 
focused upon media and incubation, inocula, surface attachment, biofilm structure 
and viability, as well as in vitro correlation. 
 
The method outline was to grow orally relevant biofilms on a hydroxyapatite 
(HA) coated microtitre 96-well polystyrene plate.  The intention of this approach 
was to fulfil as many of the required criteria as possible, i.e. orally relevant 
surface, relevant short contact time, rapid and reproducible with high number of 
replicates against a defined oral biofilm population such that a pharmaceutical 
company could have a high volume screening methodology for the investigations 
into novel test actives for use in oral care products. 
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2.1 Bioplate Methodology 
2.1.1 Manufacture of Hydroxyapatite Coated 96-Well Plates 
Twenty grams of hydroxyapatite (HA) powder (Sigma-Aldrich, Gillingham, UK) 
was measured into a 115 mm diameter crystallising basin and placed on a 
magnetic stirrer.  A magnetic stirrer bar was then added to the powder with 250 
mL of acetone (Sigma, UK) and stirred so the powder was evenly suspended in 
the acetone. Each well of a 96-well microtitre polystyrene plate (VWR, 
Lutterworth, UK) then received 60 µL of the suspension; the plate was placed on 
an orbital shaker set at 200 rpm in a 30°C incubator.  After drying, loose HA 
powder was removed by inverting and tapping sharply.  Plates were subsequently 
washed in dH2O to further remove any remaining loose HA and allowed to dry at 
37°C overnight. Any plate showing poor coverage (visible cracks or bubbles in 
the HA layer by eye) were removed and discarded.  Plates were then sterilised by 
placing in a UV cabinet overnight (Steristrom, DaRo, Sudbury, UK) at 254 nm. 
 
2.1.2 Preparation of Bioplates 
Full testing methodology concerning the donation, sampling, incubation and 
testing of the organisms used in this model is summarised here.  The full testing 
methodology can be found in section 2.2.  Two separate aliquots of 250 mL of 
tryptone soya broth (TSB; Oxoid, Basingstoke, UK) were inoculated with 3 mL of 
fresh human saliva pooled from three individuals who had abstained from any oral 
hygiene regime for 8 hours prior to collection.  All donated saliva followed 
current GlaxoSmithKline protocols.  One flask was incubated anaerobically 
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without shaking, the other incubated aerobically with shaking, both for 5 hours at 
37°C.  The contents of both flasks were combined and swirled gently to mix.  
Each well of a HA coated 96-well microtitre plate was inoculated with 20 µL of 
the freshly prepared bacterial culture.  Subsequently, 180 µL of sterile TSB was 
added to each well, plates were then incubated aerobically for 17 hours at 37°C on 
an orbital shaker set at 200 rpm. 
 
When analysing the antimicrobial activity of test agents, the plates containing the 
test agents were prepared in advance.  To each column on an uncoated 96-well 
microtitre plate was added 200 µL of the test agent.  This generated 8 replicates in 
one column for each test agents and permitted the evaluation of 10 actives with 
deionised water and 0.2% v/v chlorhexidine (CHX, 20% v/v CHX digluconate 
stock, (Sigma, UK)) used as negative and positive controls, respectively.  Taking 
an inoculated Bioplate that had been incubated overnight, exhausted media from 
each well was removed using a Nunc-Immunowash 12 (Nunc, Kamstrup, 
Denmark) manual plate washer fed with TSB and attached to an effluent bottle via 
a vacuum pump.  Wells were washed (x2) using the Immunowash to remove 
unattached or loosely bound bacterial cells, thus leaving the wells of the Bioplate 
empty.  Using a 96-Transtar pipette (Corning, Sigma-Aldrich) and the uncoated 
96-well plate, 200 µL of the test agents were transferred to the now empty 
Bioplate and incubated at 37°C for 2 minutes while shaking.  Subsequently, using 
the Nunc-Immunowash, each well was washed (x2) with sterile TSB to remove 
traces of the test agent leaving the Bioplate empty.  Using an 8x multichannel 
pipette, 200 µL of sterile TSB was added to each well on the plate and re-
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incubated for 4 hours at 37°C.  To measure the viability of the biofilm, 10% v/v 
solution of AlamarBlue™ (Serotec, Oxford, UK) in TSB was prepared.  After the 
second incubation, the Bioplate was removed from the incubator and each well 
washed twice with sterile TSB.  Using an 8x multichannel pipette, 200 µL of the 
10% v/v AlamarBlue™ solution was added to each well.  The plate was further 
incubated for 30 minutes at 37°C with shaking; Figure 12 shows a CHX dose 
response using AlamarBlue.  Fluorescence was measured using a microtitre plate 
reader (Biotek, VT, USA) using a 530 nm excitation filter and a 590 nm emission 
filter. Results were recorded as mean fluorescence units (MFU) where n=8. 
 
 
 
 
Figure 12. Image of CHX dose response in Bioplate with 10 %v/v AlamarBlue™. Pink shows 
increase in bacterial metabolism, blue shows a decrease in bacterial metabolism 
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2.2 Organisms Used to Develop Biofilms on HA Coated Plates 
2.2.1 Mixed Species Salivary Samples 
Initial research carried out utilised donated saliva with the aim to replicate mixed 
consortia that would be representative of the oral cavity.  Consent was received 
for all donated saliva and samples taken from 3 individuals working at 
GlaxoSmithKline, Weybridge, UK.  Unstimulated samples were donated in the 
morning prior to any oral care regime, with no eating permitted prior to donation.  
Subjects were requested to donate a minimum of 5 mL of saliva into 30 mL 
sterilin sterile containers (VWR), these were subsequently refrigerated (<2hours) 
until required.  All saliva was combined to ensure a more representative oral 
microbiota of what would be found in the oral cavity.  Three millilitres of the 
pooled saliva was added to each of two 250 mL brain heart infusion (BHI) broths 
(Oxoid) and incubated static at 37°C anaerobically, the other was incubated at 
37°C with shaking aerobically for 5 hours.  Subsequently, they were mixed 
together 20 µL was then added to each well of a hydroxyapatite coated 96-well 
microtitre plate. 
 
2.2.2 Defined Species Inoculum 
For a number of reasons, ease of use, reproducibility and safety, it was desirable 
to standardise the model inocula, as well as increasing opportunity of use, due to 
the introduction of the Human Tissue Act, 2004. This part-time PhD was initiated 
at the beginning of 2004 and therefore the HTA would have impacted the use of 
human derived salivary inocula.  A move towards a defined salivary inoculum 
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was investigated.  These organisms detailed below were specific oral bacteria 
chosen based on the paper “The establishment of reproducible, complex 
communities of oral bacteria in the chemostat using defined inocula.” McKee et 
al. (1985).  The organisms used in this paper were (reported as in the paper): 
Streptococcus mutans ATCC 2-27351, Streptococcus sanguis NCTC 7865, 
Streptococcus mitior EF 186, Actinomyces viscosus WVU 627, Lactobacillus 
casei AC 413, Neisseria sp. A 1078, Veillonella alkalescens ATCC 17745, 
Bacteroides intermedius T 588, and Fusobacterium nucleatum NCTC 10953.  
Due to the unavailability of some of these organisms, they were replaced with 
representative NCTC strains.  The final list of organisms chosen were, 
Streptococcus mutans NCTC 10449, Streptococcus sanguinis NCTC 10904, 
Streptococcus mitis NCTC 12261, Actinomyces viscosus NCTC 10951, 
Lactobacillus casei NCTC 10302, Neisseria mucosa var. mucosa NCTC 10774, 
Veillonella dispar NCTC 11831, Prevotella melaninogenica  NCTC 11321 and 
Fusobacterium nucleatum NCTC 10562.  These organisms were grown up on 
either tryptone soya agar (TSA) or blood agar (BA) with 6% defibrinated horse 
blood (both Oxoid).  Following the manufacturer‟s instructions for breaking the 
glass seals, each was resuspended in 1 mL of BHI broth and aspirated via a 
pipette.  One hundred microlitres of this was plated out on appropriate media, 
aerobic organisms were incubated at 37°C for 48 hours. Anaerobic organisms 
were incubated for 7-10 days.  Post incubation, representative colonies were 
removed and placed on agar slopes as stock organisms and placed in 4°C 
refrigeration for 1 month.  
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2.3 Visualisation of Biofilms 
2.3.1 Scanning Electron Microscopy (SEM) 
Twenty microlitres of a 10
8
 cfu/mL stock solution of S. mutans NCTC 10449 was 
added to 180 µL of either TSB or BHI in a microtitre plate and incubated at 37°C 
for 24 hours aerobically with shaking (TSB) and without (BHI) shaking.  
Subsequently, the wells were washed using the method described previously and 
left to dry.  A 6 mm borer (B&Q, UK) was used to remove a section from the base 
of the Bioplate well.  Microscopic analysis of uninoculated HA coated wells and 
biofilms was then carried out using a Zeiss EVO scanning electron microscope 
operated at 2.5-3 kV.  
 
 
Figure 13 Multi-stub holder which would allow investigation of more than one sample at a time in 
SEM. 
 
Samples were mounted onto standard SEM stubs (Agar Scientific, Stansted, UK), 
as in Figure 13, with double sided carbon sticky dots (Agar Scientific).  Samples 
were uncoated and representative images of the native HA coated surface were 
also taken.  
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2.3.2 Atomic Force Microscopy (AFM) 
S. mutans NCTC 10449 was inoculated into 2 x 20 mL BHI broth and incubated 
at 37°C overnight with shaking at 200 rpm.  A glass coverslip was added to one of 
the containers to allow attachment of the bacteria to the surface.  A 10 µL aliquot 
was removed from the other container and placed onto a sterilised glass cover slip 
and allowed to dry.  Glass coverslips were used in this analysis as the surface 
topography of hydroxyapatite coated polystyrene exceeded the z-plane allowed by 
the AFM.  
 
Analysis was carried out using a Multimode V AFM (Vecco, California, USA), 
using a NP-20 silicon nitride probe with a tip radius of 20 nm (Veeco Instruments 
Ltd, Cambridge, UK) as in Figure 14.  
 
(A)   (B) 
Figure 14 Image of NP-10 silicon nitride probes which are representative of NP-20 probes, 
showing tip (A) and cantilever (B). Both images from Veeco website www.veeco.com 
 
The AFM was operated in tapping mode (as contact mode would merely push the 
organisms) with images being taken at a speed of 0.447 – 0.671 Hz, with scan size 
ranging from 6.71 – 12.5 µm, line direction in all samples was retrace.  Each 
image was recorded for height, amplitude and phase.  
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2.3.3 Confocal Laser Scanning Microscopy (CLSM) 
CLSM was used in conjunction with LIVE/DEAD BacLight™ bacterial viability 
kit (Invitrogen, Paisley, UK) utilising two fluorescent dyes.  The two dyes are 
reliant on the permeability of a cell surface to differentiate those which are 
membrane-compromised and those that have an intact membrane structure.  
STYO® 9 will label live and dead bacteria with green fluorescence, however, 
when used in conjunction with propidium iodide, which is more permeable, and 
better able to transverse cell membranes, dead cells with permeable membranes 
will fluoresce red.  Red/green ratio can then be used to correlate viability of the 
sample. 
 
Biofilms were removed from either the CDFF, MBEC or Bioplate and placed in a 
small cell-culture dish (Bibby Sterilin Ltd, UK) with 10 mL distilled water 
containing 2 µL of the LIVE/DEAD BacLight™ bacterial viability stain.  These 
were incubated in the dark to allow the stain to develop for 15 minutes and rinsed 
to remove excess stain.  The biofilm structure was examined with an Olympus 
BX51 microscope to which a Bio-Rad Radiance 2100 laser scanning system and a 
LUMPlanFI ×40 water lens was incorporated.  Two-channel (viable “Live” and 
nonviable “Dead”) confocal image stacks were collected in eight-bit colour depth 
at a resolution of 1024 x 1024 pixels. The z-axis step size was optimized for each 
image stack, depending upon the total depth of each of the test samples. Images 
where collated and analysed using Image J software, available at 
http://rsbweb.nih.gov/ij/.  
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2.4 Minimum Biofilm Eradication Concentration (MBEC) 
Model  
The original model developed was called the Calgary Biofilm Device (CDB) was 
developed by Ceri et al., (1999).  A key reason for utilising this methodology is 
that it is a peer reviewed, 96-well microtitre plate biofilm screening model.  The 
MBEC model system utilises both the lid, which contains 96 pegs, corresponding 
to each of the 96-wells on the base of the plate, see Figure 15b.  Once test 
inoculum was added to each of the wells on the microtitre plate and the plate 
incubated at an appropriate temperature and time, biofilms formed on the pegs as 
in Figure 15a.  The model was developed to investigate the antibiotic 
susceptibility of attached bacteria. 
 
 
Figure 15 The MBEC™ High-throughput (HTP) Assay. A) Biofilms form on the polystyrene pegs 
B) The peg lid has 96 identical plastic pegs. Taken from 
www.innovotech.ca/documents/MBECHTPInstructions_Rev2.pdf  
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A summary schematic of the methodology can be found in Figure 16. 
 
Figure 16 Overview of the MBEC testing methodology, taken from Innovotech methodology 
(http://www.innovotech.ca/products_use.php) 
 
2.4.1 Antimicrobial Challenge for MBEC 
A number of different antimicrobial challenges were carried out, described below 
are details carried out of a dose response of a chlorhexidine (CHX). Further 
testing can be found in chapter 5.  Using a new microtitre plate, sterile deionised 
water was added to column 1 as a standard control and from column 2-9 was 
added varying concentrations of CHX including 2, 1, 0.5, 0.25, 0.1, 0.05, 0.01, 
0.001% v/v, respectively.  
 
After removing the inoculated MBEC plates from the incubator, the plates were 
rinsed in a separate plate, prepared previously, which contained R+P buffer 
solution.  Washing was carried out to remove any unattached or loosely bound 
organisms.  Three pegs were removed from column 12 using sterile forceps and 
each transferred to 10 ml of R+P diluent.  This was subsequently vortexed for 1 
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minute and serially diluted from 10
-1
 to 10
-7
 and plated in duplicate on appropriate 
agar, then incubated with respect to the requirements of the individual organism.  
The remaining pegs, still attached to the lid, were transferred to the 96-well 
microtitre plates containing the CHX and placed in 37°C incubator for two 
minutes.  Subsequently, the plate was removed from the incubator and rinsed in a 
separate plate, prepared previously, which contained R+P buffer solution. Two 
hundred microlitres of 10% AlamarBlue™ in BHI was added to a separate 96-
well microtitre plate.  The washed pegs were then added to this and re-incubated 
for 30 minutes at 37°C with shaking.  Fluorescence was measured using a 
microtitre plate reader (Biotek) using a 530 nm excitation filter and a 590 nm 
emission filter.  Results are recorded as mean fluorescence units (MFU). 
 
2.5 Constant Depth Film Fermenter (CDFF) 
The CDFF employed in this study was a modified version first developed by 
Peters and Wimpenny in 1988.  The model was manufactured by John Parry-
Jones Engineering (Cardiff, U.K) (Figure 17).  The methodology utilised is based 
on that published by Pratten (2007).  
 
  
 
102 
 
 
Figure 17 Constant depth film fermenter with power unit and turntable (Pratten, 2007). 
 
2.5.1 Assembly of the Constant Depth Film Fermenter 
The CDFF has been well reported and below is the methodology employed.  The 
CDFF contains a stainless steel turntable which houses up to fifteen 
polytetrafluoroethylene (PTFE) pans.  Each pan contains up to five, 5 mm 
diameter holes which contain removable and adjustable PTFE plugs.  Biofilms 
can be grown directly on to these plugs, or a substrate of interest can be added.  In 
the present thesis hydroxyapatite sintered discs (5 ± 0.2 mm diameter, 1.8 ± 0.2 
mm deep, Clarkson Chromatography, South Williamsport, USA) were utilised.  
As the turntable rotates at 3 revolutions per minute, it passes by two angled 
scraper blades which remove any excess biomass, keeping the biofilms at a 
constant depth.  In the middle of each pan is a threaded hole for ease of removal 
of the unit from the CDFF.  The removal of individual pans results in up to 5 
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replicate biofilms. These biofilms can them be utilised for further investigations 
such as culture plating or CLSM.   
 
 
 
Figure 18 Sectional schematic showing the layout of the PTFE pans with scraper blade (Pratten, 
2007). 
 
The turntable unit was held inside a borosilicate glass unit held between two 
stainless stain plates with in/outlet ports, sealed using PTFE seals and high 
vacuum silicon grease (Dow Corning, Midland, MI, USA).  All air filter ports 
were sealed using Whatman Hepa-vent air filters (0.2 µm) (VWR).  All tubing 
was silicone based (Saint Gobain, Charny, France) and sealed using quick-connect 
fittings (VWR).  The CDFF unit was sterilised via autoclaving at 121°C for 15 
minutes. 
 
  
 
104 
 
2.5.2 Inoculation of the Constant Depth Film Fermenter 
 Full details of the inoculation of the CDFF can be found in chapter 5. A brief 
overview is given below. A defined inoculum was used to inoculate the CDFF, 
and was plated out on relevant media (full details can be found in Chapter 4) to 
obtain required concentrations.  The organisms used were, S. mutans NCTC 
10449 (1x10
8
 cfu/mL), S. mitis NCTC 12261 (1x10
10 
cfu/mL), S. sanguinis NCTC 
10904 (1x10
6
 cfu/mL), A. viscosus NCTC 10951 (1x10
6
 cfu/mL), L. casei var. 
rhamnosus NCTC 10302 (1x10
10
 cfu/mL), N. mucosa NCTC 10774 (1x10
9
 
cfu/mL), V. dispar NCTC 11831 (1x10
5
), P. melaninogenica NCTC 11321 (1x10
9
 
cfu/mL) and F. nucleatum NCTC 10562 (1x10
5
 cfu/mL).  One millilitre of each 
organism; S. mutans, S. mitis, S. sanguinis and L. casei was added along with 4 
mL of A. viscosus, N. mucosa, V. dispar, P. melaninogenica, F. nucleatum to 300 
mL of artificial saliva.   
 
The inoculum was added to the CDFF for 5 hours at a rate of 0.5 mL/min, 
incubated at 37°C aerobically and continually mixed with a magnetic stirrer.  This 
was equivalent to the mean salivary flow rate of 0.72 litres/day for humans 
(Guyton, 1992).  Subsequently, the inoculum was removed and the CDFF was 
then continually fed with artificial saliva at a rate of 0.34 mL/min.  The CDFF 
unit was incubated at 37°C aerobically.  At various time points biofilms were 
removed for analysis. 
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2.5.3 Operating Conditions of the Constant Depth Film Fermenter 
The CDFF was held in the incubator at 37°C aerobically, with an artificial saliva 
feed at a rate of 0.34 mL/min.  Effluent was collected down-stream from the 
CDFF, as seen in Figure 19. 
 
 
 
Figure 19 Schematic of the CDFF when running continuously – the dotted line represents the 
incubator (Pratten, 2007) 
 
2.5.4 Sample Removal of the Constant Depth Film Fermenter 
At defined time intervals, the CDFF rotation was stopped, allowing the removal of 
the biofilms grown on the PTFE pans to be removed via the sampling port.  
Sterilisation of the sampling tool and sampling port was carried out with 70% v/v 
ethanol.  Once removed the pans were placed in diluent awaiting analysis and held 
for maximum 4 hours. 
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2.6 Sorbarod Biofilm Model 
2.6.1 Assembly of Model 
A schematic diagram of the Sorbarod biofilm system is shown in Figure 20, three 
of which were run in parallel.  
 
Figure 20 Schematic and photograph of Sorbarod Biofilm Model system A) media inlet 36 mL h
-1 
B) gas inlet by peristaltic additions 50 mL h
-1
 C) test agent addition via syringe D) biofilm 
containing Sorbarod filter E) gas sampling outlet. 
 
Disposable 2 mL plastic syringes were cut and orientated using silicon tubing (Ø 
1 cm, VWR, Lutterworth, UK).  Medium was perfused through the Sorbarod 
(Figure 20A) at a flow rate of 36 mL/hour using a multichannel peristaltic pump 
(Watson and Marlow, Falmouth, UK).  Sterile lab air was introduced via a side 
arm (Figure 20B) at a flow rate of 50 mL/hour using a single peristaltic pump 
(Watson and Marlow).  A syringe was placed above the Sorbarod filter to allow 
introduction of the test agent.  Downstream from the Sorbarod filter was a three-
way tap leading to a 0.45 µm air filter (Pall Gelman, VWR) with 4 cm attached 
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silicon tubing.  A gas-tight 20 mL syringe could be connected to the outlet to 
allow sampling of gas for analysis.  Effluent from each Sorbarod flowed to a 2L 
waste carboy.  
 
2.6.2 Preparation of Inoculum 
The inoculum was generated using a sterile toothbrush (Macleans, GSK, 
Brentford, UK), autoclaved at 121°C for 15 mins, firmly brushed against the 
posterior dorsum of the tongue of a single donor and then washed in 10 mL of 
sterile phosphate buffered saline (PBS) to remove tongue biofilm.  These steps 
were repeated until an optical density equivalent to a 3.0 McFarlane standard was 
obtained.  The bacterial suspension in PBS was then added to 10 mL of sterile 
double strength Brain Heart Infusion (BHI) broth (Oxoid).  The inoculum (2 mL) 
was added to a sterile Sorbarod housed in a 2 mL syringe (Figure 20C) in the 
absence of flow.  Once inoculated, Sorbarod filters were incubated overnight in an 
anaerobic cabinet at 37°C, then connected to the gas, medium and effluent lines, 
and incubated for a further 48 h with continuous perfusion of gas and medium.  
Previous experiments showed that steady state VSC levels were reached after 48 
hours incubation of the inoculated Sorbarod under the conditions reported here 
(data not shown). 
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CHAPTER 3: Methodology refinement of an 
in vitro hydroxyapatite microtitre biofilm 
model. 
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3.1 Introduction 
Many in vitro oral biofilm studies require the development of orally relevant 
plaque.  However, many studies focus primarily on single-species biofilms which 
do not take into consideration the multi-species interactions which occur in plaque 
(Adams et al., 2002; Luppens et al., 2008; Palmer et al., 2001).  In vitro biofilm 
structure is determined by available nutrients, substratum in the model, organisms 
present and incubation conditions.  Changes in any one of these parameters will 
affect bacterial growth and biofilm development, thus affecting biofilm structure.  
Biofilms have also been shown to be more resistant when under an antimicrobial 
challenge compared with planktonic cultures of the same organism (Costerton et 
al., 1995; Larsen and Fiehn, 1996; Wilson, 1996).  This has shown to be as much 
as 1000-fold increase in resistance (Mah and O‟Toole, 2001). 
 
The development and understanding of well characterised high-throughput 
laboratory model is essential for mass screening of possible anti-plaque agents 
and formulations.  The methodology should not only allow the screening of 
different test agents, but allow the evaluation and optimisation of test agent 
activity for example, by changing pH or addition of exipients to increase activity. 
 
The effect of different surfaces on these models should be considered when it is 
known that the chemical and physical properties of the underlying substratum can 
affect the development of an acquired pellicle including its composition, density 
and configuration.  These changes in the physico-chemical properties of the 
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acquired pellicle may influence bacterial attachment and subsequent biofilm 
development.  
 
A number of different surfaces have been used in oral biofilm model development 
including glass (Stinson et al., 1981), powdered enamel (Hillman et al., 1970), 
cellulose (Greenman et al., 2005), membrane filter and agar (Milward and 
Wilson, 1989) and polystyrene (Ceri et al., 1999) to name a few.  Hydroxyapatite 
has been used for over 50 years as a replacement for enamel (Higuchi et al., 1965; 
1969). Using a Contact Angle Goniometer the surface free energy of a 
hydroxyapatite sputter-coated surface was 35.3m J m
-2
, which is within the range 
shown to be representative of human tooth enamel (Christersson et al., 1989).  
The problem with hydroxyapatite is its difficulty in adhering to the underlying 
substratum in the model.  Therefore, either hydroxyapatite discs or beads have 
been previously utilised.  However, performing adherence or biofilm assays on 
this material can be tedious due to the washing steps and can lead to physical 
disruption of the biofilm of interest or the disruption of the hydroxyapatite from 
the substratum.  
 
When developing an orally relevant biofilm model, the closer we can be to the in 
situ scenario, the more representative of the in vivo effects can be investigated in 
vitro.  Hence, to evaluate the efficacy of antimicrobial test agents, firstly, relevant 
biofilms should be employed and, secondly, growing on representative surfaces 
found in the oral cavity to determine active concentrations that may eliminate the 
organisms growing within these biofilm structures.  The initial aim of this 
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research was the development of an assay to demonstrate the antimicrobial 
efficacy of test agents against orally relevant biofilms permitting high through-put 
test agent screening of possible anti-plaque agents, or indeed formulations. 
 
3.2 Materials and Methods 
3.2.1 Hydroxyapatite Surface for Biofilm Development 
The development of a 96-well hydroxyapatite (HA) containing biofilm model 
required understanding of the associations between the bacteria and the surface.  
This experiment aimed to understand surface differences between HA discs and 
HA coated wells.  AFM studies were carried out to show differences between 
planktonic organisms settled under the force of gravity to the bottom of the wells 
and that of bacteria which had attached and were in the very early stages of 
biofilm formation.  This is important as using a system such as this where there is 
little or no shear, it is necessary to consider whether the organisms are actively 
attaching to the surface, or are being deposited.  Initial work investigated how to 
differentiate between attached and planktonic organisms, by direct comparison 
with imaging from the AFM. 
 
3.2.1.1 Hydroxyapatite Discs  
Dense HA discs (5 mm diameter, 1.8 mm deep (Clarkson Chromatography 
Products, South Williamsport, USA)) were autoclaved at 121°C for 15 minutes.  
Using sterile forceps, one disc was transferred to each of the wells of an uncoated 
polystyrene 96-well plate.  To this, 1x10
6
 cfu/mL of S. mutans in 180 µl of test 
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medium was added into each well of a 96-well plate. Each plate was incubated as 
appropriate; S. mutans was incubated at 37°C for 24 hours aerobically on an 
orbital shaker set at approximately 200 rpm.  After incubation, the HA disc was 
removed using sterile forceps taking care not to touch the top surface.  The disc 
was gently washed in R+P to remove any unattached bacteria and remove residues 
of the test medium. 
 
3.2.1.2 Hydroxyapatite Coated Surface 
Twenty µL of a 10
8
 cfu/mL stock solution of S. mutans NCTC 10449 was added 
to 180 µL of BHI in a microtire plate and incubated at 37°C for 24 hours 
aerobically without shaking to allow attachment and biofilm development.  
Subsequently, the wells were washed using the method described in chapter 2 and 
left to dry.  A 6 mm borer (B&Q, UK) was used to remove a section from the base 
of the well.  The analysis of uninoculated HA coated wells and biofilms was 
carried out using a Zeiss EVO scanning electron microscope operated at 2.5-3 kV.  
Samples were mounted onto standard SEM stubs (Agar Scientific, Stansted, UK) 
with double sided carbon sticky dots (Agar Scientific).  Samples were uncoated 
and representative images of the surface were taken.  
 
3.2.1.3 Scanning Electron Microscopy 
Samples of hydroxyapatite coated wells and dense hydroxyapatite discs (which 
were exposed to bacteria) were imaged.  Test samples were mounted on 
appropriate stubbie holders (Agar Scientific, Standsted, UK) and imaged uncoated 
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in a Zeiss EVO Scanning electron Microscope operated at 3.5-3.75 kV (Carl Zeiss 
SMT Ltd, Cambridge, UK). 
 
3.2.1.4 Atomic Force Microscopy 
S. mutans NCTC 10449 was inoculated into 2 x 20 mL BHI broth with shaking to 
prevent settling and biofilm development of the base of the container, and 
incubated at 37°C overnight.  To one container was added a glass coverslip to 
allow attachment of the bacteria to the surface.  From the non-coverslip 
containing inoculum, a 10 µL aliquot was removed and placed onto a sterilised 
glass cover slip and allowed to dry.  Glass coverslips were used in this analysis as 
the surface topography of hydroxyapatite coated polystyrene exceeded the z-plane 
allowed by the AFM.  Analysis was carried out using a Multimode V AFM 
(Vecco), using a NP-20 silicon nitride probe with a tip radius of 20 nm (Vecco).  
The AFM was operated in tapping mode with images being taken at a speed 0.447 
– 0.671 Hz, with scan size ranging from 6.71 – 12.5 µm, line direction in all 
samples is retrace. 
 
3.2.2 Correlation Between Saliva Inocula and Bioplate Recovery 
To investigate the correlation between saliva inoculum and Bioplate recovery, a 
microtitre plate biofilm disruption method was developed to optimise bacterial 
cell recovery. This methodology was utilised throughout this research. 
 
  
 
114 
 
3.2.2.1Biofilm Disruption  
Due to the nature of biofilm growth (micro/macro colonies associated with a 
surface) it is feasible that when determining bacterial viability all of the organisms 
may not be removed from the surface and that aggregates of bacteria may form 
and give inaccurate counts.  Therefore, the aim of this experiment was to develop 
a reproducible method for the disruption of biofilms grown on hydroxyapatite 
coated surface and dense hydroxyapatite discs.  The protocol developed aimed to 
ensure bacterial recovery was an accurate presentation of actual bacteria present; 
therefore the method used only single species at a time.  
 
3.2.2.2 Preparation of HA Discs and HA Coated Bioplates 
S. sanguinis NCTC 10904 was grown on tryptone soya agar (TSA) (Oxoid, UK) 
at 37°C for 24 hours and V. dispar NCTC 11831 was grown on brain heart 
infusion agar (BHI) (Oxoid) agar at 37°C for 48-120 hours as orally representative 
organisms in this method development.  Suspensions of 10
8
 cfu/mL were prepared 
in reduced transport fluid. Reduced transport fluid was manufactured as below in 
Table 3. Using a spectrophotometer set at λ= 550 nm, absorbance of the 
suspension was read and adjusted to be between 0.2 - 0.4 to equate to 10
8 
cfu/mL.
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Table 3 Formulation for the manufacture of reduced transport fluid. Composition per litre of 
deionised water, pH 8.0 ± 0.2 at 25°C 
 
Stock mineral salt solution No. 1 75 mL 
Stock mineral salt solution No. 2 75 mL 
Ethylenediamine tetraacetic acid (1M solution) (Sigma) 10 mL 
Sodium carbonate (8% solution) (VWR) 5 mL 
Dithiothreitol (1% solution) (VWR) 20 mL 
Resazurin (0.1% solution) (Sigma) 1 mL 
Stock Mineral Salt Solution No 1 Composition per 
100 mL of deionised water 
 
Dipotassium hydrogen phosphate (VWR) 0.6 g 
Stock Mineral Salt Solution No 2 Composition per 
100 mL of deionised water 
 
Sodium chloride (VWR) 1.2 g 
Ammonium sulphate (VWR) 1.2 g 
Dipotassium hydrogen phosphate (VWR) 0.6 g 
Magnesium sulphate heptahydrate (VWR) 0.25 g 
 
Two 500 mL duran flasks containing 250 mL of TSB fitted with screw caps were 
prepared and autoclaved at 121 C for 15 minutes.  When cooled the flasks were 
inoculated with 3 mL of the 10
8
 suspension and incubated depending on organism 
used for 6 hours at 37°C either aerobically (S. sanguinis) with shaking or 
anaerobically (V. dispar) without shaking.  To each of the HA coated wells and 
HA disc containing wells was added 20 L of the freshly prepared bacterial 
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culture using separate plates for each of the different species.  Using the prepared 
plates, 180 L of TSB was added to each of the wells.  Plates were incubated 
dependent on the species being investigated.  S. sanguinis was incubated at 37°C 
overnight aerobically with shaking.  V. dispar was incubated at 37°C overnight 
anaerobically without shaking.  
 
3.2.2.3 Test Method for the Disruption of the Biofilms 
3.2.2.3.1 Disruption Procedure – Hydroxyapatite Discs 
Ringers and peptone diluent containing either 0.0% v/v, 0.1% v/v, 1.0% v/v or 
5.0% v/v Tween20 (Sigma) was manufactured and dispensed in 10 mL aliquots in 
McCartney bottles (VWR) and autoclaved at 121°C for 15 minutes.  Using sterile 
forceps a HA disc with biofilm was removed and placed in McCartney bottle. 
Each disc being placed individually in the bottles (n=8, for each test condition).  
Hydroxyapatite discs were then exposed to a number of experimental conditions 
to determine optimum bacterial recovery.  Discs were either vortexed at the 
highest speed for 30 seconds, 1 and 2 mins in each of the test diluents either with 
or without glass beads to aid in disruption.  Each of the columns on the 96-well 
plate related to different test parameters as below in Table 4. After vortexting, 1 
mL was removed and serially diluted to 10
-6
 in R+P.  S. sanguinis was plated out 
on tryptone soya agar (TSA) (Oxoid) and incubated at 37°C aerobically for 24-80 
hours.  V. dispar was plated on BHI agar (Oxoid) and incubated at 37°C 
anaerobically for 48-120 hours.  
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Table 4 Test conditions for bacterial recovery from HA disc. 
Column Biofilm disruption conditions 
1 R+P, vortexed 30 seconds 
2 R+P, vortexed 1 minute 
3 R+P, vortexed 2 minutes 
4 R+P with 0.1% v/v Tween20, vortexed 30 seconds 
5 R+P with 0.1% v/v Tween20, vortexed 1 minute 
6 R+P with 0.1% v/v Tween20, vortexed 2 minutes 
7 R+P with 1.0% v/v Tween20, vortexed 30 seconds 
8 R+P with 1.0% v/v Tween20, vortexed 1 minute 
9 R+P with 1.0% v/v Tween20, vortexed 2 minutes 
10 R+P with 5.0% v/v Tween20, vortexed 30 seconds 
11 R+P with 5.0% v/v Tween20, vortexed 1 minute 
12 R+P with 5.0% v/v Tween20, vortexed 2 minutes 
 
 
3.2.2.3.2 Biofilm Disruption – Hydroxyapatite Coated Microtitre Well 
Using the same media as the hydroxyapatite disc biofilm disruption method, the 
biofilms grown on the hydroxyapatite coated wells were removed by disruption 
with a cocktail stick sterilised at 121°C for 15 minutes.  This biofilm disruption 
device was used to scrape both the base and sides of the wells for differing lengths 
of time, using a fresh cocktail stick for each well.  The disruption device was 
placed in 10 mL of diluent with 100 L of broth from the test well.  All test 
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samples were vortexed for 30 seconds and serially diluted and tested as above.  
Each of the columns on the 96-well plate related to different test parameters as 
below in Table 5: 
Table 5 Test conditions for bacterial recovery from hydroxyapatite coated well 
Column Biofilm disruption conditions 
1 R+P, scraped 20 seconds, vortexed 30 seconds 
2 R+P, scraped 40 seconds, vortexed 30 seconds 
3 R+P, scraped 60 seconds, vortexed 30 seconds 
4 R+P with 0.1% v/v Tween 20 , scraped 20s, vortexed 30s 
5 R+P with 0.1% v/v Tween 20, scraped 40s, vortexed 30s 
6 R+P with 0.1% v/v Tween 20, scraped 60s, vortexed 30s 
7 R+P with 1.0% v/v Tween 20, scraped 20s, vortexed 30s 
8 R+P with 1.0% v/v Tween 20, scraped 40s, vortexed 30s 
9 R+P with 1.0% v/v Tween 20, scraped 60s, vortexed 30s 
10 R+P with 5.0% v/v Tween 20, scraped 20s, vortexed 30s 
11 R+P, with 5.0% v/v Tween 20 scraped 40s, vortexed 30s 
12 R+P with 5.0% v/v Tween 20, scraped 60s, vortexed 30s 
 
 
3.2.2.4 Saliva Inocula and Bioplate Recovery Correlation 
To correlate the predominant oral genera found in donated saliva to that found in 
the Bioplate after incubation, traditional microbiological culturing techniques 
were employed.  Using the method stated previously in chapter 2, HA coated 
microtitre plates were generated.  Bacterial enumeration was determined on, 
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Veillonella agar (VA- composition per L: 5 g Tryptone (Sigma-Aldrich), 3 g yeast 
extract (Oxoid), 0.75 mL sodium thioglycollate (Sigma-Aldrich), 0.002 g basic 
fuchin (Sigma-Aldrich), 2.4 mL 60% sodium lactate (Fisher), 15 g Agar (Oxoid)), 
Mitis Salivarius agar (MSA- Europa Bioproducts), Blood agar  + 7% defibrinated 
horse blood (BA – Oxoid), Fusobacterium agar (FA- Anaerobe Systems, CA, 
USA),  and Fastidious anaerobic agar (FAA- Oxoid) and FAA supplemented with 
0.0005% w/v metronidazole (FAAM- composition per L: 45.6 g FAA 
(Bioconnections), 50 mL defibrinated horse blood (Southern Group Laboratory), 
1 mL 2.9 mM metronidazole (Sigma-Aldrich).  BA and MSA incubated 
aerobically at 37°C for 4 days; the remaining media was incubated at 37°C for 7 
days. 
 
Two 500 mL flasks containing 250 mL of TSB were prepared, to which 3 mL of 
donated saliva was added.  One bottle was incubated aerobically with shaking 
(200 rpm) for 6 hours at 37°C.  The second bottle was incubated anaerobically 
without shaking at 37°C.  One millilitre of the donated pooled saliva was serially 
diluted to 10
-8
 cfu/mL in R+P.  One hundred microlitres of each dilution was 
spread plated in duplicate on each test medium.  BA and MSA incubated 
aerobically at 37°C for 4 days; the remaining media was incubated at 37°C for 7 
days. 
  
After incubation of the pooled saliva and media, 1 mL was removed from each of 
the flasks and serially diluted and spread plated on the test media, as stated above.  
After 6 hours incubation, the 2 x 250 mL of inoculated TSB, one incubated 
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aerobically the other anaerobically were combined and gently mixed.  Twenty 
microlitre aliquots of the bacterial suspension were added to each of the HA-
coated test wells.  Plates were incubated for 24 hours aerobically with shaking 
(200 rpm).  Subsequently, using the biofilm disruption method stated previously, a 
sample of the bacteria present on the HA surface was serially diluted and spread 
plated as above. 
 
3.2.2.5 Molecular Analysis 
From the work carried out in section 3.2.2.4. using the two 250 mL TSB that were 
inoculated with pooled saliva, with one flask being incubated at 37°C aerobically 
with shaking and the other flask incubated at 37°C anaerobically without shaking.  
One millilitre was removed from each of the flasks and serially diluted and spread 
plated on BA.  Colonies with differing morphologies were selected for 16S rDNA 
sequence analysis.  From the 10
-1 
plated dilution, 8 colonies were selected using a 
sterile applicator stick and suspended in 100µL of mastermix (78.7 µL dH2O, 10 
µL 10x NH4 buffer (Bioline), 5 µL 50 mM MgCl2 (Bioline), 2 µL10 mM dNTPs 
(Promega Life Sciences), 2 µL of 27f and 1492r primers (10 mM, Sigma-
Aldrich), 0.3 µL BioTaq (Bioline)). 
 
Subsequently, the mix was run on the following thermocycling programme to 
amplify 16S rDNA.  Samples were held at 94°C for 5 minutes followed by 29 
cycles of 94°C for 1 minute, 54°C for 1 minute and 72°C for 5 minutes.  PCR 
products were confirmed on a 1% w/w agarose gel where the product was 
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expected to be around 1.5 kbp.  Therefore, a 100 bp ladder (Promega) as a size 
marker was used.  Product was cleaned using PCR purification kit (QIAGEN). 
 
To sequence the PCR product, a PCR reaction mix was manufactured which 
contained, 1 µL dH2O, 3 µL of amplified PCR product, 1 µL 357f primer (5 
pmol/µL), 2 µL BigDye DNA Sequencing kit (first diluted 1 in 4 with 5x SEQ 
buffer (400 mM TRIS and 10 mM MgCl2 – Applied Biosciences).  Subsequently 
the mix was run on the following thermocycling programme which contained 99 
cycles of being held at 95°C for 10 seconds, 50°C for 5 seconds and then at 60°C 
for 4 minutes. DNA was then subjected to ethanolic precipitation and resuspended 
in 20 µL of TSR (Template Suppresser Reaction – Applied Biosciences) and then 
used for sequencing.  The sequences generated were checked using the 
CHROMAS program and entered into BLAST 
(http://www.ncbi.nlm.nih.gov/Blast/) and RDP 
(www.cme.msu.edu/RDP/html/index.html) for sequence matches. 
 
3.2.3 Effect of Media on Biofilm Viability 
Due to the results received from the study carried out in section 3.2.2.4, the effect 
of media on the developing biofilm viability was investigated. 
 
Hydroxyapatite coated microtitre plates were manufactured as reported 
previously.  Donated saliva was collected and incubated in either BHI broth or 
TSB for 5 hours at 37°C.  Subsequently, 20 µL was added to two HA coated 
microtitre plates.  Test medium was prepared in advance and included, artificial 
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saliva (composition per L, porcine stomach mucins 2.5 g (Sigma-Aldrich), NaCl 
3.5 g (Sigma-Aldrich), KCl 0.2g (Sigma-Aldrich), CaCl2.2H2O 0.2g (Sigma-
Aldrich), Yeast extract 2.0g (Oxoid), Lab lemco powder 1g (Oxoid), proteose 
peptone 5.0g (Oxoid), 40% urea solution 1.25 mL (Oxoid)), TSB and BHI all 
manufactured in single, ½, ¼ and 1/10
th
 strength.  To each well, 180µL of test 
medium was added (one column = one test media, n=8) and incubated aerobically 
for 24 hours at 37°C, one plate with shaking, the other without.  Subsequently, the 
plates were washed using the method stated previously and left empty.  To each 
well 200 µL of 10% v/v AlamarBlue™ in TSB was added and re-incubated for a 
further 30 minutes with shaking (200 rpm), at 37°C.  
 
3.2.4 Bioplate Testing CHX Dose Response 
HA coated microtitre plates were prepared using the method stated previously in 
chapter 2, incorporating the knowledge from this chapter.  The wells were 
inoculated with a mixed salivary culture in BHI, salivary organisms were derived 
from pooled saliva from 3 donors.  Biofilms formed following overnight 
incubation without shaking at 37°C aerobically.  Biofilms were washed twice with 
BHI using a Nunc-Immunowash 12.  Doubling dilutions of 20% v/v CHX were 
manufactured in dH2O, test concentrations of CHX ranged from 0.002-2% v/v 
with dH2O used as negative control.  CHX was applied to the wells for 2 minutes 
(n=8) and biofilms were washed twice to remove unattached residual CHX.  Two 
hundred microlitres of BHI was added to each well for 4 hours at 37°C without 
shaking to allow recovery of the organisms. Subsequently, the wells were washed 
again with fresh BHI containing 10% v/v AlamarBlue™.  Following 30 minutes 
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incubation with shaking (200 rpm) at 37°C, cell viability was determined by 
measuring fluorescence using a 530 nm excitation filter and 590 nm emission 
filter.  Viability results are recorded as Mean Fluorescence Units (MFU).  
 
3.3 Results 
3.3.1 Investigation of HA Surface for Biofilm Development  
3.3.1.1 Hydroxyapatite Disc Surface 
Using SEM to analyse surface features, which may appear after incubation for 24 
hours in one of the test broths, in Figure 21, a rehydrated blank hydroxyapatite 
disc shows typical features to compare against any surface modifications with the 
test broths. 
 
Figure 21 Micrograph of a Hydroxyapatite disc (Bar = 10µm). Image shows rough surface area 
for bacterial attachment and biofilm development. Red arrow highlights HA material associated 
with the surface. 
 
  
 
124 
 
Figure 21 shows a number of surface features on the HA disc, including large 
hydroxyapatite particles on the surface (Figure 21; red arrow). At a higher 
magnification it was found the surface of the disc contained a “scale-like” surface, 
(Figure 22; orange arrow).  It is believe that this surface is a result of the 
manufacturing process which compresses hydroxyapatite crystals to form the disc.   
 
 
Figure 22 Micrograph of HA disc surface (Bar = 1µm). The blue arrow highlights Streptococcus 
mutans chains associated with the surface. The orange arrow highlights compressed HA crystals. 
The HA disc is manufactured via compression, and these structures would be expected to be seen. 
 
3.3.1.2 Hydroxyapatite Coated Surface 
The surface of the hydroxyapatite coated well was imaged using SEM to 
understand the surface topography.  The surface contains large hydroxyapatite 
crystals and amorphous HA seen as large globular material as seen in Figure 23.  
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Figure 23 Micrograph of a hydroxyapatite coated well (Bar= 20µm). Image shows two main HA 
structures, one crystalline the other amorphous. It is hypothesised the amorphous material is 
created via the manufacture of HA coating on the microtitre plate, from the evaporation of the 
acetone. 
 
Interestingly, when the HA crystals are dissolved from the surface with 10% w/w 
citric acid, it was clearly seen the close relationship the HA crystals and 
amorphous material has with the microtitre surface (Figure 24).  
 
 
Figure 24 Micrograph showing microtitre plate polystyrene surface after dissolving attached HA. 
(Bar= 10µm). Image shows where the plastic has melted from the addition of acetone. The 
structures seen are the imprints left by the HA which are attached to the surface. In the image 
centre it is clearly seen the outline of two HA crystals. 
  
 
126 
 
From Figure 25, it is clearly seen a bacterial lawn growing on the HA crystals. 
 
 
Figure 25. Micrograph of bacterial attachment after overnight incubation with Streptococcus 
mutans. (Bar= 3µm). The organisms have grown around the HA crystals forming a dense bacterial 
covering. 
 
AFM was also used to determine whether, differences between planktonic grown 
S. mutans which had been dehydrated on to a surface (Figure 26) and those which 
were grown associated with a surface could be detected (Figure 27). This is 
important, as using a system such as this, where there is little or no shear, it is 
necessary to consider whether the organisms are actively attaching to the surface 
or being deposited. 
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Figure 26. Planktonic S. mutans dehydrated onto a glass slide. Utilising amplitude and phase 
modes show that although the organisms are deposited on the surface by the absence of excreted 
material „anchoring‟ the cells to the surface. 
 
 
 
 
Figure 27 S. mutans grown on the surface of a glass slide. Amplitude, reveals the presence of the 
organisms on the surface, phase mode reveals a material of different „stickiness‟ exuding from the 
organisms attached to the surface.  
 
An excreted material can clearly be seen in Figure 27 (Phase image); this 
substance is in close relationship to the growing cells.  This material was not 
found in either of the images in Figure 26.  It is believed that this material is 
excreted EPS from the bacterial cells.  AFM force studies would have helped 
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investigate wither these cells were indeed attached to the surfaces, however, due 
to limitations in the equipment; this aspect of the study was not progressed at this 
time.  The AFM was unable to determine differences in the attachment to the test 
surfaces due to the rough surface topography.  The test surfaces were replaced 
with glass discs and attachment to this surface was investigated.  Using a 
smoother surface resulted in differences in attachment by planktonic and attached 
cells to the surface being easily seen.  
 
3.3.2 Biofilm Disruption Methodology 
Reliability in the recovery of organisms from the bioplate, required an exploratory 
study to be carried to ensure consistency of bacterial recovery and ensure that the 
method employed to recovered the organisms revealed the true numbers of 
organisms available. In this analysis, Tween 20 was employed as an adjunct to the 
buffer solution to aid biofilm distruption and to allow bacterial separation, for 
ease of counting. As discussed by Xaio and Stewart (2000), Tween 20 may 
disrupt the biofilm matrix by interfering with the hydrophobic interactions 
involved in crossing linking of the structure. Indeed, Walker and Sedlacek (2007) 
showed that 0.5% Tween 20 was appropriate to reduce bacterial clumping without 
affecting viability. 
 
3.3.2.1 Streptococcus sanguinis Biofilm Disruption Studies 
Disruption and recovery from S. sanguinis biofilms grown on hydroxyapatite 
coated wells (n=8) show little variability in recovery, as seen in Figure 28.  This 
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initial study was carried out only once. Recovery using each of the diluents and 
techniques were similar with an average of approximately 1.5x10
6 
cfu/mL.  The 
only exception was the 5.0%v/v Tween20 when the surface was also scraped for 
60 seconds.  There was found to be no benefit in scraping the surface for greater 
than 20 seconds.  The inclusion of Tween20 into the medium to aid 
disaggregation also conferred no benefit.  Therefore, all future experiments used 
the protocol of scraping the well surface for 20 seconds and vortexing in R+P for 
30 seconds to remove adhered cells in the absence of Tween20.  
 
Treatment Media Time well scraped 
1 R+P only 20 seconds 
2 R+P only 40 seconds 
3 R+P only 60 seconds 
4 R+P with 0.1% Tween 20 20 seconds 
5 R+P with 0.1% Tween 20 40 seconds 
6 R+P with 0.1% Tween 20 60 seconds 
7 R+P with 1% Tween 20 20 seconds 
8 R+P with 1% Tween 20 40 seconds 
9 R+P with 1% Tween 20 60 seconds 
10 R+P with 5% Tween 20 20 seconds 
11 R+P with 5% Tween 20 40 seconds 
12 R+P with 5% Tween 20 60 seconds 
Figure 28 Streptococcus sanguinis recovery from hydroxyapatite coated well, treatment regimes 
in table above. Using a number of different levels of Tween20 to aid in biofilm disruption and 
varying the time wells scraped, it was found that the use of 5.0%v/v Tween20 in the diluent had a 
negative effect on organism recovery. All other results are comparable with one another. For all 
experiments n=8. 
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S. sanguinis log10 recovery from HA coated wells were analysed using a one–way 
analysis of variance with a factor for treatment, where p<0.05. 
Analysis of Variance 
----------------------------------------------------------------------------- 
Source             Sum of Squares     Df  Mean Square    F-Ratio      P-Value 
----------------------------------------------------------------------------- 
Between groups            6.85583     11     0.623258      14.97       0.0000 
Within groups             3.4975      84     0.0416369 
----------------------------------------------------------------------------- 
Total (Corr.)             10.3533     95 
 
 
Treatments with the same letter are not significant 
Multiple Range Tests for Col_2 by Col_1 
 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Treatment    Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
12             8         5.5375            A      
11             8         6.1375             B     
7              8         6.2125             BC    
2              8         6.25               BCD   
5              8         6.35                CDE  
10             8         6.4125              CDEF 
3              8         6.4125              CDEF 
4              8         6.4375               DEF 
9              8         6.4625                EF 
1              8         6.4625                EF 
6              8         6.5125                EF 
8              8         6.6125                 F 
 
Treatment 12 (R+P with 5% Tween 20), was the only treatment to be statistically 
distinct from the other treatments, however, this was due to the treatment regime 
negatively impacting bacterial viability. From the initial work carried out above, 
testing carried out on the hydroxyapatite discs was reduced to n=4 as a reflection 
on the tight standard deviations across the test plate. Results for recovery on a 
hydroxyapatite disc can be found in Figure 29. 
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Treatment Biofilm disruption conditions 
1 R+P, vortexed 30 seconds 
2 R+P, vortexed 1 minute 
3 R+P, vortexed 2 minutes 
4 R+P with 0.1%v/v Tween20, vortexed 30 seconds 
5 R+P with 0.1%v/v Tween20, vortexed 1 minute 
6 R+P with 0.1%v/v Tween20, vortexed 2 minutes 
7 R+P with 1.0%v/v Tween20, vortexed 30 seconds 
8 R+P with 1.0%v/v Tween20, vortexed 1 minute 
9 R+P with 1.0%v/v Tween20, vortexed 2 minutes 
10 R+P with 5.0%v/v Tween20, vortexed 30 seconds 
11 R+P with 5.0%v/v Tween20, vortexed 1 minute 
12 R+P with 5.0%v/v Tween20, vortexed 2 minutes 
 
Figure 29 Streptococcus sanguinis recovery on hydroxyapatite disc. Test conditions in each of the 
columns can be found below; figure shows little difference on Streptococcus sanguinis recovery 
using glass beads to disrupt the surface. At the higher levels of Tween20, there was not found a 
reduction in cell viability.  
 
The results across all the wells show no pronounced benefit to using glass beads 
to dislodge the biofilms from the hydroxyapatite disc surface; increasing 
vortexing time also seems to offer little benefit, as was the inclusion of Tween20.  
With this investigation a reduction in cell viability was not found using the 
highest concentration of Tween20.  There was found a 1 Log10 reduction in 
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recovery using hydroxyapatite discs in comparison to using the hydroxyapatite 
coated well.  In this study however, there was no evidence of a statistical 
difference between treatments (p=0.3006). 
 
3.3.2.2 Veillonella dispar Biofilm Disruption Studies 
All results from the Veillonella dispar studies (n=4) and the highest concentration 
of Tween20 were not included in these studies due to the negative results found 
with the S. sanguinis HA-coated microtitre biofilm disruption studies.  
 
Treatment Biofilm disruption conditions 
1 R+P, scraped 0 seconds, vortexed 30 seconds 
2 R+P, scraped 30 seconds, vortexed 30 seconds 
3 R+P, scraped 60 seconds, vortexed 30 seconds 
4 R+P, scraped 120 seconds, vortexed 30 seconds 
5 R+P with 0.1%v/v Tween 20, scraped 0 seconds, vortexed 30 seconds 
6 R+P with 0.1%v/v Tween 20, scraped 30 seconds, vortexed 30 seconds 
7 R+P with 0.1%v/v Tween 20, scraped 60 seconds, vortexed 30 seconds 
8 R+P with 0.1%v/v Tween 20, scraped 120 seconds, vortexed 30 seconds 
9 R+P with 1.0%v/v Tween 20, scraped 0 seconds, vortexed 30 seconds 
10 R+P with 1.0%v/v Tween 20, scraped 30 seconds, vortexed 30 seconds 
11 R+P with 1.0%v/v Tween 20 scraped 60 seconds, vortexed 30 seconds 
12 R+P with 1.0%v/v Tween 20, scraped 120 seconds, vortexed 30 seconds 
Figure 30 Veillonella dispar recovery from hydroxyapatite coated wells (n=4). Using a number of 
different concentrations of Tween20 to aid in biofilm disruption and varying the time wells 
scraped, it was found that the use of  R+P diluent with no Tween20 gave lower recover than that of 
all other test conditions. Results where no scraping was carried out show comparable recovery to 
that of the well in which scraping took place.  
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V. dispar log10 recovery from HA coated wells were analysed using a one-way 
analysis of varience with a factor for treatment, where p<0.05 
                            Analysis of Variance 
----------------------------------------------------------------------------- 
Source             Sum of Squares     Df  Mean Square    F-Ratio      P-Value 
----------------------------------------------------------------------------- 
Between groups            72.0442     11      6.54947     748.51       0.0000 
Within groups               0.315     36      0.00875 
----------------------------------------------------------------------------- 
Total (Corr.)             72.3592     47 
 
Treatments with the same letter are not significant. 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Treatment     Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
1              4         2.0               A     
9              4         6.0                B    
5              4         6.2                 C   
10             4         6.3                 CD  
11             4         6.325               CD  
12             4         6.425                DE 
8              4         6.475                 E 
7              4         6.5                   E 
6              4         6.525                 E 
3              4         6.525                 E 
2              4         6.525                 E 
4              4         6.55                  E 
 
Statistical analysis show that treatment regimes 1 (R+P, scraped 0 seconds, 
vortexed 30 seconds) and 9 (R+P with 1.0%v/v Tween 20, scraped 0 seconds, 
vortexed 30 seconds) are statistically distinct. This is due to both these wells not 
being scraped to aid bacterial removal. Interesting the third treatment leg which 
was also not scraped (treatment 5) showed directionality to split from treatments, 
but was statistically similar to treatments 10 and 11.  
 
Veillonella dispar recovery from hydroxyapatite disc again showed that the use of 
glass beads to help dislodge bacteria from the surface does not increase organisms 
recovered from the diluent. 
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Figure 31Veillonella dispar recovery from hydroxyapatite disc (n=2). Test conditions in each of 
the columns can be found above; figure shows little difference on Veillonella dispar recovery 
using glass beads to disrupt the surface. 
 
The results from both studies looking at V. dispar recovery from hydroxyapatite 
disc and coated wells show little difference in bacterial recovery after 30 seconds 
of scraping or vortexing.  Therefore, it is recommended that this step in the 
method need not exceed 30 seconds.  As with all the media types a slight 
reduction in R+P recovery is found.  Although this recovery is within the limits of 
the test, it is still recommended that the diluent formulations contain R+P with 
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Treatments Biofilm disruption conditions 
1 R+P, vortexed 0 seconds 
2 R+P, vortexed 30 minute 
3 R+P, vortexed 1 minutes 
4 R+P, vortexed 2 minutes 
5 R+P with 0.1%v/v Tween20, vortexed 0 minute 
6 R+P with 0.1%v/v Tween20, vortexed 30 seconds 
7 R+P with 0.1%v/v Tween20, vortexed 1 minute 
8 R+P with 0.1%v/v Tween20, vortexed 2 minute 
9 R+P with 1.0%v/v Tween20, vortexed 0 seconds 
10 R+P with 1.0%v/v Tween20, vortexed 30 seconds 
11 R+P with 1.0%v/v Tween20, vortexed 1 minute 
12 R+P with 1.0%v/v Tween20, vortexed 2 minutes 
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0.1%v/v Tween20.  Unlike the results from S. sanguinis there was no statistical 
difference between treatments (p=0.2555). 
 
3.3.3 Saliva Inocula Results 
The exploratory results below show Log10 bacterial recovery from each of the 
incubation steps currently involved in the Bioplate method, post-donation from 
saliva, aerobic and anaerobic incubation, mixing and biofilm development. Two 
growth media we investigated on their ability to retain mixed populations in the 
developed biofilm.   
Table 6 Bacterial recovery (Log10) using different incubation media (TSB, BHI) after different 
incubation conditions (from saliva, aerobic, anaerobic incubation, post-mixing, post-biofilm 
formation) 
Broth Sample Media (recovery Log10) 
  Veillonella MS BA Fuso. FAA FAAM 
TSB Saliva 7.8 7.5 8.0 5.6 8.2 8.0 
 Aerobic  6.4 9.2 9.2 4.3 9.4 9.2 
 Anaerobic  6.1 9.3 9.3 4.9 9.3 9.3 
 Mixed 6.1 8.3 8.4 3.1 8.3 8.2 
 Biofilm <1 <1 3.4 <1 <1 <1 
BHI Saliva 6.9 6.8 6.9 5.2 7.7 7.3 
 Aerobic  5.4 8.5 8.9 3.1 8.8 8.7 
 Anaerobic  5.4 9.3 9.2 3.7 9.5 9.3 
 Mixed 5.5 8.3 8.4 2.5 8.4 8.5 
 Biofilm <1 <1 <1 <1 <1 <1 
MS = Mitis salivarius agar, BA = Blood agar, Fuso. = Fusobacterium agar, FAA = Fastidious 
anaerobe agar, FAAM = Fastidious anaerobic agar with 0.0005% metronidazole. 
 
There was little change in the viable cells recovered following the aerobic and 
anaerobic incubation steps.  However, the recovery of viable cells after incubation 
of the biofilm in both TSB and BHI reduced complexity compared with the 
donated saliva (Table 6).  After incubation and biofilm development, there was a 
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gross loss off bacterial recovery, highlighting that the methodology currently 
employed did not support, either retaining mixed species or subsequent 
development into a biofilm. 
 
 Molecular identification was carried out on isolates taken from the intial 
incubation step and recovered on BA; 8 distinct colonies of differing 
morphologies were selected for 16SrDNA. The sequences generated were entered 
into BLAST.  In this preliminary study only 8 colonies were sequenced and 5 
samples came back with a positive result following searches, three sequences 
returned no results due to the short squences.  When these sequences were initially 
entered in to BLAST in 2005 all were identified as uncultured bacterial clones.  
These sequences were run again through BLAST in Jan 2012 and 5 matched 
sequences now in the database. All samples came back as Streptococcus spp. In 
particular, Streptococcus infantis ATCC 700779, S. oralis ATCC 35037, S. mitis 
NS51, S. salivarius ATCC 7073. All results have greater than 93% similarity.  
 
3.3.4 Effect of Media on Biofilm Viability 
Previous analyses (3.3.3) revealed that the current methodology employed lost 
bacterial viability, therefore this study inestigated which incubation and media 
would optimise bacteria viability and biofilm development in the bioplate. This 
study was concerned with determining the effect on the strength of media and the 
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effect of shaking during incubation on biofilm growth.   This study utilised 
donated saliva incubated in BHI, TSB or artificial saliva. 
 
 Figure Legend -Media 
1 TSB – full strength  5 BHI-Full strength  9 Artificial saliva – full strength 
2 TSB – ½ strength 6 BHI-½ strength 10 Artificial saliva – ½ strength 
3 TSB – ¼ strength 7 BHI – ¼ strength 11 Artificial saliva – ¼ strength 
4 TSB – 1/10 strength 8 BHI – 1/10 strength 12 Artificial saliva – 1/10 strength 
Figure 32 reveals that incubating the inoculated hydroxyapatite plate with shaking reduced 
biofilm viability, this effect was noted across all test media. Artificial saliva at all concentration 
tested showed the least biofilm viability. TSB gave a good dose response with respect to the 
concentration tested however BHI half strength medium incubated without shaking gave the best 
improvement in biofilm viability. 
 
Post-incubation without shaking, was analysed using a one-way analysis of 
variance with a factor for treatment. There was evidence of difference between 
treatments (p<0.05).   
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Treatments with the same letter are not the significant.  
 
------------------------------------------------------------------------------ 
Method: 95.0 percent LSD 
Treatment   Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
12             8         667.875           A      
11             8         835.25            A      
8              8         920.0             A      
4              8         1054.63           AB     
9              8         1161.5            AB     
10             8         1242.5            ABC    
7              8         1743.88            BC    
3              8         1936.38             C    
2              8         3477.75              D   
6              8         4253.63               E  
1              8         4867.88               E  
5              8         7020.13                F 
 
Statistical analyses reveal that treatment group 5, gave the best retention of 
biofilm viability in this study. Therefore going forward the methodology 
employed will include incubation with full strength BHI broth with the bioplate 
being incubated statically. 
 
3.3.5 Chlorhexidine Dose Response 
Chlorhexidine digluconate dose response indicates that the concentrations 
required to reduce fluorescence was 0.031% v/v CHX.  There was no 
antimicrobial activity at chlorhexidine levels below 0.016% v/v CHX (Figure 33).  
Figure 34 shows the visual change from the unreduced blue resazurin to the 
reduced pink resorfin. Chlorhexidine dose response was analysed using a one-way 
analysis of variance with a factor for treatment, where p<0.05 
                            Analysis of Variance 
----------------------------------------------------------------------------- 
Source             Sum of Squares     Df  Mean Square    F-Ratio      P-Value 
----------------------------------------------------------------------------- 
Between groups           6.6011E8     11      6.001E7     760.06       0.0000 
Within groups           6.63214E6     84      78954.1 
----------------------------------------------------------------------------- 
Total (Corr.)           6.66742E8     95 
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Figure 33. Chlorhexidine dose response against an orally relevant biofilm drived from salivary 
inoculum and grown in BHI broth incubated statically. 
 
 
Figure 34. Image of CHX dose response in Bioplate with 10 %v/v AlamarBlue™. 
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 Treatments with the same letter are not significant. 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Col_1          Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
1              8         961.25            X      
2              8         965.125           X      
3              8         1074.13           X      
4              8         1465.13            X     
5              8         1905.75             X    
6              8         2055.88             X    
7              8         2781.0               X   
8              8         6282.75               X  
11             8         6926.63                X 
10             8         6935.0                 X 
12             8         6944.38                X 
9              8         6997.0                 X 
 
Statistical analysis on the bioplate results show good statistical separation of the 
CHX dose response. It was found that treatment groups 9-11 (0.002-0.008% v/v 
CHX) did not split from the water control. Treatment groups 1-3 (0.5-2.0% v/v 
CHX) did not split, where 2.0% v/v CHX was the positive control in this study.   
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3.4 Discussion 
The key attribute of this assay is to demonstrate the antimicrobial efficacy of test 
agents against orally relevant biofilms, using the initial methodology as discussed 
in Chapter 2.  The bioplate assay has to fulfil many of the required criteria, i.e. 
orally relevant surface, short contact time, reproducible with high number of 
replicates against an oral biofilm population.  By defining each of the test 
parameters, a robust and reproducible method for the evaluation of antimicrobials 
has been developed. 
 
Initial investigations have shown that simple changes to the methodology can 
improve bacterial coverage of the HA surface.  Changing biofilm incubating 
media from TSB to BHI, from incubating with shaking to incubating without 
shaking of the inoculated HA plate conferred the greatest improvement of the 
assay.  This was confirmed via SEM imaging of the surface using existing 
methodology (image not shown) to that of the optimised method.  The initial 
results showed little bacterial recovery after incubation whether in TSB or BHI,  
giving rise to the hypothesis that incubating the Bioplate without shaking gives 
the greatest increase in bacterial attachment and biofilm development.  In contrast, 
the protocol for the CBD device states that shaking is required (Ceri et al., 1999). 
Further work (not shown here) was carried out to investigate any benefit to 
pelliclising the HA surface with artificial saliva for 30 minutes.  This step 
conferred no benefit to bacterial attachment and development.  It is proposed that 
this is due to the proteins within the BHI broth forming a pellicle over the HA 
surface, very much like what is seen with salivary protein deposition on HA. 
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AFM can determine differences between bacteria that are attached and developing 
into a micro-colony to those which have settled via gravity to the surface.  The 
methodology employed a number of washing steps to remove unattached or 
loosely bound organisms, therefore, we have shown this technology has the ability 
to confirm the bacteria attached to the HA crystals are attached. 
 
Two parallel studies were undertaken that investigated the use of a defined 
inoculum based on the work by Marsh (1985) to that of pooled donated human 
saliva.  Initial molecular analysis suggests the existence of uncultured bacterial 
clones within the donated saliva, which may add to biofilm complexity, therefore, 
more closely reflecting in vivo biofilms.  However, it has been shown previously 
that the complexity of the microbiota is lost when using in vitro systems (Pratten 
et al., 2003) and there are possible problems when using such inocula in 
maintaining reproducibility.  Therefore, to further aid in the refinement of the 
model a defined inoculum was investigated.  It has been identified that the inocula 
should contain precise quantities of each strain to prevent overgrowth and 
competition amongst species.  It is envisaged that it could be possible to change 
the composition of the mixed consortia in order to replicate the microbiotas which 
will be relevant to the three disease states under investigation.  Such studies on 
shifting the microbiota with dual and microcosm oral biofilms have been 
successfully carried out previously (Dalwai et al., 2006). 
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4.1 Introduction 
Building on the initial research carried out in chapter 3, optimising the standard 
Bioplate methodology, the investigations carried out in this chapter look to 
maximise the model usability, standardisation and stability.  The use of 
microcosm model systems, i.e. using plaque or saliva, has been advocated for 
many scenarios and has many advantages when trying to replicate the in vivo 
situation.  However, issues with reproducibility arise with using a microcosm, as 
only a limited number can ever be obtained and samples from different 
geographical locations would differ hugely.  Furthermore, as stated previously, it 
has been studied and reported by Pratten (2003), “…that an inoculum with a 
diverse bacterial population resulted in biofilms which appeared to contain a far 
less diverse microbiota, as a result possibly of selection processes inherent in 
modelling.”  This in turn, could have an adverse effect on the reproducibility of 
the developing biofilms within the model system, adversely effecting results.  
Thus, even with a microcosm inoculum, a reduction in speciation can occur in an 
in vitro system.  Therefore, to overcome these difficulties, a defined inoculum was 
investigated, based on its relevance to oral biofilms and ease in culturability, 
utilising reduced bacterial species that could be easily monitored.  This choice of 
species for the inoculum was established on the research carried out by McKee 
(1985) and discussed in chapter 2. The defined inoculum has been utilised in a 
number of previous studies investigating oral bacteria metabolism (Bradshaw et 
al., 1994a/b), effect of environmental pH (McDermid et al., 1986; Bradshaw et 
al., 1989) and effect of antimicrobial agents (McDermid et al., 1987, Bradshaw et 
al., 1993). 
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As discussed in chapter 2, the organisms utilised by McKee (1985) were, 
Streptococcus mutans ATCC 2-27351, Streptococcus sanguis NCTC 7865, 
Streptococcus mitis EF 186, Actinomyces viscosus WVU 627, Lactobacillus casei 
AC 413, Neisseria sp. A 1078, Veillonella alkalescens ATCC 17745, Bacteroides 
intermedius T 588 and Fusobacterium nucleatum, NCTC 10593.  Due to the 
unavailability of some of these organisms, they have been replaced for use in the 
Bioplate with more easily available representative NCTC strains, S. mutans 
NCTC 10449, S. sanguinis NCTC 10904, S. mitis NCTC 12261, A. viscosus 
NCTC 10951, L. casei var. rhamnosus NCTC 10302, N. mucosa var. mucosa 
NCTC 10774, V. dispar NCTC 11831, P. melaninogenica NCTC 11321 and F. 
nucleatum NCTC 10562. 
 
When carrying out in vitro biofilm model studies, set-up, organism growth and 
sample preparation can be as long as, or longer than, the actual analysis carried 
out on the biofilm.  To try and increase the through-put of this model system, the 
ability to prepare a frozen defined inocula which can be kept until required, would 
decrease model preparation by 7 days for organism growth.  For this protocol this 
was investigated using the organisms frozen (-80°C) in glycerol, either within 
prepared Bioplates or within 2 mL tubes waiting to be dispensed onto HA-coated 
mictotitre plates.  Glycerol‟s cryoprotection properties were first reported over 60 
years ago (Polge et al., 1949), since then it has been further studied to identify the 
optimal concentrations for bacterial cell preservation, these range from 2-55% 
(Harrison, 1956; Hollander and Nell, 1954; Howard, 1956; Postgate and Hunter, 
1961). 
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In this model system AlamarBlue® is utilised to measure cell viability. 
AlamarBlue® is based on the compound resazurin, first introduced by Guilbault 
and Kramer (1964).  When placed in a reducing environment AlamarBlue® is 
reduced to resofurin as shown in Figure 35. Resofurin, when in its reduced form 
will fluoresce, which can be monitored at 530 nm – 560 nm excitation wavelength 
and 590 nm emission wavelength (AlamarBlue Product data sheet). It is this 
change in fluorescence which is used as a viability indicator of both planktonic 
and biofilm organisms.  
 
 
Figure 35 Schematic of resazurin reduction to resorufin 
 
Using the diaphorase-resazurin pathway, Mashige et al., (1976) found that the 
released hydrogen from NADH (as in Figure 35) would reduce resazurin.  
However, it has also been shown that a number of reductant pathways where 
NADH is reduced can also affect resofurin generation, such as lactic acid 
dehydrogenase pathway (Guilbault and Kramer, 1964). 
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Resazurin has been widely used to assess cell viability post-exposure to 
antimicrobial agents (Bürgers et al., 2009; Mariscal et al., 2008; Toté et al., 
2009).  To decrease assay time, it has been noted by a number of investigators that 
having greater than 1x10
5
 CFU present, will help decrease exposure time to 
resazurin as the metabolic activity will initiate the change in fluorescence faster 
(O‟Brien et al., 2000; Shiloh et al., 1997; Peters et al., 2008).  Previous studies 
have tried to use various rapid methods to quantify bacterial numbers to the same 
detection limit currently available with standard culturing techniques.  This 
detection level could be generally stated as 10-10
2
 CFU.  Yamashoji et al., (2004) 
investigated the possibility that bioluminescence or chemical luminescence could 
be utilised to quantify total viable counts.  Unfortunately the authors found under 
certain assay conditions a correlation between CFU and luminescence could not 
be found.  Marciscal et al. (2009), tried again to correlate total viable count and 
viability fluorescence, but this time utilised resazurin.  In this investigation they 
found that the resazurin proved to be sufficient for measuring reductions in cell 
viability of 5-log CFU.  However, this too lacked the specificity that is currently 
found with tradition plating techniques for investigating total viable counts. The 
authors do discuss that “…..since each microorganisms has different resazurin 
kinetics it is necessary to generate a standard curve for each assay.”  
 
In this chapter, the generation of a standard inoculum to generate standard 
biofilms will be investigated.  The long term storage of this inoculum and the 
correlation between viable cells within this inocula and fluorescence will be 
determined.  
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4.2 Materials and Methods 
4.2.1 Species Evaluation 
4.2.1.1 Correlation between Absorbance and CFU 
Ringers and Peptone (R+P) diluent was manufactured and dispensed into 9 mL 
and 10 mL aliquots.  Blank control readings were taken using R+P diluent in a 
spectrophotometer set at λ=600 nm and the readings blanked to the R+P control.   
The same blank was used throughout the experiment.  
 
The organisms used in this study were S. mutans NCTC 10449, S. sanguinis 
NCTC 10904, S. mitis NCTC 12261, A. viscosus NCTC 10951, L. casei var. 
rhamnosus NCTC 10302, N. mucosa var. mucosa (var. heidelbergensis) NCTC 
10774, V. dispar NCTC 11831, P. melaninogenica NCTC 11321 and F. 
nucleatum NCTC 10562.  Streptococcal species were grown on TSA and 
incubated at 37°C aerobically for 48 hours.  The remaining organisms were grown 
on BA and incubated at 37°C anaerobically for 5-7 days.  Representative colonies 
were removed and placed in 10 mL of R+P; this was repeated until a density 
equivalent to 2.0 McFarland standard was reached.  Diluent was vortexed to 
ensure sample was completely homogenised.  One millilitre sample was removed 
and placed in a cuvette and placed in the spectrophotometer set at λ=600 nm.  
Absorbance was measured and recorded.  Five millilitres of the initial stock was 
dispensed and further diluted to an absorbance of 1.0.  Once reached, the sample 
was further diluted in 0.1 Abs increments and plated on appropriate agars for each 
organism and incubated as appropriate.  For absorbance increments from 1.0-0.6, 
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serial diluting of the sample was carried out to 10
-10 
in R+P, for absorbance 
increments between 0.5 - 0.1, samples were serially diluted to 10
-8 
in R+P.  Post-
incubation the relationship between absorbance and cfu/mL was calculated. This 
calculation was to ensure that all the microorganisms used in the defined 
inoculum were added at the correct concentrations. 
  
4.2.1.2 Growth Curves 
Using the organisms outlined in 4.2.1.1 and incubated as previously discussed in 
this chapter.  Representative colonies were removed and placed in BHI broth to a 
density equal to 0.5 McFarland standard.  Using 9 mL aliquots of BHI serial 
dilutions were generated to 10
-9
.  One hundred microlitres of each dilution was 
plated on BA in duplicate and incubated at 37°C either aerobically or 
anaerobically for between 2-7 days (species dependent). 
 
Using an uncoated 96-well microtitre plate each of the dilutions were added to 
each column (where n=8).  Growth was measured using an automatic microtitre 
plate reader set for absorbance at 450 nm using BHI as a blank.  Readings were 
taken every 30 minutes for 10-20 hours.  The plate reader was set with shaking to 
reduce settling at 37°C for the duration of the experiment.  Each dilution was 
plated on appropriate agar to give initial counts for each of the absorbencies.   
Readings were taken at 450 nm due to the limitations of the microtitre plate 
reader.  
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4.2.2 Inoculum Stability 
4.2.2.1 Generation of Inoculum for Long-Term Storage 
Using the data generated in the previous section, each of the concentrations of the 
organisms were made in R+P.  The following bacterial concentrations were 
generated, following the methods previously discussed in chapter 2, S. mutans 
(1x10
7
 cfu/mL), S. sanguinis (1x10
8
 cfu/mL), S. mitis (1x10
10
 cfu/mL), A. 
viscosus (1x10
6
 cfu/mL), L. casei (1x10
9
 cfu/mL), N. mucosa var. mucosa (1x10
6 
cfu/mL), V. dispar (1x10
9
 cfu/mL), P. melaninogenica (1x10
7
 cfu/mL) and F. 
nucleatum (1x10
8 
cfu/mL).  This was defined using the absorbance graphs in 
Figure 36.  One hundred microlitres of each organism was added to a 2 mL sterile 
tube, 16 tubes were filled.  Each container was vortexed at 8000 rpm for 10 
minutes and the supernatant was removed.  One millilitre of R+P with 5% 
glycerol was added to 8 tubes, 1 mL of R+P with 10% glycerol was added to the 
remaining 8 tubes.  Seven of each of the samples were placed in a -80°C freezer.  
Using the freshly filled tube, this was used to calculate initial cfu/mL bacterial 
counts. 
 
4.2.2.2 Stability Testing of Manufactured Inoculum 
Viable counts were taken at various time points to determine what expiry date 
should be assigned to the defined inoculum.  Viable counts were taken at the 
following time points whilst being stored at -80°C; initial (as discussed above), 
and at 1, 2, weeks, then 1, 2, 3, months.  At each time point a sample vial was 
removed from -80°C storage and allowed to come to room temperature.  To each 
vial was added 1 mL of BHI to resuspend the organisms.  One millilitre was 
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removed and added to 9.0 mL R+P. This was vortexed to ensure homogeneity of 
sample (this will equal a 1x10
-1
 dilution).  This was subsequently serially diluted 
to 1x10
-10
 and a 100 µL sample plated out in duplicate on appropriate agar and 
incubated as appropriate. 
 
4.2.3 Bioplate Storage 
To allow the development of an „off-the shelf‟ biofilm model, understanding the 
stability of the organisms during storage is paramount to ensure retention of 
bacterial viability and subsequent biofilm development. The research carried out 
here, investigated the stability of the organisms for 3 months in glycerol, on a HA 
coated microtitre plate. 
 
4.2.3.1 Stability of Organisms in a HA coated Microtitre Plate 
Hydroxyapatite plates were manufactured as in chapter 2, using the inoculum 
generated in section 4.2.2.1, 1 mL of each of the organisms were added to 30 mL 
sterile container, to this was added 9 mL of either 10 or 20% v/v glycerol.  An 
exception was N. mucosa, which was manufactured to 1x10
6 
cfu/mL to ensure 
detection above the limit of the agar plating methodology.  To each well on the 
HA coated microtitre plate was added 20 µL of test inoculum containing glycerol, 
assuming dilution to 5% and 10% v/v respectively.  For each time point a separate 
microtitre plate was utilised to ensure no interference with continual removal from 
storage, however, the 5% and 10 % v/v glycerol were tested on the same plate.  
Therefore, 6 HA coated plates are stored.  At each time point, 1 week, 2 week, 1 
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month, 2 months and 3 months a plate is removed and following the methodology 
for bacterial recovery from HA-coated microtitre plates in chapter 3, the 
organisms were recovered by adding 180 µL BHI and plated on BA incubated 
aerobically 37°C and modified BA containing haemin, manufactured as 
previously, incubated anaerobically at 37°C.  This was done due to the very small 
sample size available in each well, where it would be impractical to test for all 
species in this first evaluation. 
 
4.2.4 Correlation of Mean Fluorescence Units 
4.2.4.1 Planktonic Cells 
The organisms used in this study were S. mutans NCTC 10449, S. sanguinis 
NCTC 10904, S. mitis NCTC 12261, A. viscosus NCTC 10951, L. casei var 
rhamnosus NCTC 10302, N. mucosa var mucosa (var. Heidelbergensis) NCTC 
10779, V. dispar NCTC 10831, P. melaninogenica NCTC 11321 and F. 
nucleatum NCTC 10562.  Streptococcal species were grown on TSA and 
incubated at 37°C aerobically for 48 hours.  The remaining organisms were grown 
on BA and incubated at 37°C anaerobically for 5-7 days.  Representative colonies 
were removed and placed in 10 mL of R+P.  This was repeated.  The density was 
measured by removing 1 mL sample and placing in a cuvette and placing in a 
spectrophotometer set at λ=600 nm.  Absorbance was measured and recorded to 
generate a stock solution of 1x10
8
 cfu/mL, using the generated data in Figure 36.  
One millilitre of each of the stock solutions were added to 200 mL BHI or a 
modified BHI broth (37g BHI, Merck; 0.5 mL haemin, Sigma (manufactured by 
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adding 200 mg haemin in 50 mL 1M potassium hydroxide with 50 mL ethanol); 
0.2 mL vitamin K, (Sigma; manufactured by adding 0.15g vitamin K with 30 mL 
ethanol); 1 L deionised water.  This media was used for the growth of Prevotella 
sp.  All organisms, dependent on requirements were incubated either aerobically 
with shaking at 37°C or anaerobically without shaking at 37°C.  
 
One millilitre samples were removed from the broths after 2, 4, 6, 24 and 48 hours 
post-inoculation. The sample was placed in 9 mL R+P and serially diluted in 9 
mL R+P to 10
-8
.  One millilitre of each dilution was plated in duplicate on either 
TSA for streptococcal species and incubated at 37°C aerobically for 48 hours; the 
remaining organisms were grown on BA and incubated at 37°C anaerobically for 
5-7 days.  One millilitre sample was also removed at each time point and placed in 
a cuvette and placed in a spectrophotometer set at λ=600 nm and absorbance 
recorded. 
 
One hundred microlitre aliquots (in triplicate) were taken and placed in an HA-
coated microtitre plates, to which was added 20% v/v AlamarBlue® in BHI.  
Fluorescence was measured using a microtitre plate reader using a 530 nm 
excitation filter and a 590 nm emission filter.  Results were recorded as mean 
fluorescent units. 
 
4.2.4.2 Biofilm Cells 
Using the data generated in the previous section, each of the concentrations of the 
organisms were made in R+P.  The following organism concentrations were 
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generated, S. mutans (1x10
7
 CFU/mL), S. sanguinis (1x10
8
 CFU/mL), S. mitis 
(1x10
10
 CFU/mL), A. viscosus (1x10
6
 CFU/mL), L. casei (1x10
9
 CFU/mL), N. 
mucosa var. mucosa (1x10
6 
CFU/mL), V. dispar (1x10
9
 CFU/mL), P. 
melaninogenica (1x10
7
 CFU/mL) and F. nucleatum (1x10
8 
CFU/mL).  This was 
defined using the absorbance graphs in Figure 36, where n=8. 
 
One millilitre of each organism was added to a sterile container and vortexed to 
ensure fully mixed. Using a multichannel (x8) pipette, 20 µL of the inoculum was 
added to a pre-prepared HA coated microtitre plate following the method 
described in chapter 2. Subsequently, to each well was added 180 µL of BHI, the 
plate was then placed in a 37°C incubator aerobically for 24 hours, without 
shaking.  
 
 The plate containing the test agents were prepared in advance, CHX (Sigma) was 
used in this study at 0.2, 0.02 and 0.002% v/v, with deionised water as a negative 
control.  To each column on an uncoated microtitre plate, 200 µL of the test agent 
was added.  In this study, the dose response was repeated on the same plate, where 
the second dose response would be utilised to investigate cfu/biofilm. 
 
Taking an inoculated Bioplate that had been incubated overnight, exhausted 
media from each well was removed using a Nunc-Immunowash 12 manual plate 
washer fed with BHI and attached to an effluent bottle via a vacuum pump.  Wells 
were washed (x2) using the Immunowash to remove unattached or loosely bound 
bacterial cells, thus leaving the wells of the Bioplate empty.  Using a 96-Transtar 
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pipette (Corning, Sigma-Aldrich) and the uncoated 96-well plate, 200 µL of the 
test agents were transferred to the now empty Bioplate and incubated at 37°C for 
2 minutes while shaking.  Subsequently, using the Nunc-Immunowash, each well 
was washed (x2) with sterile BHI to remove traces of the test agent leaving the 
Bioplate empty.  Using an 8x multichannel pipette, 200 µL of sterile BHI was 
added to each well on the plate and re-incubated for 4 hours at 37°C.  To measure 
the viability of the biofilm, 10% v/v solution of AlamarBlue™ in BHI was 
prepared.  After the second incubation, the Bioplate was removed from the 
incubator and each well washed twice with sterile BHI.  Using an 8x multichannel 
pipette, 200 µL of the 10% v/v AlamarBlue™ solution was added to each well.  
The plate was further incubated for 30 minutes at 37°C with shaking.  
Fluorescence was measured using a microtitre plate reader using a 530 nm 
excitation filter and a 590 nm emission filter. Results were recorded as mean 
fluorescence units (MFU) where n=8. 
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4.3 Results 
4.3.1 Correlation between Absorbance and CFU 
 
 
Figure 36 Results showing linear correlation between CFU and absorbance at 600nm. 
 
The results in Figure 36 show the relationship between CFU counts and 
absorbance taken over one time point.  A linear relationship is shown in this 
study, if this analysis was carried out with respect to time, a linear relationship 
would not be expected, a typical bacterial growth curve would be anticipated. 
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4.3.2 Growth Curves 
Of all the species investigated, S. mutans, S. mitis, A. viscosus, L. casei var. 
rhamnosus, N. mucosa var. mucosa (var. heidelbergensis), P. intermedia and F. 
nucleatum only the results for the Streptococcus sanguinis, Veillonella dispar and 
S. mitis will be shown here due to space.  The results show that lag phase depends 
on the initial bacterial concentration of the planktonic cells. It is hypothesised that 
this is due to the faster utilisation of food source by the organisms contained 
within the medium. 
 
 
Figure 37 Graph showing S. sanguinis differences in growth curves dependent on initial bacterial 
starting concentration (n=8).  
 
Figure 38 shows V. dispar has a shorter exponential phase that S. sanguinis as in 
Figure 37. To ensure a defined population is representative of supragingival 
plaque these different growth rates will need to be considered. 
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Figure 38 Graph showing V. dispar differences in growth curves dependent on initial bacterial 
starting concentration (n=8). 
 
Growth curves in microtitre plate results were similar to that seen for all species 
tested, in that the initial starting concentration affected the length of time take to 
reach stationary and death phase.  
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Figure 39 Graph showing S. mitis differences in growth curves dependent on initial bacterial 
starting concentration (n=8). 
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4.3.3 Stability Testing of Inoculum 
The results in Table 7 show the recovery of the organisms in 5% glycerol held at -
80°C for up to three months in 2 mL Eppendorf tubes. 
 
Table 7 Stability of individual organisms held in 5% Glycerol for three months at -80°C, reported 
in Log10 
Organisms 
(starting 
concentration) 
Initial 
(post-
dilution) 
1 
week 
2 
weeks 
1 
month 
2 
months 
3 
mont
hs 
S. mutans 
1x10
7
 cfu/mL 
7.5 7.1 <1 <1 <1 <1 
L. casei 
1x10
9
 cfu/mL 
8.3 8.4 <1 <1 <1 <1 
A. viscosus 
1x10
6
 cfu/mL 
6.5 6.4 <1 <1 <1 <1 
N. mucosa 
1x10
4
 cfu/mL 
6.3 <1 <1 <1 <1 <1 
V. dispar 
1x10
9
 cfu/mL 
8.7 8.8 <1 <1 <1 <1 
P. melanogenicus 
1x10
7
 cfu/mL 
7.6 7.5 <1 <1 <1 <1 
F. nucleatum 
1x10
8
 cfu/mL 
8.3 8.2 <1 <1 <1 <1 
S. mitis 
1x10
10
 cfu/mL 
8.4 8.4 5.3 <1 <1 <1 
S. sanguinis 
1 x 10
8
 cfu/mL 
7.4 7.1 5.1 <1 <1 <1 
 
The results show that after 1 week storage at -80°C in 5% v/v glycerol, there was 
a marked reduction in viability of all species.  Therefore, it can be concluded that 
5% v/v glycerol is not able to provide a suitable shelf-life that would add any 
benefit to the model system. 
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The results in Table 8 show the recovery of the organisms in 10% glycerol held at 
-80°C for up to three months in 2 mL Eppendorf tubes. 
 
Table 8 Stability of individual organisms held in 10% glycerol for 3 months at -80°C, reported in 
Log10 
 
Organisms 
(starting 
concentration) 
Initial 
(post-
dilution) 
1 
week 
2 
weeks 
1 
month 
2 
months 
3 
months 
S. mutans 
1x10
7
 cfu/mL 
7.5 7.5 7.4 7.4 7.3 <1 
L. casei 
1x10
9
 cfu/mL 
8.3 8.4 8.4 8.4 6.0 <1 
A. viscosus 
1x10
6
 cfu/mL 
6.5 6.5 6.5 6.4 5.4 <1 
N. mucosa 
1x10
4
 cfu/mL 
6.3 6.2 6.4 6.3 <1 <1 
V. dispar 
1x10
9
 cfu/mL 
8.7 8.8 8.7 8.6 <1 <1 
P. melanogenicus 
1x10
7
 cfu/mL 
7.6 7.5 7.5 7.5 5.1 <1 
F. nucleatum 
1x10
8
 cfu/mL 
8.3 8.3 8.3 8.3 <1 <1 
S. mitis 
1x10
10
 cfu/mL 
8.4 8.4 8.4 8.4 7.5 <1 
S. sanguinis 
1x10
8
 cfu/mL 
7.4 7.6 7.5 7.4 7.3 <1 
 
The results from Table 7 and Table 8 both show bacterial viability can be retained 
after -80°C storage.  Ten per cent v/v glycerol showed the better recovery; 
however, even at this concentration viability was lost after two months storage.  
Therefore, it is recommended that the defined inoculum be stored at 10% v/v 
glycerol for 1 month at -80°C.  This would be a considerable time saving to the 
running of the methodology.  Investigating 15% v/v glycerol, may help extend 
this further, however this was not carried out at this time. 
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4.3.4 Stability Testing of Individual Inoculum in HA-Coated 
Microtitre Plates 
The results in Table 9 show the results for individual inoculum held at -80°C in 
5% glycerol for up to three months in the HA coated microtitre plates. 
 
Table 9 Stability of individual organisms held in a HA-coated microtitre plate in 5% glycerol for 3 
months at -80°C, reported in Log10 
 
Organisms 
(starting 
concentration) 
Initial 
(post-
dilution) 
1 
week 
2 
weeks 
1 
month 
2 
months 
3 
months 
S. mutans 
1x10
7
 cfu/mL 
7.5 <1 <1 <1 <1 <1 
L. casei 
1x10
9
 cfu/mL 
9.3 <1 <1 <1 <1 <1 
A. viscosus 
1x10
6
 cfu/mL 
6.4 <1 <1 <1 <1 <1 
N. mucosa 
1x10
4
 cfu/mL 
4.5 <1 <1 <1 <1 <1 
V. dispar 
1x10
9
 cfu/mL 
9.3 <1 <1 <1 <1 <1 
P. melanogenicus 
1x10
7
 cfu/mL 
7.6 <1 <1 <1 <1 <1 
F. nucleatum 
1x10
8
 cfu/mL 
8.3 <1 <1 <1 <1 <1 
S. mitis 
1x10
10
 cfu/mL 
9.4 <1 <1 <1 <1 <1 
S. sanguinis 
1x108 cfu/mL 
8.3 <1 <1 <1 <1 <1 
 
Unfortunately, the results show again that 5% v/v glycerol is not suitable for 
preserving the inoculum during storage at -80°C on a HA coated microtitre plate. 
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Table 10 Stability of individual organisms held in a HA-coated microtitre plate in 10% glycerol 
for 3 months at -80°C, reported in Log10 
 
Organisms 
(starting 
concentration) 
Initial 
(post-
dilution) 
1 
week 
2 
weeks 
1 
month 
2 
months 
3 
months 
S. mutans 
1x10
7
 cfu/mL 
7.5 <1 <1 <1 <1 <1 
L. casei 
1x10
9
 cfu/mL 
9.3 <1 <1 <1 <1 <1 
A. viscosus 
1x10
6
 cfu/mL 
6.4 <1 <1 <1 <1 <1 
N. mucosa 
1x10
4
 cfu/mL 
4.5 <1 <1 <1 <1 <1 
V. dispar 
1x10
9
 cfu/mL 
9.3 <1 <1 <1 <1 <1 
P. melanogenicus 
1x10
7
 cfu/mL 
7.6 <1 <1 <1 <1 <1 
F. nucleatum 
1x10
8
 cfu/mL 
8.3 <1 <1 <1 <1 <1 
S. mitis 
1x10
10
 cfu/mL 
9.4 <1 <1 <1 <1 <1 
S sanguinis 
1x10
8
 cfu/mL 
8.3 <1 <1 <1 <1 <1 
 
Again, it was seen that in the HA coated microtitre plate, the inoculum did not 
remain viable under starage at -80°C. In comparison with storage in the 2 mL 
Eppendorf tubes (Table 8), there is no retention of activity, even with the 10% v/v 
glycerol.  
 
Thus, it is recommended that the defined inoculum be stored at in 10% v/v 
glycerol in 2 mL Eppendorf tubes for a maximum of one month to ensure viability 
of all species is retained. 
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4.3.5 Correlation of MFU with Planktonic CFU 
Below are the results comparing cfu/mL with MFU and absorbance in  
Table 11.  
 
Table 11 Correlation of absorbance at 600 nm with CFU in BHI and BHI + 10% glycerol broth. 
 BHI BHI+10% Glycerol 
Ab@ 
600nm 
Log10 
CFU 
MFU 
Count 
Ab@ 
600nm 
Log10 
CFU 
MFC 
Count 
S. mutans 
Inoc = 
2.3x10
8 
cfu/mL 
Base 0.000 ---------- 429 0.000 -------- 459 
1 hr 0.003 6.07 366 0.006 6.24 545 
2 hrs 0.004 6.03 510 0.003 6.13 672 
3 hrs 0.006 7.28 361 0.003 6.18 524 
4 hrs 0.009 6.23 691 0.003 6.68 934 
5 hrs --------- ---------- ------- -------- -------- ------- 
6 hr 0.016 6.47 540 0.005 6.26 380 
7 hrs 0.023 7.08 903 0.006 6.33 524 
24 hrs 0.338 11.72 5172 0.713 11.74 4872 
48 hr 0.603 11.21 3281 0.798 11.65 1174 
L. casei 
Inoc. = 
2.1x10
9  
cfu/mL 
Base 0.000 ---------- ------- 0.000 -------- ------- 
2 hrs 0.005 7.50 452 0.003 6.59 508 
4 hrs 0.009 7.47 585 0.006 6.51 578 
6 hrs 0.021 6.65 602 0.011 6.86 844 
24 hrs 0.554 9.48 4640 0.199 10.49 2781 
48 hrs 0.511 10.76 4470 0.255 7.77 3265 
N. mucosa 
Inoc.= 
4.5x10
5 
cfu/mL 
Base 0.000 -------- ------- 0.000 ------- ------- 
2 hrs 0.010 4.44 457 0.001 4.83 530 
4 hrs 0.010 5.28 475 0.004 4.24 553 
6 hrs 0.010 6.51 466 0.005 3.57 503 
24 hrs 1.332 9.17 4503 0.070 9.70 939 
48 hrs 1.150 8.41 4145 0.627 11.30 4396 
S.mitis 
Inoc. = 1856 
cfu/mL 
Base 0.000 --------- ------- 0.000 ------ ------ 
2 hrs 0.022 3.26 230 0.011 2.99 252 
4 hrs 0.031 4.60 443 0.021 4.67 493 
6 hrs 0.034 2.94 439 0.025 2.16 491 
24 hrs 0.462 7.31 538 0.400 4.51 293 
48 hrs 0.561 6.89 4014 0.443 6.69 1843 
S.sanguinis 
Inoc. = 
2.27x10
4
 
cfu/mL 
Base 0.000 --------- ------- 0.000 ------- ------- 
2 hrs 0.124 4.67 233 0.003 4.62 244 
4 hrs 0.139 3.15 443 0.007 4.42 494 
6 hrs 0.141 8.04 439 0.010 4.56 496 
24 hrs 1.188 9.32 538 0.763 8.62 3818 
48 hrs 1.182 7.30 4080 0.748 9.4 3600 
F. nucleatum 
Inoc. 
=2.00x10
4
 
cfu/mL 
Base 0.000 --------- -------- 0.000 ------- ------- 
2 hrs 0.002 3.33 462 0.001 3.40 956 
4 hrs 0.004 3.98 884 0.003 3.51 2363 
6 hrs 0.005 2.31 542 0.005 3.31 1336 
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24 hrs 0.012 3.30 590 0.010 3.31 1551 
48 hrs 0.013 1.20 415 0.010 1.30 657 
P. 
melaninogen
icus 
Inoc. = 
9.4x10
3
 
cfu/mL 
Base 0.000 --------- -------- 0.000 -------- ------- 
2 hrs 0.002 8.66 557 0.002 8.51 1576 
4 hrs 0.006 8.56 936 0.001 8.67 3011 
6 hrs 0.007 8.22 576 0.009 8.54 2165 
24 hrs 0.021 8.12 428 0.019 6.66 1912 
48 hrs 0.191 4.54 428 0.020 3.59 765 
A. viscosus 
Inoc. = 
2.64x10
9
 
cfu/mL 
Base 0.000 -------- -------- 0.000 ------- ------- 
2 hrs 0.001 8.66 391 0.002 8.51 353 
4 hrs 0.003 8.56 455 0.001 8.67 404 
6 hrs 0.010 8.22 859 0.009 8.54 662 
24 hrs 0.174 8.12 1334 0.019 6.66 854 
48 hrs 0.191 4.54 670 0.020 3.59 543 
V. dispar 
Inoc.= 
5.28x10
9 
cfu/mL 
Base 0.000 -------- ------- 0.000 ------- ------- 
2 hrs 0.004 9.22 423 0.001 9.52 347 
4 hrs 0.005 9.13 472 0.003 9.31 401 
6 hrs 0.013 10.06 859 0.007 8.48 662 
24 hrs 0.152 9.99 1618 0.025 7.30 707 
48 hrs 0.163 8.91 684 0.031 6.19 433 
 
The relationship analysis looked at the change in ratio over time verses Log10 cfu 
as this is the known variable, and MFU and Ab as the unknown variables. All the 
results were graphically represented below, however, between 6-7 hour 
measurement and 24 hours, some of the relationships were compromised. It is 
hypothesied that this was due to the rate limiting step of available nutrients. 
Therefore, to fully understand any relationships, the results will be graphically 
represented from1 to 6-7 hours.  
 
In this analysis R
2 
was calculated where R2= correlation coefficient where 1= 
perfect correlation. For this analysis R
2
< 0.98 was not deemed to be a close 
correlation. R
2
>0.98 was deemed to be a close correlation where the results could 
be utilised to determine MFU, Ab or cfu where one parameter was already known. 
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Figure 40 Streptococcus mutans relationship analaysis. The results show poor correlation where 
R
2
< 0.98, where no relationship could be identified between MFU, cfu or Ab. 
 
The results from Figure 40 show that no correlation could be identified between 
cfu, MFU and absorbance measurements. 
 
 
Figure 41 Lactobacillus casei relationship analysis.The results show poor correlation where 
R
2
<0.98 for the organisms grown in BHI + 10% v/v glycerol. A good correlation was identified 
between cfu, MFU and absorbance for organisms grown in BHI 
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Figure 41 shows a poor correlation between cfu, absorbance and MFU for L. casei 
grown in BHI + 10% v/v glycerol. However, a good correlation was found where 
L. casei was grown in BHI. Therefore, for up to 6 hours post-incubation, where 
one parameter is known, using the ratio, the other parameters can be determined. 
 
 
Figure 42 Neisseria mucosa relationship analysis. The results show poor correlation where 
R
2
<0.98 for the organisms grown in BHI + 10% v/v glycerol. A good correlations was identified 
between cfu, MFU and absorbance for organisms grown in BHI. 
 
Figure 42 shows a poor correlation between cfu, MFU and absorbance for N. 
mucosa grown in BHI + 10% v/v glycerol. However, a good correlation was 
found where N. mucosa was grown in BHI. Therefore, for up to 6 hours post-
incubation, where one parameter is known, using the ratio, the other parameters 
can be determined. 
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Figure 43 Streptococcus mitis relationship analysis. The results show poor correlations where 
R
2
<0.98, where no relationship could be identified between MFU, cfu or Ab 
 
Figure 43 showed that no correlation could be identified between cfu, MFU or 
absorbance for S. mitis. 
 
 
Figure 44 Streptococcus sanguinis relationship analysis. The results show poor correlation where 
R
2
<0.98, where no relationship could be identified between MFU, cfu or Ab. 
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Figure 44 show that no correlation could be identified for S. sanguinis between 
cfu, MFU and absorbance. 
 
 
Figure 45 Fusobacterium nucleatum relationship analysis. The results show poor correlation 
where R
2
<0.98, however a good correlation was identified when the organism is grown in BHI, 
between cfu and absorbance where R=0.9957. 
 
Figure 45 show that only one correlation could be identified for F. nucleatum and 
the relationship between cfu and absorbance. No other correlations were identified 
using this species between MFU, cfu and absorbance, where, in all instances 
R
2
<0.98. 
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Figure 46 Prevotella melaninogenicus relationship analysis. The results show poor correlation 
between cfu, MFU and absorbance where in all instances R
2
<0.98. 
 
Figure 46 shows no correlation could be identifeied for P. melaninogenicus 
between cfu, MFU and absorbance. 
 
 
Figure 47 Actinomyces viscosus relationship analysis. The results show poor correlation between 
cfu, MFU and absorbance where R
2
<0.98. 
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The results from Figure 47 shows that no correlation could be identified for A. 
viscosus between cfu, MFU and absorbance. 
 
 
Figure 48 Veillonella dipar relationship analysis. The results show good correlation where 
R
2
=0.9985 for the organisms grown in BHI + 10% v/v glycerol (cfu/Ab). For all other results the 
correlations was poor where R
2
<0.98. 
 
Figure 48 shows that only one analysis showed good correlation, where 
R
2
=0.9985. This was where V. dispar was grown in BHI + 10% v/v glycerol and 
investigated for cfu/Ab correlation. Therefore, for up to 6 hours post-incubation, 
where one parameter is known (cfu or absorbance), using the ratio, the other 
parameter can be identified. 
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4.3.6  Correlation of MFU with Biofilm CFU 
From Figure 49 (A and B) is is seen that the repeatability of the CHX dose 
response is positive, if indeed excellent on the same plate. Figure 49 (B) was 
further utilised to determine cfu/biofilm. The results can be found in Figure 50 
and Table 12.  
 
 
Figure 49 Repeating CHX dose response in the developed Bioplate. No statistical differences 
between repeat treatments was identified. A continued reduction in viability was seem with an 
increase in CHX concentration, deionised water was used at a negative control (n=8). 
 
Using One-Way ANOVA between similar test treatments, no statistical 
differences were found. There is a correlation, in this study that increasing MFU 
equates to an increase in cfu/biofilm, however, it cannot be extrapolated which 
organisms are affecting MFU from the results in Figure 50.  It should be taken 
with caution that this result, from Figure 49 can show that MFU and cfu are 
closely related.  The results show, 0.02% v/v CHX to have very low MFU, 
however, when the organisms are regrown on nutrient agar the cfu is higher than 
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expected, showing the organisms capacity to recover, as seen in Figure 50.  
Possibly indicating both bacterial kill and reduction in metabolism due to 
environmental stresses. 
 
 
Figure 50 Effect of CHX dose response on bacterial recovery from the Bioplate where n=8. . 
 
 
Table 12 Effect of CHX dose response on bacterial recovery from the Bioplate 
 0.2% 0.02% 0.002% Deionised 
Water 
Media Log10 Counts 
Total Counts <1 4.5 6.4 7.5 
Gram negative <1 <1 3.3 4.2 
Streptococcus spp. <1 4.1 4.5 5.4 
Lactobacillus spp. <1 2.4 4.3 5.3 
Neisseria spp. <1 2.2 3.0 4.4 
Actinomyces spp. <1 <1 4.2 4.5 
Veillonella spp. <1 2.5 3.4 5.4 
S. mutans  <1 2.7 3.0 3.3 
 
 
0 
1 
2 
3 
4 
5 
6 
7 
8 
0.20% 0.02% 0.00% Deionised 
Water 
Lo
g1
0
  c
fu
/b
io
fi
lm
 
% v/v CHX 
Total Counts 
Gram negative 
Strep spp. 
Lactobacillus spp. 
Neisseria spp. 
Actinomyces spp. 
Veillonella spp. 
S. mutans  
  
 
174 
 
4.4 Discussion 
This section investigated the possibility of improving the model system by 
investigating the stability of the bioplate, therefore, offering a truly „off-the-shelf‟ 
biofilm model system. The key finding in this chapter was the utilisation of mixed 
species inocula held at -80°C for one month in 10% glycerol.  This permits a 
faster turnaround for testing, as the initial bacteria growth and set up has been 
removed.  This is a saving of 7 days set up before each analysis.  None of the 
analyses utilising 5% glycerol, showed any retention of bacterial cell viability 
beyond 2 weeks.  
 
It should be noted, it was anticipated that the organisms would remain viable on 
the HA coated microtitre plates, in 10% glycerol after storage at -80°C for at least 
1 month.  This however was not the case, where a reduction in viability was seen 
with a number of species at this time point.  It is hypothesised that this may be due 
to the very small volume placed in each of the wells, and the large surface area 
created via the HA coating.  A review of the literature shows no research into the 
effect of small volume storage, with respect to surface area, to support or 
contradict this hypothesis and furthermore, further work would need to be carried 
out to support this hypothesis. 
 
It is also recommended the following concentrations be generated following that 
recommended by McKee (1985), S. mutans (1x10
7
 cfu/mL), S. sanguinis (1x10
8
 
cfu/mL), S. mitis (1x10
10
 cfu/mL), A. viscosus (1x10
6
 cfu/mL), L. casei (1x10
9
 
cfu/mL), N. mucosa var. mucosa (1x10
6 
cfu/mL), V. dispar (1x10
9
 cfu/mL), P. 
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melaninogenica (1x10
7
 cfu/mL) and F. nucleatum (1x10
8 
cfu/mL) for use as the 
defined inoculum.  One hundred microlitres of each organism should be added to 
a 2 mL Eppendorf tube and centrifuged at 8000 rpm for 10 minutes and the 
supernatant removed. This should then be replaced with 900 µL of 10% v/v 
glycerol in R+P and store at -80°C for 1 month. 
 
As stated in the introduction, Mariscal et al. (2009) utilised resazurin dye as an 
indicator of bacterial respiration.  In this study correlation with bacterial numbers 
was also investigated and showed that it is possible to estimate bacterial counts 
via the generation of initial growth curves.  It should be noted that this method 
was recommended if the bacterial numbers were between 1x10
3
 – 1x108 CFU for 
an estimate of the CFU to be made after 5 hours.  However, this study utilised 
single species.  The biofilm model developed as part of this PhD utilised mixed 
species biofilms to be more representative of what would be found in the oral 
cavity.  These differences in growth rates and respiration of these different 
organisms make this method of correlation between cell count and MFU 
unreliable in this biofilm model.  
 
In the next chapter, I aim to investigate other peer reviewed biofilm model 
systems for the development or orally relevant biofilms, and their ability to rank 
and screen antimicrobial actives.  
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CHAPTER 5: Comparison of Bioplate model 
with peer reviewed in vitro model systems 
  
 
177 
 
5.1 Introduction 
The search for new antimicrobial agents for improved biofilm control within the 
oral cavity requires that appropriate screening models be put in place.  Key 
criteria for these models would ideally include; 1. The ability to be predictive of 
clinical outcome, 2. The use of orally relevant organisms (mixed species), 3. 
Bacteria present in biofilms, 4. Short contact time relevant to the use of oral care 
products, 5. Reproducibility and 6. High-throughput. 
 
In situ oral biofilm models are considered the „gold standard‟ of oral biofilm 
research as they permit the generation and testing of biofilms under their native 
environments, reflecting what would be seen clinically in the absence of host 
factors.  A number of in situ models have been developed to investigate caries 
(Gameiro et al., 2009; Zero, 1995), dentinal caries (Lima et al., 2009), fluoride 
penetration through plaque (Robertson et al., 1997; Watson et al., 2004; Watson 
et al., 2005) and to monitor the effect of preservatives on oral biofilms (Arweiler 
et al., 2008).  However, these studies tend to very expensive and time consuming 
to run as screening models. 
 
In vitro model systems offer controlled systems for the evaluation of biofilms.  
There are a number of peer reviewed systems currently available, CDFF, MBEC 
and Sorbarod for modelling biofilms found in the oral cavity, and subsequent 
testing of antimicrobial agents against these biofilms. 
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The constant depth film fermenter (CDFF) concept was originally discussed in 
1974 by Atkinson and Fowler, focussing primarily on a microbial film fermenter.  
Utilising this concept and building on research carried out by Coombe (1981), 
further model developments by Peters and Wimpenny in 1988, resulted in a model 
that would allow the development of replicate biofilms of a defined thickness.  
This model permits the development of biofilms between 50-600 µm thick due to 
the biofilms being grown in recessed pans.  The thickness is limited by a static 
Teflon blade which sweeps excess biomaterial from the pans as the turntable 
rotates.  This is a closed model system where the environmental gas, medium and 
inoculum can be controlled.  The biofilms can be removed and evaluated for 
bacterial counts, architecture and antimicrobial efficacy of any test substances. 
The CDFF model system has been widely used in oral biofilm development and 
research (McBain et al., 2003; Metcalf et al., 2006; Pratten et al., 1998; Vroom et 
al., 1999; Wilson, 1990). 
 
The MBEC model was developed from the Calgary Biofilm Device (CBD) and 
developed by Ceri et al., (1999).  A key reason for utilising this methodology is 
that it is a peer reviewed, 96-well microtitre plate biofilm screening model.  The 
MBEC model system utilises both the lid, which contains 96 pegs, corresponding 
to each of the 96-wells on the base of the plate.  Once a test inoculum is added to 
the microtitre plate and the plate incubated at an appropriate temperature and time, 
biofilms will form on the pegs.  The model was developed to investigate the 
antibiotic susceptibility of attached bacteria, whilst in a biofilm state. 
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Previous studies have demonstrated that the perfused Sorbarod biofilm system can 
maintain stable bacterial communities (Ledder et al., 2006; McBain et al., 2005).  
Orally generated malodour can be controlled by a number of methods such as 
masking, inactivation/neutralisation of malodourous molecules or use of 
antimicrobial agents to kill the volatile sulphur compound (VSC) producing 
organisms (Carvalho et al., 2004; Young et al., 2003).  The Sorbarod biofilm 
permits the development of an orally relevant mixed species biofilm model in 
which test actives can be evaluated for their impact on VSC levels and 
antibacterial ability under conditions of flow.  The model is based on the Perfused 
Biofilm Model (Hodgson et al., 1995), modified to include an orally relevant 
malodourous biofilm derived from tongue dorsum scrapings (Greenman et al., 
2005), and uses a Sorbarod filter (cylindrical paper sleeve encasing a compacted 
concertina of cellulose fibres, like a cigarette filter) to allow the attachment and 
growth of bacteria.  Continuous flow of media provides a substantivity challenge 
when evaluating the efficacy of test agents.  The model was used to compare the 
anti-VSC efficacy of various agents with antimicrobial and/or VSC neutralising 
activity employing gas chromatograph analysis for the determination of hydrogen 
sulfide and methyl mercaptan concentrations, building on a model designed by 
Spencer et al. (2007) utilising a Halimeter to monitor total VSC‟s. 
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5.2 Materials and Methods 
5.2.1 Constant Depth Film Fermenter 
The CDFF employed in this study was a modified version first developed by 
Peters and Wimpenny in 1988.  An overview of the model is discussed in chapter 
2. 
 
5.2.1.1 Inoculation of the Constant Depth Film Fermenter 
A defined inoculum was used to inoculate the CDFF, and was plated out on 
relevant media (full details can be found in chapter 4) to obtain required 
concentrations.  The organisms used were, S. mutans NCTC 10449 (10
8
 cfu/mL), 
S. mitis NCTC 12261 (10
10 
cfu/mL), S. sanguinis NCTC 10904 (10
6
 cfu/mL), A. 
viscosus NCTC 10951 (10
6
 cfu/mL), L. casei var. rhamnosus NCTC 10302 (10
10
 
cfu/mL), N. mucosa NCTC 10774 (10
9
 cfu/mL), V. dispar NCTC 11831 (10
5 
cfu/mL), P. melaninogenica NCTC 11321 (10
9
 cfu/mL) and F. nucleatum NCTC 
10562 (10
5
 cfu/mL).  One millilitre of each organism; S. mutans, S. mitis, S. 
sanguinis and L. casei was added along with 4 mL of A. viscosus, N. mucosa, V. 
dispar, P. melaninogenica, F. nucleatum to 300 mL of artificial saliva. The 
artificial saliva was prepared by mixing: 
 0.7 g Lab-lemco powder (Oxoid, UK), 
 0.14 g yeast extract (Oxoid, UK), 
 3.5 g proteose peptone (Oxoid, UK), 
 1.75 g hog gastric mucin (Sigma, UK), 
 0.245 g sodium chloride (Sigma, UK), 
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 0.14 g calcium chloride (Sigma, UK), 
 0.14 g potassium chloride (Sigma, UK) 
 300 mL deionised water 
and autoclaving at 121°C for 15 minutes.  When cooled 0.875 mL of 40% w/v 
urea (Oxoid, UK) was aseptically added to the medium.  This is based on the 
artificial saliva developed by Russell and Coulter (1975). 
 
The inoculum was added to the CDFF for 5 hours at a rate of 0.5 mL/min, 
incubated at 37°C aerobically and continually mixed with a magnetic stirrer. This 
was equivalent to the mean salivary flow rate of 0.72 litres/day for humans 
(Guyton, 1992). Subsequently, the inoculum was removed and the CDFF was then 
continually fed with artificial saliva at a rate of 0.34 mL/min.  The CDFF unit was 
incubated at 37°C aerobically.  At various time points biofilms were removed for 
analysis. 
 
5.2.1.2 Susceptibility Testing of the Constant Depth Film Fermenter 
At defined time points (1, 3, 5 and 8 days) a PTFE pan with associated biofilm 
was removed from the CDFF using the procedure above.  Two of the biofilms 
were aseptically removed from the PTFE pan and each placed in 10 mL sterile 
R+P individually.  This was then vortexed for 1 minute to disrupt the biofilms.  
Serial dilutions were carried out in 9 mL of R+P from 10
-2
 to 10
-10
 dilution on 
selective and non-selective agars in duplicate (as noted in Table 13).  This gave 
baseline counts for the biofilms samples at each time point. 
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Table 13 Selective and non-selective agars 
Organism Media 
Total Counts 6% v/v Horse blood agar 
Gram-negative 6% v/v Horse blood agar + 2.5 µg/mL 
vancomycin, incubate anaerobically 
Streptococcus spp. Mitis salivarius agar (BD, Franklin Lakes, USA) 
Lactobacilli spp. Rogosa agar (Fluka) 
S. mutans 6% v/v Horse blood agar + 100 µg/mL 
streptomycin 
Neisseria spp. 6% v/v Horse blood agar + 2.5 µg/mL 
vancomycin incubate aerobically  
Actinomyces spp. Actinomyces Isolation Media (Zylber and 
Jordan, 1982) 
Fusobacterium spp. Fusobacterium media 
Veillonella spp. Veillonella agar 
 
Agars were prepared using the following methods, for 6% v/v horse blood agar, 
42.5 g blood agar base No 2 (Sigma), and boiled in 1 L of deionised water to 
dissolve, a magnetic flea was added to the container, and autoclaved at 121°C for 
15 minutes.  Once cooled to 45-55°C, 60 mL of defibrinated horse blood 
(Southern Group Laboratories, Corby, UK) was aseptically added and mixed.  
Agar was pour plated into 90 mm Petri dishes, expiry dated for two weeks and 
stored between 2-8°C until use.  Following the above method to prepare 6 % 
horse blood, to make the gram-negative media, 0.25 g of vancomycin (Sigma) 
was added to 100 mL of sterile deionised water and mixed to dissolve.  One mL 
of this was added to 1 L of the prepared horse blood media to generate an in-use 
concentration of 2.5 µg/mL at the same time as addition of the horse blood.  For 
the recovery of S. mutans the same method was followed with respect to the 
preparation of 6% v/v horse blood agar, to generate 100 µg/mL final 
concentration of streptomycin, 1 g of streptomycin (Sigma)  was added to 10 mL 
of sterile deionised water, and mixed to dissolve.  One millilitre was subsequently 
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added to the autoclaved media once cooled to between 45-55°C.  Rogosa agar was 
manufactured following the manufacturers (Fluka) instructions, 73 g of the 
dehydrated media was added to 1 L and boiled to dissolve, one vial of Tween 80 
(Fluka) was added and the media filled into 90 mm Petri dishes.  This media is not 
autoclaved.  Actinomyces isolation media was based on the media developed by 
Zylber and Jordan (1982), and was purchased pre-prepared from Anaerobe 
Systems (Morgan Hill, CA, USA).  Mitis salivarius agar (BD, Franklin Lakes, NJ, 
USA) was prepared following the manufacturer‟s instructions, 90 g of the 
dehydrated media was added to 1 L deionised water and a magnetic flea added to 
the mixture, boiled to dissolve and autoclaved at 121°C for 15 minutes.  Once 
cooled, 1 mL of 1% Tellurite solution (BD) was aseptically added and mixed.  
Fusobacterium agar was purchased pre-prepared from Anaerobe systems.  
Veillonella media was prepared as follows, agar (Oxoid), 15 g; tryptone (Sigma), 
5 g; yeast extract (Oxoid), sodium thioglycollate (Sigma), 0.75 mL, basic fushcin 
(Sigma), 0.002 g; sodium lactate (VWR), 2.4 mL was added to 1 L deionised 
water.  Media was autoclaved at 121°C for 15 minutes and once cooled, 1 mL of 5 
mg/mL vancomycin (Bioconnections, Weatherby, UK) was added and mixed. 
 
5.2.1.3 Antimicrobial Testing of Developed Biofilms 
As found in the previous study to reach a steady biofilm state took 5 days post-
inoculation.  Two biofilms were removed after 5 days incubation from a pan, and 
placed in 10 mL R+P individually and vortexed for one minute to remove the 
biofilm from the HA substrate.  Serial dilutions were carried out in 9 mL R+P 
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from 10
-2
 to 10
-10
 dilutions on selective and non-selective agars in duplicate as 
described in 5.2.1.5.  This gave initial counts prior to testing. 
 
Subsequently, after 5 days a pan was removed and placed in a 60 mL Sterilin pot 
containing either 0.5, 0.1 or 0.1% v/v CHX or a 60 mL Sterilin pot containing 
either 1 or 0.5% triclosan, taking care not to disturb the intact biofilms.  After two 
minutes the pans were removed and gently washed in sterile R+P, again, taking 
care not to disrupt the biofilms.  Subsequently, two biofilms were removed and 
placed in 10 mL R+P and vortexed for 1 minute to remove the biofilm from the 
HA substrate.  Serial dilutions were carried out in 9 mL R+P from 10
-2
 to 10
-10
 
dilutions on selective and non-selective agars in duplicate as described in 5.2.1.2. 
 
5.2.2 Minimum Biofilm Eradication Concentration (MBEC)  
The original model developed was called the Calgary Biofilm Device (CDB) and 
was developed by Ceri et al. (1999). A key reason for utilising this methodology 
is that it is a peer reviewed, 96-well microtitre plate biofilm screening model.  An 
overview of the model can be found in chapter 2.  
 
5.2.2.1 Growth of Bacterial Subcultures  
Utilising the stock organisms held on either TSA or 6% blood agar slopes, S. mitis 
NCTC 12261, A. viscosus NCTC 10951, L. casei var. rhamnosus NCTC 10302, 
N. mucosa var. mucosa NCTC 10774, V. dispar NCTC 11831, P. melaninogenica  
NCTC 11321 and F. nucleatum NCTC 10562 were sub-cultured onto appropriate 
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agar, either TSA or 6% blood agar to obtain enough viable organisms, and to 
confirm purity of sub-culture to be utilised in these studies.  Sub-cultures were not 
grown on agars containing selective agent, some antibiotics can initiate an 
adaptive response in the culture and this may result in modified biofilms.  Each 
organism was subsequently suspended in R+P diluent, suspension was adjusted to 
1.0 McFarland standard.  One millilitre of S. mutans, S. sanguinis and S. mitis, 
was placed in 29 mL BHI broth, A. viscosus, L. casei, N. mucosa var. mucosa, V. 
dispar, P. melaninogenica and F. nucleatum were placed in a modified BHI with 
0.0001% w/v haemin (Sigma, UK).  Haemin stock solution (0.2% w/v) was 
manufactured by first adding 200 mg of haemin in 50 mL 1M potassium 
hydroxide solution and adding 50 mL ethanol.  All standard inocula were serially 
diluted and plated to determine the initial bacterial concentrations.  
 
Defined inoculum was used to inoculate the MBEC model using the same inocula 
generated in 5.2.1.2 using the method in chapter 4. To summarise, the organisms 
used were S. mutans NCTC 10449 (10
8
 cfu/mL), S. mitis NCTC 12261 (10
10
 
cfu/mL), S.sanguinis NCTC 10904 (10
6
 cfu/mL), A. viscosus NCTC 10951 (10
6
 
cfu/mL), L. casei var rhamnosus NCTC 10302 (10
10
 cfu/mL), N mucosa NCTC 
10774 (10
9
 cfu/mL), V. dispar NCTC 10831 (10
5
 cfu/mL), P. melaninogenica 
NCTC 10321 (10
9
) cfu/mL and F. nucleatum NCTC 10562 (10
5
 cfu/mL).  One 
millilitre of each organism suspension was added to a 30 mL sterile container, to 
this was added 1 mL of R+P and 10 mL of 20% glycerol in BHI, this was 
subsequently vortexed to ensure homogeneity.  Two millilitres of this inoculum 
was added to 28 ml BHI and added to the reagent reservoir, ensuring all pegs 
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reached the growth media.  Excess was stored in 2 mL Eppendorfs and stored at -
80°C for up to one month. 
 
Opening a MBEC plate, one for each organism, the inocula was added to the 
reagent reservoir, ensuring all the pegs are placed and reaching the growth media.  
The plates were then placed on a rocking table in a 37°C incubator.  Aerobic 
organisms were incubated at 37°C for 24 or 48 hours.  Organisms which required 
anaerobic or increased CO2 environments were incubated without shaking at 37°C 
for between 1-5 days.   
 
5.2.2.2 Antimicrobial Challenge for MBEC 
Described below are details carried out of a dose response of a chlorhexidine, 
triclosan and zinc chloride.  Using a new microtitre plate, sterile deionised water 
was added to column 1 as a standard control and from column 2-9 was added 
varying concentrations of CHX including 2, 1, 0.5, 0.25, 0.1, 0.05, 0.01, 0.001% 
v/v, respectively.  Triclosan was solubilised in propylene glycol (5% v/v) and 
evaluated at 1, 0.5, 0.25, 0.125, 0.063, 0.031, 0.016, 0.008 and 0.004% w/v.  
Propylene glycol (5% v/v) was also used as a negative control.  Zinc chloride was 
dissolved in sterile deionised water and evaluated at 5, 2, 1, 0.8, 0.4, 0.2, 0.1, 0.05, 
0.01, 0.001% w/v.  In all assays 0.2% v/v CHX and sterile deionised water were 
used as positive and negative controls respectively.  
 
After removing the inoculated MBEC plates from the incubator, the plates were 
rinsed in a separate plate prepared previously, which contained R+P buffer 
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solution.  Washing was carried out to remove any unattached or loosely bound 
organisms.  Three pegs were removed from column 12 using sterile forceps and 
each transferred to 10 mL of R+P diluent. This was subsequently vortexed for 1 
minute and serially diluted from 10
-1
 to 10
-7
 and plated in duplicate on appropriate 
agar, then incubated with respect to the requirements of the individual organism.  
The remaining pegs, still attached to the lid, were transferred to the 96-well 
microtitre plates containing the CHX and placed in 37°C incubator for two 
minutes.  Subsequently, the plate was removed from the incubator and rinsed in a 
separate plate, prepared previously, which contained R+P buffer solution.  Two 
hundred microlitres of 10% AlamarBlue™ in BHI was added to a separate 96-
well microtitre plate.  The washed pegs were then added to this and re-incubated 
for 30 minutes at 37°C with shaking.  Fluorescence was measured using a 
microtitre plate reader (Biotek) using a 530 nm excitation filter and a 590 nm 
emission filter. Results are recorded as mean fluorescence units (MFU). 
 
5.2.3 Sorbarod Biofilm Model 
An overview of the model system can be found in chapter 2.  This model system 
was developed to inoculate and investigate tongue derived organisms. 
 
5.2.3.1 Preparation of Inoculum 
The inoculum was generated using a sterile toothbrush (Mcleans, GSK, Brentford, 
UK; autoclaved at 121°C for 15 mins) firmly brushed against the posterior dorsum 
of the tongue of a single donor and washed in 10 mL of sterile phosphate buffered 
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saline (PBS).  These steps were repeated until an optical density equivalent to a 
3.0 McFarlane standard was obtained. The PBS was then added to 10 mL of 
sterile double strength Brain Heart Infusion (BHI) broth (Oxoid).  The inoculum 
(2 mL) was added to a sterile Sorbarod housed in a 2 mL syringe in the absence of 
flow.  Once inoculated, Sorbarod filters were incubated overnight in an anaerobic 
cabinet at 37°C, then connected to the gas, media and effluent lines and incubated 
for a further 48 h with continuous perfusion of gas and media.  Previous 
experiments show that steady state VSC levels were reached after 48 hours 
incubation of the inoculated Sorbarod under the conditions reported here (data not 
shown). 
 
5.2.3.2 Evaluation of Test Agents 
Chlorhexidine digluconate (0.2% v/v) (Sigma-Aldrich), and two metal salts (0.1% 
w/v copper (II) gluconate (Sigma-Aldrich) and 0.1% w/v zinc acetate (Sigma-
Aldrich) were used to characterise the system.  Prior to exposing the tongue 
biofilms to test agents, peristaltic pumps supplying gas and media were switched 
off and a gate clip below the Sorbarod was closed to hold the test solutions in 
contact with the biofilm.  Test agents (1 mL) were introduced to the surface of the 
Sorbarod using a hypodermic needle and.  After 1 min contact time, the gate clip 
was opened and gas and media lines switched on, with the syringe remaining in 
place.  Immediately prior to addition of test agents and at various time points after 
addition (up to 60 min), 20 mL gas samples were collected and the VSC 
concentrations determined. 
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5.2.3.3 Determination of VSC Levels 
VSC concentrations were determined by gas chromatography using an Agilent 
6890N GC (Agilent Technologies, Stockport, Cheshire, UK) equipped with sulfur 
specific flame photometric detector (hydrogen 40 mL/min, air 100 mL/min, 
nitrogen make-up gas 40 mL/min).  The system was fitted with a 0.1 mL gas 
sampling valve held at 120°C.  The gas sampling valve and all associated tubing 
was sulfinert™ treated to minimise loss in VSCs through adsorption to tubing 
(Thames Restek, UK).  The GC was equipped with an 8ft x 1/8-inch Teflon 
support Chromosil 330 (Supelco, UK) packed column held at 60°C, carrier gas 
was helium at a flow rate of 45 mL/min.  Quantitation of hydrogen sulfide and 
methyl mercaptan in gas samples was achieved by comparison of peak areas with 
those obtained from standard hydrogen sulfide and methyl mercaptan gas 
permeation tubes (Kin Tek Precision Gas Standards Generator, Eco Scientific, 
Stroud, UK). 
 
5.2.3.4 Scanning Electron Microscopy of Biofilms 
Full methodology can be found in chapter 2.  The outer sheaths of two Sorbarod 
filters (one sterile, one containing a 48h old biofilm) were removed and the 
concertina of fibres opened.  Representative samples were mounted on appropriate 
stubbie holders (Agar Scientific, Stanstead, Cambridgeshire, UK) and imaged 
uncoated in a Zeiss EVO Scanning Electron Microscope operated at 2.5-3kV 
(Carl Zeiss SMT Ltd, Cambridge, UK). 
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5.2.4 Developed Bioplate Model 
5.2.4.1 Manufacture of Inocula 
Defined inoculum was used to inoculate the Bioplate model using the same 
inoculum generated in 5.2.1.2 using the method in chapter 4.  To summarise, the 
organisms used were S. mutans NCTC 10449 (10
8
 cfu/mL), S. mitis NCTC 12261 
(10
10
 cfu/mL), S. sanguinis NCTC 10904 (10
6
 cfu/mL), A. viscosus NCTC 10951 
(10
6
 cfu/mL), L. casei var rhamnosus NCTC 10302 (10
10
 cfu/mL), N mucosa 
NCTC 10774 (10
9
 cfu/mL), V. dispar NCTC 10831 (10
5
 cfu/mL), P. 
melaninogenica NCTC 10321 (10
9
 cfu/mL) and F. nucleatum NCTC 10562 (10
5
 
cfu/mL).  One millilitre of each organism suspension was added to a 30 mL sterile 
container, to this was added 1 mL of R+P and 10 mL of 20% glycerol in BHI, this 
was subsequently vortexed to ensure homogeneity.  Twenty microlitres of this 
inoculum was used to inoculate each well on each of the test wells on a HA coated 
microtitre plate.  Excess was stored in 2 mL Eppendorfs and stored at -80°C for 
up to one month. 
 
5.2.4.2 Bioplate Testing 
Hydroxyapatite coated 96 well microtitre plates were manufactured as in chapter 2 
section 2.1.1.  To each of the HA coated wells was added 20 µL of the test inocula 
prepared in section 5.2.1.2.  Subsequently, 180 µL of sterile BHI was added to 
each well.  Plates were then incubated aerobically for 24 hours at 37°C on an 
orbital shaker set at 200 rpm.  Full testing methodology can be found in section 
2.1.2. 
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5.2.5 Confocal Laser Scanning Microscopy of Developed Biofilms 
Full methodology can be found in section 2.3.2. Biofilms were removed from the 
CDFF, MBEC or Bioplate and placed in a small cell-culture dish (Bibby Sterilin 
Ltd, UK) with 10 mL distilled water containing 2 µL of the LIVE/DEAD 
BacLight™ bacterial viability stain.  These were incubated in the dark to allow 
the stain to develop for 15 minutes and rinsed to remove excess stain.  The biofilm 
structure was examined with an Olympus BX51 microscope to which a Bio-Rad 
Radiance 2100 laser scanning system and a LUMPlanFI ×40 water lens was 
incorporated.  Two-channel (viable “Live” and nonviable “Dead”) confocal image 
stacks were collected in eight-bit colour depth at a resolution of 1024 x 1024 
pixels.  The z-axis step size was optimized for each image stack, depending upon 
the total depth of each of the test samples. Images were collated and analysed 
using Image J software, available at http://rsbweb.nih.gov/ij/.  
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5.3 Results 
5.3.1 Constant Depth Film Fermenter 
Using the CDFF, initial investigations were carried out to understand how the 
biofilm developed overtime with the standardised inoculum. The results below 
show and increase trend in bacterial recovery post inoculation with the defined 
inoculum in the CDFF after 1, 3, 5 and 8 days, as seen in Table 14 
 
Table 14 Recovery of organisms from a defined inoculum post incubation in CDFF, utilising a 
number of selective and non-selective media. Results reported in Mean Log10.(n=5) 
 Day 1 Day 3 Day 5 Day 8 
Total Count 9.6±0.8 10.7±2.3 10.5±1.2 10.4±1.8 
Gram-ve 5.7±1.4 5.7±2.1 6.5±1.3 6.5±1.3 
Streptococcus spp. 7.5±1.2 8.5±1.1 8.7±2.0 8.6±0.7 
Lactobacillus spp. 5.5±0.9 5.6±0.9 6.5±1.5 6.5±0.5 
S. mutans 6.6±0.8 5.7±1.2 7.4±0.9 7.6±1.3 
Neisseria spp. 6.5±1.3 7.3±0.3 7.6±1.7 7.6±0.9 
Actinomyces spp. 4.7±2.1 5.2±0.5 5.8±0.6 6.1±0.7 
Fusobacterium spp. 4.9±1.1 5.1±1.0 5.6±1.4 5.6±1.6 
Veillonella spp. 4.3±0.6 5.0±1.0 5.6±0.9 5.6±1.4 
 
The results do show a decrease in S. mutans recovery at day 3. From the results 
received, subsequent biofilm analysis will be carried out on biofilms after 5 days 
incubation due to the relative stability seen with the bacterial recovery as seen in 
Figure 51. 
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Figure 51 Graphical representation of bacterial recovery using a defined inoculum, post 
incubation at 1, 3, 5 and 8 days. Recovery on a number of selective and non-selective media, 
results reported in mean Log10. 
 
From the results in Figure 51, it is seen a steady increase in bacterial counts, after 
8 days a number of the results show a „settling‟ in bacterial counts, for example 
Fusobacterium sp., Veillonella sp.  and Neisseria sp. If we look at the total counts, 
a slight decrease was found. In this study, it would, with hindsight, been 
beneficial to have extended the testing period to 15 days to understand more fully, 
whether these organisms were reaching steady state.  However, it was decided that 
after 5 days incubation, it would be appropriate for the generation of suitable 
biofilms for further testing. 
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5.3.2 Antimicrobial Testing of Biofilms from the CDFF 
5.3.2.1 Chlorhexidine Analysis 
Bacterial recovery from the initial biofilms prior to exposure show reduced oral 
bacteria recovery than was seen previously in section 5.3.1.  The results show that 
0.5 % v/v CHX was sufficient to kill organisms in the biofilm, however at 0.1% 
and below, there was still recovery of some of the test organisms from the defined 
inoculum. 
 
Table 15 Recovery of organisms from a defined inoculum post incubation in CDFF, utilising a 
number of selective and non-selective media. Biofilms were exposed to 0.5, 0.1 or 0.01% CHX. 
Results reported in Mean Log10. 
 Initial 0.5% CHX 0.1% 
CHX 
0.01% 
CHX 
Total Count 8.6±2.1 <1 5.4±0.7 7.4±2.0 
Gram-ve 5.3±0.9 <1 4.3±0.6 5.1±1.5 
Streptococcus spp. 6.4±1.3 <1 4.7±0.4 5.2±0.5 
Lactobacillus spp 4.6±1.6 <1 4.1±0.6 4.6±0.8 
S. mutans 4.9±1.6 <1 3.9±1.1 4.3±0.9 
Neisseria spp. 4.8±1.1 <1 3.7±0.9 4.3±0.3 
Actinomyces spp. 4.7±0.3 <1 <1 1.1±0.1 
Fusobacterium spp. 4.5±0.7 <1 <1 4.5±0.7 
Veillonella spp 4.5±1.6 <1 <1 3.2±1.1 
 
Figure 52, shows graphically the reduction in bacterial viability with the 
increasing concentrations of CHX, where 0.5% CHX was sufficient to kill all 
organisms in the developed biofilms.  With 0.01 and 0.1% CHX showing an 
overall reduction in bacterial numbers, but a retention of bacterial viability. 
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Figure 52 Graphical representation of bacterial recovery using a defined inoculum, post 
incubation of the CDFF for 5 days after exposure to 0.5, 0.1 or 0.01% v/v CHX. Recovery on a 
number of selective and non-selective media, results reported in mean Log10. 
 
5.3.2.2 Triclosan Analysis 
The results below in Figure 53 show a reduction in antimicrobial activity in 
comparison to what was seen with the CHX in Figure 52, even at the highest 
concentrations tested.  At the higher concentration of 1% w/v triclosan, an 
approximate 4 Log10 reduction in bacterial recovery was seen.  There was a 
reduction in bacterial recovery of Veillonella spp. with 0.5% triclosan.  It should 
be noted that there was a greater than 1 Log10 increase in total bacterial counts 
with the biofilms exposed to 0.5% w/v triclosan.  There is no experimental 
hypothesis to support triclosan increasing bacterial viability at sub-lethal 
concentrations, rather the hypothesis that this may be excess biomass from the 
CDFF. 
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Table 16 Recovery of organisms from a defined inoculum post incubation in CDFF, utilising a 
number of selective and non-selective media. Biofilms were exposed to 1, 0.5 or 0.1% w/v 
triclosan. Results reported in Mean Log10 (n=5). 
 
 Initial 1% 
Triclosan 
0.5% 
Triclosan 
0.1% 
Triclosan 
Total Count 8.6±1.2 4.7±0.3 9.9±1.6 8.5±1.5 
Gram-ve 5.3±0.9 4.4±0.6 4.8±1.7 5.2±0.6 
Streptococcus spp. 6.4±0.5 4.5±0.4 5.6±1.7 6.4±0.4 
Lactobacillus spp 4.6±1.1 <1 4.3±0.4 5.1±0.3 
S. mutans 4.9±0.3 <1 4.4±0.5 4.8±1.2 
Neisseria spp. 4.8±0.7 <1 4.7±0.9 4.8±1.1 
Actinomyces spp. 4.7±0.8 <1 4.6±1.2 4.6±0.6 
Fusobacterium spp. 4.5±1.3 <1 4.5±0.3 4.5±0.5 
Veillonella spp 4.5±1.2 <1 1.9±0.5 4.6±0.8 
 
 
 
Figure 53 Graphical representation of bacterial recovery using a defined inoculum, post 
incubation of the CDFF for 5 days after exposure to 1, 0.5 or 0.1% w/v triclosan. Recovery on a 
number of selective and non-selective media, results reported in mean Log10. 
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5.3.3 Minimum Biofilm Eradication Concentration Model 
The results obtained from this study included all the individual organisms tested 
against each of the test agents, as well as the defined mix species inocula 
described in previous chapters.  
 
5.3.3.1 Chlorhexidine Results 
Using clorhexidine the effect was investigated in the developed biofilms using the 
MBEC biofilm model system. 
 
5.3.3.1.1 Individual Species Biofilm Results using MBEC 
 
Figure 54 Effect of CHX (v/v) dose response on S. mutans biofilm viability using the MBEC 
model system (n=8). Showing a reduction in biofilm viability at higher than 0.006% v/v CHX 
concentrations. 
 
The effect of CHX on S. mutans viability was analysed using a one-way analysis 
of variance with a factor for treatment, where p<0.05.  
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                            Analysis of Variance 
----------------------------------------------------------------------------- 
Source             Sum of Squares     Df  Mean Square    F-Ratio      P-Value 
----------------------------------------------------------------------------- 
Between groups           663435.0     11      60312.2      44.16       0.0000 
Within groups            114712.0     84      1365.62 
----------------------------------------------------------------------------- 
Total (Corr.)            778147.0     95 
 
Treatments with the same letter are not significant 
 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Treatment          Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
1              8         135.625           A    
7              8         145.0             AB   
2              8         147.5             AB   
4              8         163.625           AB   
5              8         166.125           AB   
6              8         171.75            AB   
3              8         177.125            B   
8              8         254.625             C  
9              8         263.75              C  
11             8         338.375              D 
10             8         353.0                D 
12             8         361.375              D 
 
Statistical analysis on the MBEC showed good seperation of the CHX dose 
response. It was found that treatment groups 1-7 (0.03 – 2% v/v CHX) did not 
split, where 2% w/w CHX was the positive control in this analysis. Treatment 
groups 8, 9 (0.006 – 0.013% w/w CHX) were similar, and treatment groups 10-12 
(<0.003 w/w CHX) did not split from the water control (treatment 12).  
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Figure 55 Effect of CHX (% v/v) dose response on F. nucleatum biofilm viability using the 
MBEC model system (n=8). Showing a reduction in biofilm viability at higher than 0.013% v/v 
CHX concentrations. 
 
The effect of CHX on F. nucleatum viability was analysed using a one-way 
analysis of variance with a factor for treatment, where p<0.05.  
 
Treatments with the same letter are not significant. There treatments 7-12 are 
statistically different to treatment 1-6, where treatment 1 is the 2% w/w CHX 
control and treatment 12 is the deionised water control. 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Treatments    Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
2              8         174.5             A   
1              8         222.125           AB  
5              8         247.625            B  
4              8         252.375            B  
6              8         256.375            B  
3              8         280.0              B  
12             8         356.375             C 
7              8         372.875             C 
11             8         380.875             C 
8              8         396.75              C 
10             8         397.625             C 
9              8         402.0               C 
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Figure 56 Effect of CHX (% v/v) dose response on S. sanguinis  biofilm viability using the MBEC 
model system (n=8). Showing a reduction in biofilm viability at higher than 0.013% v/v CHX 
concentrations. 
 
The effect of CHX on S. sanguinis viability was analysed using a one-way 
analysis of variance with a factor for treatment, where p<0.05.  
 
Treatments with the same letter are not significant. The results show less 
differentiation between each of the test treatments, however treatments 8, 10-12 
are statistically similar, where treatment 9 is not distinct from the water control 
(treatment 12). All other treatment regimes are not statistically different from the 
positive control 0.2% w/w CHX (treatment 1). 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Col_1          Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
7              8         176.125           A    
2              8         190.75            A    
1              8         194.125           AB   
4              8         208.125           AB   
3              8         210.375           AB   
5              8         217.25            AB   
6              8         240.125           AB   
9              8         260.5              BC  
12             8         312.875             CD 
10             8         335.25               D 
8              8         340.125              D 
11             8         349.25               D 
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Figure 57 Effect of CHX (% v/v) dose response on S. mitis biofilm viability using the MBEC 
model system (n=8). Showing a reduction in biofilm viability at higher than 0.03% v/v CHX 
concentrations. 
 
The effect of CHX on S. mitis viability was analysed using a one-way analysis of 
variance with a factor for treatment, where p<0.05.  
 
Treatments with the same letter are not significant. Treatments 9-12 were 
statatistically similar to the negative control deionised water, treatments 1-6 were 
statistically similar to the positive control 2% w/w CHX. Treatments 7 and 8, 
although similar to each other, were not statistically similar to either the negative 
or positive controls. 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Treatments   Count      Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
3              8         130.75            A    
6              8         139.0             AB   
5              8         143.0             AB   
2              8         145.375           AB   
1              8         146.125           AB   
4              8         163.125            B   
7              8         249.375             C  
8              8         253.875             C  
11             8         344.375              D 
10             8         345.25               D 
9              8         347.75               D 
12             8         357.375              D 
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Figure 58 Effect of CHX (% v/v) dose response on A. viscosus biofilm viability using the MBEC 
model system (n=8). Where all treatments were statistically similar, where p=0.0153. 
 
The effect of CHX on A. viscosus viability was analysed using a one-way analysis 
of variance with a factor for treatment, where p=0.0153.  All the treatments, 
against A. viscosus,  were statistically similar. 
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Figure 59 Effect of CHX (% v/v) dose response on L. casei biofilm viability using the MBEC 
model system (n=8). Showing a reduction in biofilm viability at higher that 0.03% CHX 
concentrations. 
 
The effect of CHX on L. casei viability was analysed using a one-way analysis of 
variance with a factor for treatment, where p<0.05.  Treatments with the same 
letter are not significant.  Treatments 10-12 were statatistically similar to the 
negative control deionised water, treatments 1-6 were statistically similar to the 
positive control 2% w/w CHX.  Treatments 7 and 8, although similar to each 
other, were not statistically similar to either the negative or positive controls. 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Treatment     Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
2              8         154.375           A   
1              8         154.75            A   
4              8         157.375           A   
5              8         165.25            A   
3              8         173.25            A   
6              8         180.0             A   
8              8         246.875            B  
7              8         249.0              B  
9              8         334.75              C 
10             8         346.375             C 
12             8         351.875             C 
11             8         355.625             C 
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Figure 60 Effect of CHX (% v/v) dose response on N. mucosa biofilm viability using the MBEC 
model system (n=8). Showing a reduction in biofilm viability at higher than 0.03% v/v CHX 
concentrations 
 
The effect of CHX on N. mucosa viability was analysed using a one-way analysis 
of variance with a factor for treatment, where p<0.05.  Treatments with the same 
letter are not significant.  Treatments 10-12 were statatistically similar to the 
negative control deionised water, treatments 1-7 were statistically similar to the 
positive control 2% w/w CHX. Treatments 8 and 9, although similar to each other, 
were not statistically similar to either the negative or positive controls. 
 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Treatment    Count     LS Mean       LS Sigma      Homogeneous Groups 
-------------------------------------------------------------------------------- 
1              8         144.0         12.8914       A    
2              8         161.5         12.8914       AB   
6              8         162.125       12.8914       AB   
3              8         162.375       12.8914       AB   
7              8         166.75        12.8914       AB   
5              8         173.0         12.8914       AB   
4              8         181.875       12.8914        B   
9              8         244.875       12.8914         C  
8              8         255.125       12.8914         C  
11             8         340.875       12.8914          D 
12             8         351.875       12.8914          D 
10             8         370.75        12.8914          D 
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Figure 61 Effect of CHX (% v/v) dose response on V. dispar biofilm viability using the MBEC 
model system (n=8). Showing a reduction in biofilm viability at higher than 0.03% v/v CHX 
concentrations 
 
The effect of CHX on V. dispar viability was analysed using a one-way analysis 
of variance with a factor for treatment, where p<0.05.  Treatments with the same 
letter are not significant.  Treatments 10-12 were statatistically similar to the 
negative control deionised water, treatments 1-7 were statistically similar to the 
positive control 2% w/w CHX.  Treatments 8 and 9, although similar to each 
other, were not statistically similar to either the negative or positive controls 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Treatment     Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
2              8         123.375           A     
4              8         145.25            AB    
1              8         155.75             BC   
7              8         171.5              BC   
3              8         172.875            BC   
5              8         177.125            BC   
6              8         178.125             C   
8              8         253.625              D  
9              8         261.875              D  
10             8         350.25                E 
11             8         350.375               E 
12             8         366.125               E 
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Figure 62 Effect of CHX (% v/v) dose response on P. melaninogenicus biofilm viability using the 
MBEC model system (n=8). Showing a reduction in biofilm viability at higher than 0.03% v/v 
CHX concentrations. 
 
The effect of CHX on P. melaninogenicus viability was analysed using a one-way 
analysis of variance with a factor for treatment, where p<0.05.  Treatments with 
the same letter are not significant.  Treatments 10-12 were statatistically similar to 
the negative control deionised water, treatments 1-7 were statistically similar to 
the positive control 2% w/w CHX.  Treatments 8 and 9, although similar to each 
other, were not statistically similar to either the negative or positive controls. 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Col_1          Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
1              8         143.0             A   
7              8         156.625           A   
3              8         164.25            A   
2              8         167.75            A   
6              8         171.125           A   
5              8         172.0             A   
4              8         173.0             A   
8              8         230.625            B  
9              8         245.5              B  
11             8         346.125             C 
10             8         358.125             C 
12             8         374.5               C 
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The results show, using the individual organisms, attached organisms to the pegs 
can be evaluated for their sensitivity to antimicrobial agents.  It should be noted 
that it was anticipated that the MFU would be higher.  In these studies reported 
here, the MFU is very low using this methodology, this was seen across all the 
analyses carried out.  This may suggest that there may not be many organisms 
attached to the pegs.  Indeed, this is supported by the confocal results later in this 
chapter 
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5.3.3.1.2 Mixed Species Defined Biofilm Results using MBEC 
 
Figure 63 Effect of CHX (% v/v) dose response to a mixed species biofilm viability using the 
MBEC model system (n=8). Showing a reduction in biofilm viability at 0.03% v/v CHX and 
higher. 
 
The effect of CHX on mixed biofilm viability was analysed using a one-way 
analysis of variance with a factor for treatment, where p<0.05.  Treatments with 
the same letter are not significant.  Treatments 10-12 were statatistically similar to 
the negative control deionised water, treatments 1-7 were statistically similar to 
the positive control 2% w/w CHX.  Treatments 8 and 9, although similar to each 
other, were not statistically similar to either the negative or positive controls 
 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Treatment          Count     LS Mean       LS Sigma      Homogeneous Groups 
-------------------------------------------------------------------------------- 
2              8         139.5         10.5344       A   
3              8         145.375       10.5344       A   
6              8         157.25        10.5344       A   
7              8         160.0         10.5344       A   
4              8         163.375       10.5344       A   
5              8         164.875       10.5344       A   
1              8         166.625       10.5344       A   
9              8         249.375       10.5344        B  
8              8         262.875       10.5344        B  
12             8         334.375       10.5344         C 
11             8         346.625       10.5344         C 
10             8         359.375       10.5344         C 
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5.3.3.2 Triclosan Results 
The low MFU results were also found with the following study. 
 
5.3.3.2.1 Individual Species Biofilm Results using MBEC 
 
Figure 64 Effect of Triclosan (% w/v) dose response on S. mutans biofilm viability using the 
MBEC model system (n=8). Showing a reduction in biofilm viability at higher than 0.063% w/v 
triclosan concentration. 
 
The effect of triclosan on S. mutans viability was analysed using a one-way 
analysis of variance with a factor for treatment, where p<0.05. 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Treatment     Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
2              8         177.5             A    
1              8         178.125           A    
5              8         214.875           AB   
4              8         225.75            AB   
3              8         239.25             B   
6              8         251.125            B   
11             8         375.875             C  
10             8         394.375             CD 
12             8         409.75              CD 
7              8         413.375             CD 
8              8         424.625             CD 
9              8         433.0                E 
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Treatments with the same letter are not significant.  Treatments 7-12 were 
statatistically similar to the negative control deionised water, treatments 1-6 were 
statistically similar to the positive control 0.2% w/w CHX. 
 
Figure 65 Effect of Triclosan (% w/v) dose response on F. nucleatum biofilm viability using the 
MBEC model system (n=8). The results showing a slight reduction in biofilm viability. 
 
The effect of triclosan on F. nucleatum viability was analysed using a one-way 
analysis of variance with a factor for treatment, where p<0.05. Treatments with 
the same letter are not significant.  Treatments 7-12 were statatistically similar to 
the negative control deionised water, treatments 1-6 were statistically similar to 
the positive control 0.2% w/w CHX. 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Treatment    Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
2              8         177.5             A    
1              8         178.125           A    
5              8         214.875           AB   
4              8         225.75            AB   
3              8         239.25             B   
6              8         251.125            B   
11             8         375.875             C  
10             8         394.375             CD 
12             8         409.75              CD 
7              8         413.375             CD 
8              8         424.625             CD 
9              8         433.0                D 
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5.3.3.2.2 Mixed Species Biofilm Results using MBEC 
 
Figure 66 Effect of Triclosan (% w/v) dose response on a defined inoculum biofilm viability using 
the MBEC model system (n=8). Showing a reduction in biofilm viability at higher than 0.063% 
w/v triclosan concentration. 
 
The effect of triclosan on biofilm viability was analysed using a one-way analysis 
of variance with a factor for treatment, where p<0.05.   
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Treatment    Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
1              8         188.375           A   
2              8         199.75            AB  
4              8         229.75            AB  
3              8         237.25            AB  
5              8         255.625            B  
6              8         258.5              B  
7              8         381.375             C 
12             8         395.125             C 
8              8         401.625             C 
11             8         404.0               C 
9              8         409.875             C 
10             8         412.75              C 
 
Treatments with the same letter are not significant.  Treatments 7-12 were 
statatistically similar to the negative control deionised water, treatments 1-6 were 
statistically similar to the positive control 0.2% w/w CHX. 
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All results received show similar dose response pattern to that seen with the CHX, 
however, in this study, triclosan was less effective at lower concentrations, less 
than 0.063% w/v triclosan, where as CHX was found to be effective below 0.03% 
v/v CHX.  Again, the results show a reduced MFC than would be anticipated. 
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5.3.3.3 Zinc Chloride Results 
The results below show the effect of the zinc chloride against biofilm viability 
ising the MBEC model.  The low MFU results can be seen with the following 
study results also.  
5.3.3.3.1 Individual Species Biofilm Results using MBEC 
 
Figure 67 Effect of Zinc chloride (% w/v) dose response on S. mutans biofilm viability using the 
MBEC model system (n=8). Showing a no reduction in biofilm viability at any concentration 
tested. 
 
The effect of zinc chloride on S. mutans viability was analysed using a one-way 
analysis of variance with a factor for treatment, where p<0.05.  
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Treatment     Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
12             8         184.75            A  
4              8         415.5              B 
11             8         420.0              B 
5              8         422.875            B 
6              8         424.0              B 
1              8         426.0              B 
7              8         427.25             B 
9              8         429.875            B 
8              8         429.875            B 
3              8         453.875            B 
10             8         454.125            B 
2              8         454.875            B 
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Treatment with the same letter are not significant. Where treatment 1-11 are 
distinct from the positive control, treatment 12. 
 
Figure 68 Effect of Zinc chloride (% w/v) dose response on F. nucleatum biofilm viability using 
the MBEC model system (n=8). Showing no reduction in biofilm viability at any concentration 
tested. 
 
The effect of zinc chloride on F. nucleatum biofilm viability was analysed using a 
one-way analysis of variance with a factor for treatment. Treatments with the 
same letter are not significant, where treatment 1-11 were statistically similar to 
the water control, and statistically distinct from the positive control CHX. 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Treatment    Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
12             8         184.375           A   
1              8         402.75             B  
8              8         405.125            B  
4              8         411.625            BC 
2              8         413.375            BC 
9              8         418.625            BC 
3              8         420.75             BC 
5              8         425.625            BC 
10             8         428.5              BC 
6              8         433.5              BC 
7              8         443.0              BC 
11             8         455.625             C 
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5.3.3.3.2 Mixed Species Biofilm Results using MBEC 
 
Figure 69 Effect of Zinc chloride (% w/v) dose response on a mixed species biofilm viability 
using the MBEC model system (n=8). Showing no reduction in biofilm viability across any tested 
concentration. 
 
The effect of zinc chloride on mixed species biofilm viability was analysed using 
a one-way analysis of variance with a factor for treatment. Treatments with the 
same letter are not significant, where treatment 1-11 are statistically similar to the 
water control, and statistically distinct from the CHX control (treatment 12). 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Col_1          Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
12             8         182.0             A     
8              8         395.25             B    
1              8         400.125            B    
10             8         400.375            B    
4              8         402.375            B    
2              8         405.25             B    
5              8         409.625            BC   
9              8         410.0              BC   
11             8         420.375            BCD  
7              8         445.875             CDE 
6              8         454.125              DE 
3              8         471.875               E 
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In this study, no reduction in attached bacteria viability was seen across all the 
concentrations tested for all organisms or the mixed species inoculums. 
 
5.3.4 Developed Bioplate Model Results 
 
Figure 70 Zinc chloride dose response in the developed Bioplate, reduction in viability is seen 
with 5% w/v Zinc chloride, no reduction in comparison with water control is seen <5% w/v zinc 
chloride. (n=8). 
 
The effect of zinc chloride on mixed species biofilm viability using the Bioplate 
was analysed using a one-way analysis of variance with a factor for treatment.  
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Treatment     Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
12             8         218.0             A     
2              8         4639.63            B    
3              8         5761.25             C   
7              8         5792.88             C   
4              8         5980.88             CD  
8              8         6022.13             CD  
5              8         6117.88              DE 
11             8         6142.63              DE 
10             8         6176.5               DE 
9              8         6192.25              DE 
6              8         6377.63               E 
1              8         6398.25               E 
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Treatments with the same letter are not significant, where treatment 12 (positive 
control 0.2% CHX was statistically different to all treatments.  Five percent zinc 
chloride showed a reduction in bacterial viability, all other test treatments are not 
statistically distince from each other.  The results from the Bioplate assay show a 
reduction in biofilm viability with the 5% w/v zinc chloride, however at all other 
concentrations there was no reduction in viability seen. In this assay water and 
0.2% CHX were used as negative and positive controls respectively. 
 
 
Figure 71 Chlorhexidine dose response in the developed Bioplate, reduction in viability is seen 
>0.006% CHX. A reduction in viability is seen until viability is similar to that of the water control 
(n=8). 
 
The effect of CHX on mixed species biofilm viability using the Bioplate was 
analysed using a one-way analysis of variance with a factor for treatment.  
Treatments with the same letter are not significant, where treatment 1 (positive 
control 2% CHX was statistically similar to all concentrations tested to 0.2% 
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CHX. Treatments from 0.0013-0.1% CHX are not statistically dissimilar, 
treatments 9-11 show good statistical differentiation, and treatments 11 and 12 are 
statistically similar where treatment 12 is the negative water control in this model. 
 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Treatments   Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
1              8         225.25            A       
2              8         236.0             A       
3              8         250.125           A       
4              8         438.75            AB      
5              8         866.875            BC     
6              8         1126.0              CD    
7              8         1278.63             CD    
8              8         1624.63              D    
9              8         3237.75               E   
10             8         4743.75                F  
12             8         5517.38                 G 
11             8         5790.5                  G 
 
The results using the Bioplate assay against a CHX dose response show good 
reduction in biofilm viability which starts to drop significantly at 0.006% w/v 
CHX.  Water is used as a negative control in this assay.  Two per cent CHX (v/v) 
was utilised as both a positive control and test active in this study. 
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Figure 72 Triclosan dose response in the developed Bioplate, reduction in viability is seen not 
seen at any concentrations tested in comparison to the water control. (n=8). 
 
The effect of triclosan on mixed species biofilm viability using the Bioplate was 
analysed using a one-way analysis of variance with a factor for treatment.  
Treatments with the same letter are not significant, where treatment 10 (positive 
control 2% CHX was statistically different to all triclosan concentrations 
evaluated  
 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Col_1          Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
10             8         328.0             A   
6              8         6425.25            B  
7              8         6591.38            BC 
1              8         6664.38            BC 
5              8         6763.5             BC 
12             8         6765.63            BC 
3              8         6834.13            BC 
4              8         6882.63            BC 
2              8         7049.0              C 
9              8         7086.25             C 
8              8         7088.13             C 
11             8         7121.5              C 
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There is no reduction in biofilm viability seen with triclosan at all concentrations 
tested post two minutes exposure.  In this study 0.2% CHX was used as a positive 
control, 5% propylene glycol (PG) and water are used as negative controls, where 
5% PG is the solubolising agent for triclosan.  
 
Across the models evaluated, consistently the Bioplate gave MFU counts that 
gave clearer differentiation of results.  To understand this more fully, samples 
were taken of the biofilms and evaluated using Live/Dead BacLight to understand 
the biomass formed on each of the surfaces.  
 
In this evaluation it was very clear that Bioplate model set up and turn around was 
some what shorter than that of the MBEC and CDFF model systems. Where the 
inocula could be pre-prepared and stored, thus reducing this initial bacteria 
recovery, incubation and inocula generation everytime a Bioplate was required. 
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5.3.5 Sorbarod Biofilm Model System 
Three Sorbarod biofilms were run in parallel and each acted as their own baseline 
control.  The data presented are representative runs of three separate runs.  
Environmental scanning electron micrographs of an uninoculated Sorbarod 
(Figure 73) show individual cellulose fibres that act as the surface for attachment 
and colonization of tongue-derived bacteria.  
 
 
Figure 73 Sterile Sorbarod Filter, micrograph showing web of cellulose fibres in an uninoculated 
Sorbarod filter (bar = 200 µm) 
 
Images of a 48 h tongue biofilm show significant material between and associated 
with the cellulose fibres (Figure 74).  Individual bacteria or microcolonies were 
not evident; however the initial partial dehydration step in the environmental SEM 
may have collapsed the extracellular matrix material produced by most biofilms. 
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Figure 74 Inoculated Sorbarod Filter, micrograph of a 48 hour old inoculated Sorbarod showing 
smooth outer edge of biofilm with a number of large channels (bar = 20 µm) 
 
 
5.3.5.1 Impact of Test Agents on Biofilm-Generated VSC Levels 
The effects of various test actives on VSC production by the Sorbarod tongue 
biofilm model are shown below.  
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Figure 75 VSC concentrations after 1 minute exposure to 0.01% w/v zinc acetate. Forty eight 
hour-old inoculated Sorbarods were exposed to 0.1% w/v zinc acetate for 1 minutes. Gas samples 
were collected for up to 60 minutes post-exposure and analysed for VSC (ppb). 
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The metal salts tested (zinc acetate and copper (II) gluconate) had a large and 
immediate impact on hydrogen sulfide (H2S) concentrations (Figure 75 and Figure 
76) such that concentration were reduced to undetectable levels after 1 min 
exposure and remained at this concentration for approximately 20 min (zinc) or 30 
min (copper).  Even 60 min after exposure, H2S concentration remained lower 
than at baseline.  
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Figure 76 VSC concentrations after 1 minute exposure to 0.2% w/w copper (II) gluconate. 48 
hour-old inoculated Sorbarods were exposed to 0.2% w/v copper (II) gluconate for 1 minute. Gas 
Samples were collected for up to 60 minutes post-exposure and analysed for VSCs (ppb). 
 
In contrast, zinc and copper salts had differential effects on methyl mercaptan 
(CH3SH) concentrations.  While biofilm exposure to 0.1%w/v zinc acetate did not 
affect CH3SH concentrations, 0.1%w/v copper (II) gluconate reduced CH3SH 
concentrations to below detectable levels over 10 min.  With both metal ions, H2S 
and CH3SH concentrations increased over time such that total VSC concentrations 
approached baseline after 60 min.  Chlorhexidine is considered the gold-standard 
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antimicrobial active for oral care based, at least in part, due to its retention in an 
active form on oral surfaces (Kinniment et al., 1996; McBain et al., 2003; Pratten 
et al., 1998).  Typical results from a 48 hour Sorbarod biofilm exposed to 0.2% 
v/v chlorhexidine are shown in Figure 77. An initial increase in total VSC 
concentrations of approximately 25% was observed followed by a return to 
baseline within 5 minutes.  
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Figure 77. VSC concentrations after 48 hrs incubation using 0.2%v/v chlorhexidine 48 hour-old 
inoculated Sobarods were exposed to 0.2% v/v chlorhexidine for 1 minute. Gas samples were 
collected for up to 60 minutes post exposure and analysed for VSCs (ppb). 
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5.3.6 Confocal Laser Scanning Microscopy 
The images below are for illustrative purposes only and no further analysis was 
carried out. The images are used to show the biomass which forms in comparison 
with the CDFF, MBEC and developed biofilm model. 
 
 
Figure 78 Optical sections (partial image stack) through a biofilm grown in a CDFF and stained 
with Live/Dead BacLight™ exhibiting structural motifs of dense matrix with channels. Each 
image 297.98x297.98 µm. 
 
Using the CDFF to develop biofilms, reveal a dense bio-matrix full of channels. 
This type of image would be expected with the CDFF, due to the model, which 
scrapes biomaterial into the individual pans, resulting in dense biofilm formation. 
Top of biofilm 
Bottom of biofilm 
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Figure 79 Optical sections (partial image stack) through a biofilm grown on an MBEC peg and 
stained with Live/Dead BacLight™ exhibiting little bacterial attachment and subsequent biofilm 
growth. Each image 297.89 x 297.98 µm. 
 
In this micrograph, it was found that very little biofilm had developmed on the 
plastic pegs of the MBEC model, indeed, a small amount of attached organisms 
can be seen in image 12 and 14. The greem line which can bee seen in all images 
is reflection off the plastic pegs and should not be confused with viable organisms 
attached to the surface. 
 
 
 
Bottom of biofilm 
Top of biofilm 
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Figure 80 Optical sections (partial image stack) through a biofilm grown on the developed biofilm 
model system and stained with Live/Dead BacLight™ exhibiting structural motifs of dense matrix 
with channels. Arrow highlights what the author to believe to be HA crystals (dark void) with 
biomass forming around crystals. Each image 297.98 x 297.98 µm. 
 
The developed biofilms from the Bioplate show structural motifs that are similar 
to those seen with the CDFF model, but slightly less dense, this is to be expeted as 
the biofilms are permitted to develop, undisturbed, where the CDFF model 
continually scrapes biomass into the recessed pans, compacting the developed 
biofilms. 
Top of biofilm 
Bottom of biofilm 
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5.4 Discussion 
Currently, there are a number of peer reviewed biofilm model systems available 
for modelling biofilms found in the oral cavity, such as the CDFF, MBEC and 
Sorbarod.  In this chapter, the developed HA-coated microtitre plate was 
evaluated against these peer reviewed model systems utilising a number of 
recognised oral care antimicrobial agents, chlorhexidine, triclosan and zinc 
chloride/acetate.  A summary of the results can be found in Table 17. 
 
Table 17 Summary of the results comparing each model system. 
 Developed 
Bioplate 
CDFF MBEC Sorbarod 
Retention of 
mixed species 
biofilms 
Yes Yes No Not tested 
here (previous 
research has 
show mixed 
species to be 
retained) 
Dose 
response 
capability 
Yes Yes Yes Require 
multiple 
Sorbarods 
Ability to 
distinguish 
antimicrobial 
activity 
Yes Yes Yes No 
Testing time With frozen 
inocula – 24 
hours 
Species 
dependent 
~5days 
1 Week 2 Days 
Resource 
required 
Microplate 
reader 
CDFF system Microplate 
reader 
GC system 
Other testing 
endpoint 
capability 
Substantivity 
(see chapter 6) 
  VSC test 
capability 
Imaging 
revealing 
biofilm 
formation 
Yes Yes No Yes 
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The CDFF model system has been widely used in oral biofilm development and 
research (McBain et al., 2003; Metcalf et al., 2006; Pratten et al., 1998; Vroom et 
al., 1998; Wilson, 1990).  In this evaluation it was shown that against developed 
biofilms CHX was the most antimicrobial, with zinc chloride being the least.  
Using CLSM, developed biofilms from the CDFF and Bioplate exhibited 
structural motifs of dense matrix and channels, similar to what has been reported 
previously (Hope and Wilson, 2003).  
 
As a peer reviewed screening model, the MBEC system is the most similar to the 
developed Bioplate model as part of this thesis, in that they both utilise a 96-well 
microtitre plate.  As in the CDFF model, the same pattern of antimicrobial activity 
was found in that CHX>triclosan>zinc chloride.  However, during the analysis, it 
was found, across all MBEC plates used, that the MFU was lower than 
anticipated; this is a potential sign that the bacteria are not attaching and 
subsequently developing into a biofilm.  Indeed, this was confirmed with the 
CLSM imaging, which confirmed the lack of biomass on the pegs.  This model 
was not originally designed for use with oral organisms; therefore concerns exist 
for the use of this model with these organisms.  The concern arises from growing 
oral biofilms on non-orally relevant surfaces, such as polystyrene for the MBEC 
pegs.  It has been shown that the chemical and physical properties of the 
underlying substratum can affect the development of the conditioning film, 
including physiochemical surface properties, composition, density and 
configuration (Fletcher, 1976; Strevett and Chen, 2003).  It has also been 
observed that oral bacteria can detach from a surface due to a cohesive fault 
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within the conditioning film (Busscher et al., 1995).  A second possible reason for 
the reduction in oral bacterial attachment to the pegs may be related to the 
findings from Parahitayawa (2006), who found that an increase in attachment of 
Candida krusei to the pegs of the MBEC, in comparison with C. albicans.  
Previous studies have shown, C. krusei to be more hydrophobic than C. albicans, 
thus having a greater propensity to attach to those surfaces (Samaranayake et al., 
1995).  Previous studies using ozone on dentine showed that modifications on the 
surface hydrophobicity prevented S. mutans from attaching (Knight et al., 2008).  
More recently, Samot et al. (2011) found that using an ATCC strain of 
Lactobacillus casei was unable to attach and subsequently develop into a biofilm 
on glass.  Highlighting the importance of appropriate substratum when developing 
model systems. In another study (Grivet et al., 2000) identified, using hexadecane 
and water contact angles, that S. mitis was hydrophobic.  It should be noted that in 
the same study, the authors also found, S. mutans, S. sanguinis, and S. oralis more 
hydrophobic than S. mitis. In this evaluation these organisms were able to develop 
biofilms on hydrophobic mental dental alloys; unlike S.mitis.  Thus, the degree of 
hydrophobicity of the underlying substratum is of importance.  Therefore, 
understanding the degree of hydrophobicity of the MBEC pegs and the test 
organisms, may help understand why there was poor biofilm formation. 
 
Copper and zinc ions have been shown previously to be effective at removing 
VSCs (Jonski et al., 2004; Rolla et al., 2002), and are currently used in a  number 
of oral care formulations (Rolla et al., 2002; Young et al., 2001).  The longevity 
of the effect of copper and zinc on VSC concentrations (to approximately 30 min-
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post dosing despite a constant flow of fresh medium at 36 ml/h post-dosing) 
suggested that the test actives demonstrated a degree of inherent substantivity to 
the biofilm or else had an impact on bacterial viability or metabolic activity as 
well as chemically neutralising VSCs.  Both metals demonstrate some 
antibacterial efficacy; however the minimum inhibitory concentration against 
Streptococcus mutans has been determined to be higher that the concentration 
required showing a chemical neutralisation effect (data not shown).  
 
In contrast to metal ions, biofilm exposure to chlorhexidine resulted in a transient 
increase in VSC levels (Figure 77).  Even 60 min post-treatment, biofilms were 
generating VSCs at baseline levels.  This somewhat unexpected observation could 
be the result of chlorhexidine disrupting the bacterial cell wall and promoting the 
release of enzymes into the system that may still be available to convert amino 
acids to VSCs.  This hypothesis requires further study to confirm, nevertheless, 
the data reported here would seem to match the in vivo situation.  Thus, a recent 
clinical study demonstrated that brushing with a dentifrice containing the 
antimicrobial agent triclosan resulted in a transient increase in malodour when 
assessed using GC of mouth air (Newby et al., 2008).  In contrast, zinc-ion 
containing pastes afforded an immediate and statistically significant reduction in 
malodour. Thus, instead of investigating antimicrobial activity, this model was 
best placed to evaluate reductions in VSC‟s generated by malodour producing 
organisms. 
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During the test analysis utilising the Bioplate model exposed to chlorhexidine, 
triclosan and zinc chloride, the same pattern of antimicrobial activity was found in 
that CHX>triclosan>zinc chloride.  In these studies the reported MFU, when 
tested against the negative control, water, was ~6000-7000 MFU, in the MBEC 
model this was ~500-600 MFU.  These higher numbers suggest higher biomass 
formation and the presence of viable organisms.  Indeed this was confirmed using 
the CLSM images, where biofilm can be seen developing around the 
hydroxyapatite crystals. 
 
It should also be noted that testing time taken with the Bioplate, is less than what 
is required for the CDFF, MBEC and Sorbarod.  Excluding initial culturing of the 
organisms, CDFF took 5 days biofilm development and 7 days for bacterial 
recovery and counts.  The MBEC model took 5 days for biofilm development of 
anaerobic species and one day for evaluation.  In comparison, the Bioplate took 
only two days to obtain test results.  
 
In conclusion, it was found that the Bioplate model was able to evaluate 
antimicrobial test agents and differentiate activities against a preformed mixed 
species biofilm, whilst taking less time per analysis in comparison as the peer 
reviewed CDFF, MBEC and Sorbarod.  Utilising an orally relevant surface, the 
Bioplate model was able to support a representative biofilms to allow in vitro high 
throughput testing against antimicrobial actives.  Table 17 compares the evaluated 
model systems to each other, to clarify key differences with each model system. 
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Due to the positive results found here, it was discussed if there could be further 
possibilities of the Bioplate model.  The desire to supplement antimicrobial 
activity with increased substantivity, akin to that seen with CHX is very desirable 
for oral health companies; however in vitro, high throughput methodology for 
specifically investigating substantivity is scare.  Therefore the purpose of the next 
chapter is to evaluate and understand if modifying the Bioplate methodology to a 
high-throughput novel model to screen substantivity and the antimicrobial 
effectiveness of test actives. 
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CHAPTER 6: Utilising the developed in vitro 
biofilm model to generate a novel 
substantivity model.  
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6.1 Introduction 
The search for new antimicrobial agents for improved plaque control requires that 
appropriate screening models be put in place.  In the development of biofilm 
model systems, the use of relevant substrata is required to ensure that both the 
developed pellicle and subsequent biofilm mimic those found in the natural 
environment.  The survival of microorganisms in various environments is 
dependent on their ability to attach/adhere to surfaces and subsequently develop 
into a biofilm.  By modifying the surface to which the organisms attach, with 
substantive compounds, the ability of an anti-biofilm agent to reduce or prevent 
bacterial colonisation on these surfaces can be quantified.  It is hoped that such a 
model will allow researchers to differentiate modes of actions between traditional 
antimicrobials and substantive/surface modifying compounds.  In the previous 
chapter, a model system was discussed which investigated the antimicrobial 
efficacy of test agents against a preformed biofilm.  The aim of this chapter was to 
develop a rapid screening system to identify novel antimicrobial agents with 
inherent substantive properties and subsequently prevent biofilm development for 
use in oral care.  
 
A number of models exist which have been used to investigate the efficacy of 
substantive antimicrobial agents, such as flow cells (Busscher et al., 2008), human 
teeth (Rasimick et al., 2010) and dentine disk (Carrilho et al., 2010) and in vivo 
analyses (van der Mei, 2006), whilst all these model systems are appropriate for 
the study of substantivity, due to current methods they are not seen as appropriate 
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for high through-put screening of novel actives due to the long set-up and testing 
time. 
 
Most oral care products specifically designed for the reduction in disease states, 
contain only a few choice actives, including chlorhexidine, triclosan and CPC.  
This review will focus primarily on the efficacy of CHX and triclosan, due to their 
differing modes of action in the oral cavity; CHX and CPC have very similar 
modes of action.  Chlorhexidine (1,1‟-hexamethylene-bis-5(4-chlorophenyl) 
bisguanide) is a broad spectrum, cationic antimicrobial with the chemical 
structure in Figure 81. 
 
 
Figure 81 Chlorhexidine chemical structure 
 
Due to its cationic nature, more specifically the hydrogen clustering, this gives 
rise to directionality of attachment, exposing the chloride ions out from the 
surface to the environment.  CHX efficacy is well studied as a two-pronged mode 
of action; antimicrobial and retention on a biological surface, (Löe and Schiøtt, 
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1970; Mandell, 1994; Carrilho, et al., 2010).  Indeed searching on PubMed using 
the search terms “antimicrobial AND chlorhexidine” identifies 5770 publications 
(as of June 2011).  Unfortunately, as well studied as the benefits of CHX are, so 
are its side effects, such as tooth staining and modified taste perception (Addy and 
Moran, 1995; Nathoo and Gaffar, 1995).  Again, due to its cationic nature, CHX 
gives rise to an increase in attachment of dietary chromagens (Addy et al., 1991) 
developing into a tenacious stain that can only be removed by the dentist. 
 
Triclosan (2,4,4‟trichlor-2‟-hydroxydiphenyl ether) is a chlorinated bisphenol 
antimicrobial, the chemical structure is seen below in Figure 82. 
 
 
 
Figure 82 Triclosan chemical structure 
 
Its antimicrobial activity has been attributed to the inhibition of the NADH enoyl-
reductase enzymes of type II fatty acid synthase leading to bacterial cytoplasmic 
membrane damage and subsequent leakage (McMurry, 1998; McMurry, 1999).  
However, it is recognised that this cannot be the only pathway affected, however, 
no other route has been elucidated (Russell, 2004).  Triclosan containing 
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toothpastes have been shown to be less effective, than when formulated in the 
presence of a retentive polymer (Gaffar et al., 1990; Renvert and Birkhed, 1995).  
In this instance, gantrez an anionic poly(methyl vinyl ether-co-maleic anhydride 
co-polymer is added to aid in the retention of triclosan to the surface to increase 
its substantivity to help increase its antimicrobial activity. 
 
The desire to supplement antimicrobial activity with increased substantivity still 
exists, while reducing / removing any of the negative side effects, such as 
staining.  The development of a daily use substantive agent for continual 
antimicrobial activity would certainly be of interest to both oral care companies 
and consumers alike.  Indeed the commercial success of Colgate Total Care 12-
hour toothpaste containing triclosan and gantrez are testament to that desire. 
 
Having the capacity to evaluate and screen for such actives are paramount for the 
optimisation and progression to more clinically relevant in vivo models.  The 
purpose of this research was to evaluate and understand the potential to modify 
the developed in vitro biofilm model as a novel model to screen substantivity and 
antimicrobial effectiveness of test actives.  This development work utilized CHX 
and triclosan, known antimicrobial actives, with differing substantivity profiles. 
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6.2 Materials and methods 
6.2.1 Minimum Inhibitory Concentration  
This in vitro method was used to evaluate the inhibitory action of chlorhexidine 
and triclosan by the determination of their minimum inhibitory concentration.  A 
series of dilutions of the test agent in a broth medium was prepared with the 
addition of an indicator dye and inoculated with S. mutans NCTC 10449.  The 
method relied on a colour change in the pH indicator dye from red to yellow as 
the bacteria grow and produce acid as a result of their metabolic activity.  
 
S. mutans was recovered from storage and plated on TSA and incubated at 37°C 
for 48 hours aerobically.  After incubation a number of representative colonies 
were removed and placed in R+P, this was subsequently vortexed to completely 
suspend the organisms.  A stock suspension with an absorbance between 0.3 - 0.4 
at 600 nm (to equate approximately 10
8
 cfu/mL).  One millilitre of the stock 
suspension was added to 19 mL of double strength (DS) BHI with 0.01% w/v 
phenol red (Sigma) indicator to generate a suspension of approximately 10
6 
cfu/mL.  Double strength BHI was prepared by adding 74 g BHI broth (Oxoid) 
and 0.1 g phenol red indicator (Sigma) to 1 L deionised water and autoclaved at 
121°C for 15 minutes. 
 
Chlorhexidine solution was prepared by adding 0.1 mL of 20% v/v CHX (Sigma) 
to 9.9 mL sterile deionised water in 30 mL sterile containers (VWR) to generate a 
0.2% v/v stock solution.  Triclosan test solution was prepared by adding 0.5g of 
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Irgasan (Sigma) to 10 mL propylene glycol (Sigma) and left overnight in 37°C 
incubator to aid solubilisation.  Once completely solubilised, 0.5 mL of the 5% 
w/v stock solution was added to 9.5 mL sterile deionised water to create a 0.25% 
v/v stock solution. 
 
Using a 96-welled microtitre plate, 100 µL of diluting diluent; water in the case of 
CHX, and 5% propylene glycol in the case of triclosan, was added to each well 
from column 2-12.  One hundred microlitres of the test samples were added in 
duplicate to row A and B (CHX) and C and D (triclosan), this was added to both 
column 1 and 2 in both occasions.  Using a multi-channel pipette, the samples in 
column two were mixed by aspiration (x3) and 100 µL transferred to column 3.  
This method was repeated across the plate to generate a doubling dilution series, 
from the last well 100 µL was removed and discarded.  To each of the 96-wells 
100 µL of the inoculum suspension in DS BHI + 0.01% v/v phenol red was added.  
The plate was covered with titre-tops (Thermo Scientific, Waltham, MA, USA) to 
prevent dehydration and incubated overnight aerobically at 37°C on an orbital 
shaker set at 200 rpm.  Controls were carried out to ensure test organism viability, 
no residual antimicrobial activity with respect to dilution diluents, and to ensure 
no test agent interference with phenol red indicator.  MIC was recorded as the last 
well that showed no colour change as seen in Figure 84. 
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6.2.2 Bioavailability Model Developments 
The model system utilises a 96-well microtitre plate coated with HA using the 
methodology described in chapter 2, and subsequently coated with a mucin-
containing artificial saliva pellicle.  
 
S. mutans NCTC 10449 was grown from stock culture, generated as in chapter 2 
and plated on TSA and incubated at 37°C for 48 aerobically. Using a sterile loop a 
representative colony was removed and inoculated into 20 mL pre-warmed BHI 
broth, this was subsequently incubated overnight at 37°C with shaking at 200 rpm. 
After incubation, one mL of the inoculated BHI was removed and added to fresh 
pre-warmed 20 mL. This was incubated at 37°C for 3 hours to obtain cultures in 
early exponential phase growth. 
 
Test solutions of chlorhexidine digluconate (substantive compound) and triclosan 
(non-substantive compound) were prepared at concentrations ranging from 1 to 
0.001%.  The concentrations tested were 1, 0.5, 0.25, 0.125, 0.063, 0.031, 0.016, 
0.008, 0.004, 0.002, 0.001% v/v.  Sterile deionised water was used as a negative 
control.  Two hundred microlitre of the test agents and controls were added to a 
blank 96-welled microtitre plate, where each concentration was added to columns, 
thus n=8 for each sample. 
 
Artificial saliva containing mucin was manufactured (2.5g porcine stomach 
mucins, Sigma; 0.35g sodium chloride, VWR; 0.2g potassium chloride, Sigma; 
0.2g calcium chloride dehydrate, VWR; 2.0g yeast extract, Oxoid; 1.0g lab lemco 
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powder, Oxoid; 5.0g proteose peptone, Oxoid; 1.25mL 40% Urea solution, Oxoid; 
1L deionised water) and sterilised.  Once cooled, 200 µL were added to each well 
in two, 96-welled microtitre plates.  These plates were then incubated at 37°C for 
30 minutes to allow the development of a pellicle over the hydroxyapatite coating 
as seen in Figure 83.  Using a Nunc-Immunowash (12 manual plate washer fed 
with TSB and attached to an effluent bottle via a vacuum pump) the artificial 
saliva was removed, however the wells were not washed. 
Hydroxyapatite layer
Test agent 
Artificial saliva layer
Test 
Media
Waste 
Media
Microtitre plate
Nunc
Immunowash
 
Figure 83 Schematic of bioavailability method, highlighting the sequence of deposition of the 
hydroxyapatite, artificial saliva and test agent. 
 
Using a Transtar pipette (Costar), the previously plated 200 µL prepared test agent 
was transferred to the artificial coated HA-coated microtitre plates.  Each plate 
was then incubated at 37°C with shaking at 200 rpm for 2 minutes, replicating 
recommended treatment timings for most oral care products.  Using the Nunc-
immunowash again, the test samples were removed and each well washed twice 
with BHI, to remove any unbound test agent.  To one plate was added 20 µL of 
BHI + inoculum and 80 µL of 10 v/v AlamarBlue™ in BHI to each well.  This 
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plate was incubated with shaking at 37°C and fluorescence read every 20 minutes 
for 300 minutes.  Fluorescence was measured using a 530 nm excitation filter and 
590 nm emission filter.  Results are recorded as mean fluorescence units (MFU). 
 
To the second plate 20 µL BHI + inoculum was added to 180 µL of BHI.  This 
plate was incubated overnight at 37°C aerobically without shaking.  After which, 
using the Nunc-Immunowash, the broth was removed from each well and washed 
twice with sterile BHI to remove any loosely attached and unbound organisms, 
leaving the developed biofilm.  After the second wash the wells are left empty and 
to each well was added 200 µL BHI with 10% v/v AlamarBlue™.  The plate was 
subsequently incubated for a further 30 minutes aerobically at 37°C with shaking 
at 200 rpm.  Fluorescence was measured using a 530 nm excitation filter and 590 
nm emission filter. Results recorded as MFU. 
 
6.2.3 Bioplate Testing 
Using the methodology developed previously in chapter 2, using donated saliva, 
following appropriate methodologies for recovery.  Each well of a HA coated 96-
well microtitre plate was inoculated with 20 µL of the freshly prepared bacterial 
culture.  Subsequently, 180 µL of sterile BHI was added to each well, plates were 
then incubated aerobically for 24 hours at 37°C without shaking. 
 
When analysing the antimicrobial activity of test agents, the plates containing the 
test agents were prepared in advance to be readily available for use.  Test 
solutions of chlorhexidine digluconate and triclosan were prepared at 
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concentrations ranging from 1 to 0.001% v/v.  These were prepared at the 
following concentrations 1, 0.5, 0.25, 0.125, 0.063, 0.031, 0.016, 0.008, 0.004, 
0.002, 0.001% v/v.  Sterile deionised water was used as a negative control.  To 
each column on an uncoated 96-well microtitre plate was added 200 µL of the test 
agent.  This generated 8 replicates in one column for each test agents. 
  
Taking an inoculated Bioplate that has been incubated overnight, exhausted media 
from each well was removed using a Nunc-Immunowash.  Wells were washed 
(x2) using the Immunowash to remove unattached or loosely bound bacterial 
cells, thus leaving the wells of the Bioplate empty except for the developed 
biofilm.  Using a 96-Transtar pipette and the uncoated, test agent containing 96-
well plate prepared previously, which contains 200 µL of the test agents in 
columns, the test agents were transferred to the now empty Bioplate and incubated 
at 37°C for 2 minutes while shaking.  Subsequently, using the Nunc-Immunowash 
each well was washed (x2) with sterile TSB to remove traces of the test agent 
leaving the Bioplate empty.  Using an 8x multichannel pipette, 200 µL of sterile 
TSB was added to each well on the plate and re-incubated for 4 hours at 37°C.  To 
measure the viability of the biofilm, a 10% v/v solution of AlamarBlue™ in TSB 
was prepared.  After the second incubation, the Bioplate was removed from the 
incubator and each well washed twice with sterile TSB.  Using an 8x multichannel 
pipette, 200 µL of the 10% v/v AlamarBlue™ solution was added to each well.  
The plate was further incubated for 30 minutes at 37°C aerobically with shaking.  
Fluorescence was measured using a microtitre plate reader using a 530 nm 
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excitation filter and a 590 nm emission filter.  Results were recorded as mean 
fluorescence units (MFU). 
 
6.3 Results   
6.3.1 Minimum Inhibitory Concentration 
The minimum inhibitory concentration (MIC) of triclosan was found to be 20 
µg/mL (0.0020%).  The MIC of CHX was found to be 2 µg/mL (0.0002%). 
Figure 84, represents the colour change seen with phenol red indicator. All 
controls used in this methodology performed as expected. 
1        2        3        4        5        6       7       8       9       10       11       12
1 2
Unused well
S. mutans and 
5% PG control
S. mutans and 
media control 
0.25% v/v 
Triclosan
0.02% v/v 
CHX
No efficacyNo growth
1 – CHX + Media 
control
2 - Triclosan and 
media control
Figure 84 Diagrammatic representation of colour change resulting from the phenol red pH 
indicator in the MIC methodology. The MIC is reported as the last well with no growth. CHX and 
triclosan tested in duplicate.  
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Initial studies were carried out (data not shown) using a lower concentration of 
triclosan, however the MIC could not be determined using this methodology, 
therefore, the starting concentration was increased to locate the MIC, using this 
model. 
 
6.3.2 Bioavailability  
Figure 85 shows the results for the CHX dose response using the new 
bioavailability model.  This result shows the antimicrobial efficacy of bound 
CHX. Noting that the wells were washed post-CHX treatment.  
 
  
Figure 85 The effect of chlorhexidine [% v/v] dilutions on the prevention of biofilm development 
on pellicle coated HA surfaces after a two minute contact time (n=8). Bacterial viability was 
monitored for 5-hours post dosing, readings taken every 20 minutes. 
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It is seen from the water control that there was no inhibition of bacterial growth, 
metabolism or viability as measured by AlamarBlue™.  At the higher 
concentrations of CHX >0.0063% v/v it was found a clear reduction in viability a 
seen in Figure 85.  All the concentrations gave a clear dose response.  
 
However, the same dose response was not seen in with the organisms incubated 
for 24 hours and allowed to attach to the treated surfaces, where a 0.008% v/v 
CHX solution was required to prevent biofilm development 24-hours post-dosing 
Figure 86. 
 
 
Figure 86 Viability of biofilms formed on 2 minute treated HA coated surfaces with CHX dose 
response, 24-hours post-dosing (n=8). 
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The effectof CHX on 24-hour biofilms post treatment of the surface was analysed 
using a one-way analysis of variance with a factor for treatment, where p<0.05.   
 
Treatments with the same letters are not significant.  Treatments 1-8 (0.008-1% 
CHX), where treatment 1 was the positive 1% CHX control, in this study. 
Treatments 11 and 12 are statistically similar, where treatment 12 is the negative 
control water. Treatments 9 and 10 are distinct from both the positive and 
negative controls.  
 
-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Treatments   Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
1              8         450.0             A    
2              8         451.5             A    
3              8         462.875           A    
4              8         535.375           A    
6              8         643.25            A    
5              8         732.625           A    
7              8         976.25            A    
8              8         1173.5            A    
9              8         4665.13            B   
10             8         5538.38             C  
12             8         7283.5               D 
11             8         7448.63              D 
 
There was no inhibition of cell viability or biofilm development on surfaces 
treated with levels 0.004% v/v or below, 24-hours post-dosing.  There was no 
reduction in cell viability with the water control.  In Figure 85, 0.008% v/v CHX 
was shown to retain some viability, however, in the biofilm development stage of 
this model there was no viability left or signs of biofilm development on the CHX 
modified surface above that concentration.  
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In contrast to chlorhexidine, when treated with a triclosan dose response, there 
was no inhibition of bacterial viability across the concentrations tested, as seen in 
Figure 87.  
 
 
Figure 87 The effect of triclosan [% v/v] dilutions on the prevention of biofilm development on 
pellicle coated HA surfaces after a two minute contact time (n=8). Bacterial viability was 
monitored for 4-hours post dosing, with readings taken every 20 minutes. Experiment stopped at 
240 minutes due to plateau.  
 
There was found to be no reduction in viability with either the water or 5 % v/v 
propylene glycol negative control.  Five % v/v propylene glycol was added to this 
evaluation to ensure no antimicrobial or substantivity could be attributed to the 
triclosan solubilisation diluent.  This study concludes that post-triclosan exposure 
and subsequent washing, no antimicrobial efficacy was retained at the surface in 
this model was found. 
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Figure 88 Viability of biofilms formed on 2 minute treated HA coated surfaces, 24-hours post-
dosing (n=8) with triclosan dose response. All samples are statistically similar where p=0.0003. 
 
When incubated overnight to allow biofilm development on the surface, it was 
found that there was no reduction in biofilm development or viabililty with a dose 
response with triclosan as seen in Figure 88, where p=0.0003. 
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6.3.3 Bioplate Results 
A chlorhexidine dose response indicates that the concentration of chlorhexidine 
required to reduce fluorescence to background levels was 0.031% v/v, at a 
concentration of 0.004% v/v there is a clear split in efficacy from higher 
concentrations.  However, a slight decrease in CHX antimicrobial efficacy can be 
seen from 0.016% v/v.  There was no antibacterial activity at chlorhexidine 
concentrations below 0.004% v/v. 
 
Figure 89 Viability of 24-hour preformed biofilms, grown on HA coated microtitre wells, using 
the developed Bioplate methodology, post 2 minute exposure to CHX dose response (n=8). 
 
The effect of CHX on a preformed biofilm using the Bioplate methodology was 
aqnalysed using a one-way analysis of variance with a factor for treatment, where 
p<0.05.  Treatments with the same letter are not significant.  
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-------------------------------------------------------------------------------- 
Method: 95.0 percent LSD 
Treatments    Count     Mean              Homogeneous Groups 
-------------------------------------------------------------------------------- 
1              8         231.625           A      
2              8         242.0             A      
3              8         284.0             A      
4              8         619.625           AB     
5              8         1080.75            BC    
6              8         1493.25             CD   
7              8         1581.75             CD   
8              8         1804.13              D   
9              8         4820.88               E  
10             8         5747.38                F 
11             8         5985.38                F 
12             8         6123.75                F 
 
Treatments 1 – 8 (0.0013 – 2% CHX are not statistically sisimilar to each other, 
treatments 10-12 are statistically similar, where treatment 12 is the deionised 
water control. Treatment 9 is statistically distinct from the negative and positive 
control. 
 
A triclosan dose response found that, in this model there was no antimicrobial 
efficacy across all the concentrations tested.  The water negative control did not 
reduce biofilm viability and seen in Figure 90. 
 
Figure 90 Viability of 24-hour preformed biofilms, grown on HA coated microtitre wells using 
the developed Bioplate methodology, post 2 minute exposure to triclosan dose response (n=8). 
Where p=0.0190 
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The effect of triclosan on a pre-formed biofilm, using the developed Bioplate 
methodology was analysed using a one-way analysis of variance with a factor for 
treatment, where p=0.0190. 
 
The results from both studies show that in this model, where there is only a two 
minute exposure to the test agents that the model has the capacity, dependant on 
test agent under evaluations, to differentiate activity on the chemical‟s attributes. 
Either surface attached, expressing an antimicrobial effect, such at the 
substantivity seen with CHX. 
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6.4 Discussion 
Due to tightening regulations, the numbers of new and novel antimicrobials being 
developed and subsequently approved is diminishing.  This model allows the 
evaluation of „traditional‟ antimicrobials and other formulation excipents, to 
understand any possible substantivity effects.  The model also allows for the 
evaluation of excipients in the presence of antimicrobials to increase substantivity.  
This high through-put screening model gives confidence of success prior to 
entering into expensive in vivo clinical studies. 
 
The test agents utilised in this initial study, CHX and triclosan are well known 
oral antimicrobial compounds with differing substantivity profiles.  Guggenheim 
(2001) found that a 1 minute exposure to a 0.2% w/v CHX solution with 10% 
ethanol resulted in a decrease in the recovery of CFU by ≥2 order of magnitude.  
This is a greater effect than what was seen using 1% w/v triclosan in his model, 
showing an increase in efficacy of CHX in comparison with triclosan.  This study 
here also found CHX to be more antimicrobial that triclosan, in the initial MIC 
studies.  Interesting a recent study carried out by Ledder et al. (2010), shows 
triclosan to be the most antimicrobial agent in comparision to stannous fluoride 
(0.45% w/v), zinc lactate (2.5% w/v), and more surprisingly sodium dodecyl 
sulfate (1.00% w/v).  Indeed, Jenkins (1991) reported a small scale clinical 
evaluation where SDS was more effective at reducing salivary bacterial counts, 
more effectively that triclosan, but not as effectively as CHX.  However, it should 
be noted that the model utilised by Ledder et al. (2010), uses a 20 minute 
exposure time.  This is not reflective of in use recommendations for these 
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compounds in oral care products.  This bioavailability model, as show in Figure 
86 and Figure 88, has the capacity to investigate the substantivity of test agents 
after only a two minute exposure; this exposure time can easily be modified to suit 
the individual evaluations of the research. 
 
As discussed previously in the introduction, the inherent hydrophobicity of the 
test substrate will affect the bacterial attachment and subsequent biofilm 
formation.  A recent study carried out by Wang et al., (2011) showed using three 
organisms of differing hydrophobicity to attach to surfaces of differing 
hydrophobicity using Escherichia coli, Pseudomonas aeruginosa and 
Pseudomonas putida attaching to glass and octadecyltrichlorosilane modified 
glass.  This study highlights the principle that depending on the substrate, changes 
in the bacterial attachment could be made.  In this study the attachment to 
hydrophilic glass the attachment was found to be E. coli> P. putida> P. 
aeruginosa.  On the hydrophobic octadecyltrichlorosilane glass bacterial 
attachment trend was P. aeruginosa> P. putida> E. coli.   It has been reported that 
the development of a conditioning film on the test substrate in the initial step for 
biofilm formation.  Changes in the substrates can modify the conditioning film 
structure (Loeb et al., 1975).  Mittelman (1996) further discusses the effect of 
changes in the conditioning film structure in biofilm attachment and subsequent 
biofilm development. 
 
With further research and the development of a mixed microcosm, this 
substantivity screening model would have the capacity to monitor the test agent 
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ability to prevent biofilm growth in the presence of mixed species and co-
aggregated bacterial communities.  Therefore, using this assay, test agents can be 
ranked by, not only their ability to kill, but also their ability to prevent biofilm 
formation. 
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Discussion  
  
 
258 
 
As previously stated, the effects of oral biofilms on the economic, social and 
personal burden can be challenging.  It has been reported by the World Health 
Organisation, that oral disease is the 4
th
 most expensive disease to treat in 
industrialised countries, with 60-90% of school children globally suffering dental 
caries (WHO Factsheet 318, 2007).  In 2006, in England alone, the National 
Health Service spent almost £2 billion in dentistry for dental treatments and 
disease prevention, equating to around £40 per head of population (NHS Report, 
2008).   
 
The human oral cavity contains a number of different surfaces each providing a 
unique physiological environment for bacterial colonisation and biofilm (plaque) 
development. The physical removal of plaque bacteria by brushing is the main 
contributor to the maintenance of healthy teeth and gums. Increasing the numbers 
of bacteria removed and/or killed during brushing is an approach favoured by 
many healthcare companies via the addition of effective antimicrobial agents to 
oral care products. Therefore, there is an ongoing need to identify novel 
antimicrobial agents that can be incorporated into oral healthcare products e.g. 
dentifrices and mouthrinses. Thus, having the ability to efficiently and effectively 
screen actives against orally relevant biofilms is a key challenge for industry to 
help address patient‟s and consumer‟s oral care needs. 
 
As previously stated, and to reiterate, when developing an orally relevant biofilm 
model, the closer we can be to the in situ scenario, the more representative the 
results will be of the in vivo effect.  The search for new antimicrobial agents for 
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improved plaque control requires that appropriate screening models be put in 
place.  Key criteria for these models include; 
- Results should be predictive of clinical outcome 
- Orally relevant organisms (including mixed species if possible)  
- Bacteria should be present in biofilms 
- Short, relevant contact time should be used 
- Reproducible methodology 
- Rapid and high throughput (~800 screenings/year) capacity 
 
The overall aim of this research was the development of a reproducible „off-the-
shelf‟ assay to demonstrate the antimicrobial efficacy of test agents against orally 
relevant biofilms.  All of the parameters described above were considered in order 
to develop a robust and reproduciable method for the evaluation of antimicrobials, 
such that a Consumer Healthcare company could have a high volume screening 
methodology for the investigations into novel test actives for use in oral care 
products. It is envisaged that the model could be modified to produce different 
microbiota associated with oral diseases including the tongue, supragingival and 
subgingival (in particular those responsible for gingivitis) populations.  The 
research carried out here focused primarily on the generation of representative 
supragingival microbiota.  Many in vitro oral biofilm studies require the 
development of orally relevant plaque.  However, many studies focus primarily on 
single-species biofilms which do not take into consideration the multi-species 
interactions which occur in plaque (Adams et al., 2002; Luppens et al., 2008; 
Palmer et al., 2001).  In vitro biofilm structure is determined by available 
  
 
260 
 
nutrients, the substratum of the model, the organisms present and the incubation 
conditions.  Changes in any one of these parameters will affect bacterial growth 
and biofilm development, thus affecting biofilm structure.  Therefore, the initial 
aim was to grow orally relevant biofilms on a hydroxyapatite (HA) coated 
microtitre 96-well polystyrene plates.   
 
Initial evaluations revealed changes to the incubation conditions and media could 
impact bacterial viability negatively.  Once the methodology was optimised to 
retain viability, it was found that the system still lacked reproducibility, thus a 
move to a defined inoculum from salivary derived inoculum was investigated.  
Two parallel studies were undertaken that investigated the use of a defined 
inoculum based on the work by Marsh (1985) to that of pooled donated human 
saliva.  Initial molecular analysis suggests the existence of uncultured bacterial 
clones within the donated saliva, which may add to biofilm complexity, therefore, 
more closely reflecting in vivo biofilms.  However, it has been shown previously 
that the complexity of the microbiota is lost when using in vitro systems (Pratten 
et al., 2003) and there are possible problems when using such inocula in 
maintaining reproducibility.  Therefore, to further aid in the refinement of the 
model a defined inoculum was investigated.  It has been shown that the inocula 
should contain precise quantities of each strain in order to obtain a final biofilm 
with a representative consortium containing proportions of bacteria as would be 
seen in vivo (Pratten et al., 1998). Furthermore, it is envisaged that it would be 
possible to change the composition of the mixed consortia in order to replicate 
different oral microbiota.  Such studies on shifting the microbiota with dual and 
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microcosm oral biofilms have been successfully carried out previously (Dalwai et 
al., 2006).  The initial findings showed that by using the defined inocula first 
described by McKee (1985) a representative biofilm could be created in the 
microtitre plates. 
 
One of the key aspects of this model to be successful is to permit faster 
throughput, and having to grow up each bacterial species prior to testing would be 
labour intensive and cumbersome. Therefore, the defined inoculum was evaluated 
for stability up to three months at -80 C in either 5 or 10% v/v glycerol incubated 
either in an Eppendorf tube, or on the Bioplate.  The key finding was the retention 
of the mixed species viability for one month in 10% v/v glycerol. Five percent 
glycerol, showed little retention of viability over the three month stability test, in 
both the Eppendorf tube and the HA coated microtitre plate.  The method permits 
faster turnaround for testing, as the initial bacteria growth and set up has been 
removed.  This is a saving of 7 days set up before each analysis.  To truly offer an 
„off-the-shelf‟ model system it would have been preferred that the organisms 
remained viable on the HA coated plate. Further analysis looking at larger sample 
volumes during storage and increased glycerol concentration, may still offer 
opportunities to deliver pre-inoculated HA coated microtitre plates from storage. 
 
Previously, Mariscal et al. (2009) utilised resazurin dye as an indicator of 
bacterial respiration.  The author reported correlation with bacterial numbers and 
showed that it is possible to estimate bacterial counts via the generation of initial 
growth curves.  It should be noted that this method was recommended if the 
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bacterial numbers were between 1x10
3
 – 1x108 CFU for an estimate of the CFU to 
be made after 5 hours.  However, this study utilised single species.  The biofilm 
model developed as part of this PhD utilised mixed species biofilms to be more 
representative of what would be found in the oral cavity.  These differences in 
growth rates and respiration of these different organisms make this method of 
correlation between cell count and MFU unreliable in this biofilm model.  
 
To further investigate the model system it was evaluated alongside peer reviewed 
model systems currently available for modelling biofilms found in the oral cavity, 
such as the CDFF, MBEC and Sorbarod. The comparison focussed on comparing 
a number of recognised oral care antimicrobial agents, chlorhexidine, triclosan 
and zinc chloride/acetate.  Table 18 provides a summary of the models in 
comparison with one another.  The CDFF concept was originally discussed in 
1974 by Atkinson and Fowler, focussing primarily on a microbial film fermenter.  
Utilising this concept and building on research carried out by Coombe (1981), 
further model developments by Peters and Wimpenny in 1988, resulted in a model 
that would allow the development of replicate biofilms of a defined thickness.  
This model permits the development of biofilms between 50-600 µm thick due to 
the biofilms being grown in recessed pans. 
  
  
 
263 
 
 
Table 18 Comparison of model systems for oral biofilm development and subsequent 
antimicrobial analysis. 
 Developed 
Bioplate 
CDFF MBEC Sorbarod 
Capable of 
growing mixed 
species 
biofilms 
Yes Yes Yes Yes 
Peer reviewed 
with respect to 
oral bacteria 
No Yes No Yes 
Orally 
relevant 
surface 
Yes Yes No No 
Time to 
evaluate 
With frozen 
inocula – 24 
hours 
Species 
dependent 
~5days 
1 Week 2 Days 
Number of 
agents per 
evaluation 
12 7 12 1 
Replicates 8 5 biofilms 
per pan 
8 Dependent on 
set up – Three 
possible 
High 
throughput 
Approx 6 
plates daily 
No Approx 6 
plates daily 
No 
Availability Inhouse 
manufactured- 
raw materials 
easily 
available 
Only at 
academic 
institutes 
Commercially 
available 
In house 
manufactured 
Other testing 
capabilities 
Substantivity 
– see chapter 
6 
VSC, 
longitudinal 
studies, 
intermittent 
pulsing of 
the 
antimicrobial 
or antibiotic 
MIC VSC analysis 
using GC 
Dose response Yes Yes Yes Yes 
Culture Batch Continuous Batch Continuous 
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This is a closed model system where the environmental gas, medium and 
inoculum can be controlled.  The biofilms can be removed and evaluated for 
bacterial counts, architecture and antimicrobial efficacy of any test substances. 
The CDFF model system has been widely used in oral biofilm development and 
research (McBain et al., 2003; Metcalf et al., 2006; Pratten et al., 1998; Vroom et 
al., 1999; Wilson, 1990). The MBEC model was developed from the Calgary 
Biofilm Device (CBD) and developed by Ceri et al., (1999).  A key reason for 
utilising this methodology is that it is a peer reviewed, 96-well microtitre plate 
biofilm screening model.  The MBEC model system utilises both the lid, which 
contains 96 pegs, corresponding to each of the 96-wells on the base of the plate.  
Once a test inoculum is added to the microtitre plate and the plate incubated at an 
appropriate temperature and time, biofilms will form on the pegs.  The model was 
initially developed to investigate the antibiotic susceptibility of attached bacteria, 
whilst in a biofilm state. 
 
During this evaluation it was shown that against developed biofilms CHX was the 
most effective antimicrobial, with zinc chloride being the least, this was seen 
across all model systems used. Interestingly, there was little evidence in this 
anyalsis, using CDFF, MBEC, or Bioplate of zinc chloride‟s antimicrobial 
activity, however in the Sorbarod model, zinc was effective at reducing VSCs.  
Using CLSM, developed biofilms from the CDFF and Bioplate exhibited 
structural motifs of dense matrix and channels, similar to what has been reported 
previously (Hope and Wilson, 2003).  However, during the analysis, it was found, 
across all MBEC plates used, that the MFU was lower than anticipated; this is a 
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potential sign that the bacteria are not attaching and subsequently developing into 
a biofilm.  Indeed, this was confirmed with the CLSM imaging, which confirmed 
the lack of biomass on the pegs.  This model was not originally designed for use 
with oral organisms; therefore concerns exist for the use of this model with these 
organisms.  The concern arises from growing oral biofilms on non-orally relevant 
surfaces, such as polystyrene for the MBEC pegs.  It has been shown that the 
chemical and physical properties of the underlying substratum can affect the 
development of the conditioning film, including physiochemical surface 
properties, composition, density and configuration (Fletcher, 1976; Strevett and 
Chen, 2003).  Having the capability to grow biofilms on a hydroxyapatite surface 
that reflects surface characteristics similar to enamel, is paramount for the 
development of orally relevant biofilms, AFM studies have shown that the 
development of biofilms on surfaces can be monitored, indeed in the limited 
studies carried out here, showed that the technology was capable of differentiating 
organisms merely settled to the surface and those actively attached. 
 
It should also be noted that testing time taken with the Bioplate, is less than that 
required for the CDFF, MBEC and Sorbarod.  Excluding initial culturing of the 
organisms, CDFF took 5 days biofilm development and 7 days for bacterial 
recovery and counts.  The MBEC model took 5 days for biofilm development of 
anaerobic species and one day for evaluation.  In comparison, the Bioplate took 
only two days to obtain test results, thus the desire to have a high thoughput 
model capable of ~800 actives a year can be met with this model system.  
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Taking the developed model further, it was investigated whether minor 
modifications to the Bioplate model would result in a rapid screening system to 
identify novel antimicrobial agents with inherent substantive properties and 
subsequently prevent biofilm development. The survival of microorganisms in 
various environments is dependent on their ability to attach/adhere to surfaces and 
subsequently develop into a biofilm.  By modifying the surface to which the 
organisms attach, with substantive compounds, the ability of an anti-biofilm agent 
to reduce or prevent bacterial colonisation on these surfaces can be quantified.  
The desire to supplement antimicrobial activity with increased substantivity, akin 
to that seen with CHX is very desirable for oral health companies.  A number of 
models exist which have been used to investigate the efficacy of substantive 
antimicrobial agents, such as flow cells (Busscher et al., 2008), human teeth 
(Rasimick et al., 2010) and dentine disk (Carrilho et al., 2010) and in vivo 
analyses (van der Mei, 2006), whilst all these model systems are appropriate for 
the study of substantivity, due to the methodologies they employ they are cannot 
be appropriate for high through-put screening of novel actives.  Most oral care 
products specifically designed for the reduction in disease states, contain only a 
few choice actives, including chlorhexidine, triclosan and CPC.  This evaluation 
focussed on CHX and triclosan, due to their differing modes of action in the oral 
cavity; CHX and CPC have very similar substantivity and antimicrobial profiles.  
The development of a daily use substantive agent for continual antimicrobial 
activity would certainly be of interest to both oral care companies and consumers 
alike.  With further research and the development of a mixed microcosm, this 
substantivity screening model would have the capacity to monitor the test agent 
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ability to prevent biofilm growth in the presence of mixed species and co-
aggregated bacterial communities.  Therefore, using this assay, test agents can be 
ranked by, not only their ability to kill, but also their ability to prevent biofilm 
formation. 
 
In conclusion to this thesis, two models have been developed  
1. Utilising a preformed biofilm to evaluate antimicrobial activity. 
2.  Using a HA coated plate exposed to test agents to evaluate, substantivity to 
HA surface and the prevention of biofilm development on that surface. 
 
Each model, allows for a high-throughput system to evaluate a number of test 
agents, utilising defined orally relevant organisms, thus ensuring the system 
repeatability. Both systems also offer the capability to control exposure time to 
the actives. This being of important when current oral health guidance show that 
mouthwashes should be used for 30 second to 1 minute, and toothpaste for 2 
minutes (for adults).   
 
Both these model systems have been successful trained to peer microbiologists at 
GlaxoSmithKline for the rapid and high-throughput of initial antimicrobial 
efficacy, where the organisms should be present in biofilms. 
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